You get everything paid subscribers see, sleeves, gauges, calendar, performance, the Baron’s Book, plus three things nobody else does. Log in at dashboard.boredombaron.com with founding-june.

1. The full Regime Radar. A weekly, model-driven read on the mood of eleven European markets (bull, …

Read more

It’s live at dashboard.boredombaron.com. Your password is paid-june

Enter it once and it remembers you for about a month. This will be updated each month in a pinned post.

Here’s what’s behind the door:

• The machine, at a glance. NAV indexed to 100 at inception, blended yi…

Read more

I have spent a good while with the scalpel.

The patient is not dying. It is not even especially unwell. It has a cold.

And the funeral, frankly, is a buying opportunity for me.

Company: Terveystalo Oyj · Ticker: TTALO · Nasdaq Helsinki · ISIN: FI4000252127 · Price: EUR 7.03 (15 Jul 2026) · Mkt cap: approx. EUR 0.89bn · EV: approx. EUR 1.4bn

New here? The Boredom Baron hunts boring, dominant, mispriced European businesses everyone else is too impatient to value properly. Today's is a healthcare champion at a nine-year low. The first four parts are free. Subscribe (it's free) so the next teardown lands in your inbox.

What this autopsy covers

1. The panic, and a nine-year chart that should embarrass the sellers

2. The business: a national utility that happens to have a ticker

3. The SOTE reform, explained properly (the tailwind nobody prices)

4. The anatomy of the slump: three cyclical excuses in a lab coat

5. Quality under the hood: ROIC and a five-step DuPont

6. The IFRS-16 illusion: why the earnings line lies to you

7. Long-term EPS and free cash flow: the real earning power

8. The dividend, traced over time and mapped against cash

9. The balance sheet, sturdier than the net-debt number pretends

10. Valuation: what you pay, what it is worth, versus peers

11. The bear case: nine attacks, each answered at length, two with charts

12. My valuation ramblings: deriving every price, bear, base and bull

13. Why I changed my mind, and the call

How to lose a year of gains before the afternoon coffee

At half past three on the afternoon of 15 July 2026, Terveystalo cleared its corporate throat and filed a profit warning as inside information, six weeks ahead of its scheduled half-year report. It trimmed full-year adjusted EBIT guidance to EUR 120 to 140 million, down from EUR 135 to 165 million, a new range that sits entirely below the EUR 156.3 million the company actually earned in 2025. The market, which had apparently persuaded itself that a private healthcare provider would be immune to the common cold, responded with the emotional maturity of a toddler denied a biscuit: it knocked 7.38% off the shares in a single session, to EUR 7.03, on roughly seven times the normal trading volume.

Now, a 13% cut to one year’s profit guidance is a genuine disappointment. It is not, however, a reason to reprice a national healthcare champion as damaged goods. To see just how disproportionate the reaction has been, widen the lens all the way back to the 2017 initial public offering and look at what nine years of Terveystalo actually looks like.

Two features of that chart should stop a value investor in their tracks. First, this business made an all-time high fourteen months ago. Structurally broken companies do not tend to set records the year before they collapse; cyclical ones do exactly this, lurching between euphoria and despair while the underlying franchise plods on unchanged. Second, at EUR 7.03 you are being offered the number-one private healthcare provider in Finland for less than the people who bought the 2017 IPO paid, and that is before you pocket nine years of dividends. Either this company has quietly rotted for the better part of a decade, a thesis the numbers we are about to examine flatly reject, or the market periodically loses its nerve about a resilient, dominant, structurally-favored franchise and marks it to a silly price. This entire piece is an argument, exhaustively evidenced, for the second interpretation.

One housekeeping note before we open the chest cavity. The pitch that landed on my desk quoted a market capitalization of about EUR 1.15 billion. At EUR 7.03 across 126.8 million shares, the real figure is nearer EUR 0.89 billion. The larger number is a fossil from a higher price. I mention it not to be pedantic (well, not only to be pedantic) but because the whole game is what you pay today, and the stock is a good deal cheaper than the write-up believed.

A national utility that happens to have a ticker

Terveystalo will never trend. There will be no breathless documentary, no founder cult, no product launch queued around the block. Thank goodness. It is the largest private healthcare provider in Finland by revenue, and it is not a close contest. It operates the widest clinic network in the country, employs roughly 14,400 healthcare professionals, and runs a digital front door that around 2.7 million people actually use, in a nation of 5.6 million. When roughly half your compatriots have your medical app installed, you have stopped being a company and become a piece of national infrastructure with a stock quote attached.

The beating heart of the franchise is occupational health: the corporate-funded, effectively state-encouraged system by which Finnish employers provide healthcare to their staff. This is contracted, recurring, sticky revenue of precisely the sort this newsletter was founded to venerate. Employers are obliged to arrange occupational healthcare, and most buy it from private clinics; Terveystalo is the market leader. Wrapped around that core sit a growing public-partnership business (private clinics delivering publicly-funded care), a Swedish operation, and a portfolio of adjacent services. Management now frames the group around three strategic buckets: Healthcare Services for profitable growth, Portfolio Businesses for turnaround, and Sweden for turnaround and public-market opportunity.

The corporate biography is a familiar carousel. Founded in 2001, the business was taken private by Bridgepoint, delisted, then owned by EQT before its 2017 flotation, which was the largest Finnish IPO since 1998. Today the shareholder register reads like a directory of the least excitable money in Europe: the mutual pension insurer Varma sits at around 17%, alongside Rettig Group, Hartwall Capital, Pohjola and OP, with institutions owning the clear majority. This is not a slight. Patient, long-horizon Finnish institutions are exactly the owners you want for a business whose entire charm is that nothing dramatic is supposed to happen to it. When the stock does something dramatic anyway, as it just has, it is usually the price that has gone wrong, not the company.

The financial signature of all this dominance is a revenue line so stable it is almost soporific. Group revenue has sat between EUR 1.15 billion and EUR 1.34 billion in every single year since 2021. What actually moves, and what has just triggered the collective swoon, is the margin.

Management has not exactly sat on its hands, either. Alongside the recent weakness it launched a EUR 50 million annualized profit-improvement program, a cost-and-efficiency drive that provides a self-help lever for margins even if demand takes its time returning. In a business this dominant, with this much fixed cost, a EUR 50 million structural cost-out on a EUR 130 to 156 million EBIT base is not a rounding error. It is a meaningful chunk of the recovery, and it is within management’s own control rather than dependent on the Finnish weather.

The tailwind nobody bothers to price

If the demand slump is the cyclical bad news dominating the headlines, the structural news is quietly, unglamorously excellent, which is precisely why nobody is shouting about it. To understand it you need to understand Finland’s healthcare reform, the so-called SOTE reform, in a bit more depth than a ticker-watcher ever will. So indulge me.

In January 2023, Finland executed the largest administrative overhaul in its modern history, transferring responsibility for health, social care and rescue services from 300-odd municipalities to 21 regional wellbeing services counties (the hyvinvointialueet), plus Helsinki. The point of the reform was to put healthcare organization on a footing large enough to cope with an aging population and to even out the wild variation in service quality between a rich southern city and a sparse northern municipality. For our purposes, the salient fact is this: these counties are explicitly permitted to procure services from private companies, and private providers already supply more than a quarter of all social and health services in the country.

Here is where it gets interesting for a Terveystalo shareholder. The counties are drowning. They inherited enormous care backlogs, a chronic shortage of doctors and nurses, and a statutory obligation to hit treatment-guarantee deadlines. Faced with that, they have been forced to lean heavily on outsourced private capacity to clear waiting lists, because they simply cannot hire fast enough to do it in-house. The political direction of travel under the current government has been to remove the barriers that constrain counties from buying private capacity, not to erect them, and to broaden the machinery of patient choice. Terveystalo’s own operating-environment disclosures point to a freedom-of-choice pilot for over-65s, launched in September 2025, which had already generated roughly 50,500 visits at Terveystalo by the end of March 2026, at high satisfaction. That is a brand-new, publicly-funded, privately-delivered revenue channel opening up while everyone stares at the flu chart.

On top of the reform, the reimbursement regime is being widened rather than cut. The 2025 changes to Kela reimbursement (Kela being Finland’s social insurance institution, which partially reimburses patients for private care) expanded the range of eligible services, from ophthalmology to gynecology to mental health. More reimbursable services means more affordable private care means more volume for the dominant private provider. It is not complicated.

And underneath the reform sits the slowest, most powerful tide of all: demographics. This is not a forecast that requires courage. It requires only that Finns keep aging, which they will.

So tally the structural ledger. An aging population that consumes ever more care. A public system so overstretched it is being told, by its own government, to outsource more. A reimbursement regime being broadened. And a dominant private operator sitting at the confluence of all three. That is not the profile of a business in secular decline. That is a business enjoying a genuine structural tailwind while the market fixates, myopically, on a single soft quarter. Confusing a cyclical dip with a structural break is the single most expensive error in equity investing, and the market is committing it in Terveystalo in real time, on camera, for our benefit.

Three cyclical excuses wearing a lab coat

Let us actually read the profit warning, which is more than the tape appears to have managed. Management attributed the miss to three causes, and each is so aggressively cyclical it verges on comedy. First, a mild respiratory-infection season: fewer coughs, colds and flus, therefore fewer occupational-health visits, that being the bread and butter of the corporate contracts. Second, cautious corporates trimming discretionary health spending as the Finnish economy sulks and unemployment ticks up. Third, excess industry capacity stoking price competition on new contract tenders. Recovery, they added, has begun but will arrive in the second half rather than immediately.

Notice what is gloriously absent from that list. No new competitor is stealing the franchise. No regulator is dismantling the model, indeed the regulator is quietly helping, as we just saw. There is no structural flight from private healthcare, no technological disruption, no balance-sheet emergency. Every named cause is, functionally, a weather report. A cold winter, a flicker of corporate confidence, or simply the industry rationalizing its own excess capacity, and the occupational-health volume walks back through the door it left by.

In fairness to the bears, and I do try to be fair to the bears, this is not a one-quarter wobble. It has been a slow, grinding disappointment, and honesty requires me to show it in its full, unflattering glory.

The second quarter, the one that finally tipped management into the warning, is where the demand shortfall collided head-on with a cost base built for busier clinics.

And here, finally, is the guidance cut that touched off the stampede, drawn so you can appreciate how small a revision produced how large a tantrum.

The setup is free. The verdict, and the arithmetic behind it, is for subscribers.

That is the background, and it is a genuinely interesting one: Finland’s dominant private-healthcare franchise, a national utility with a two-decade moat, marked down below its own 2017 IPO price because Finns had a mild flu season and their employers turned cautious. The demand dip is real but cyclical; the structural tailwinds are real and ignored. A fascinating setup. It is not yet a thesis.

Because a dominant, cheap-looking business in a cyclical trough is precisely where value investors earn their finest returns or lose their shirts, and the entire difference comes down to three questions the market is currently getting wrong:

• Is this actually a good business, or merely a big one? The reported return on capital says “fine.” The real operating return is north of 40%, and I will show you exactly why the headline number hides it.

• Is that 9% dividend a gift or a trap? The market is certain it is a trap. The market is misreading a single lease-accounting quirk, and I will walk you through the mechanics until it is obvious.

• Is it genuinely cheap, and what is it actually worth? Six times cash flow against peers at eleven, with a full three-scenario valuation, every price derived out loud, the arithmetic left on the page.

Everything below answers those three in detail, then spends three thousand words trying to demolish its own conclusion across nine separate bear attacks, before landing on a verdict and a price. That is the work the sell-side charges a fortune for and still gets wrong. Here it costs less than a coffee a week, and I show every step.

If the boring, dominant, mispriced businesses everyone else is too impatient to value properly are your idea of a good time, that is the entire reason The Boredom Baron exists. Subscribe, and let me show you what it is worth.

You already get The Boredom Baron in your inbox, so you know I show my work. Everything below is the part I reserve for paid members: why the real return on capital is north of 40%, why the "dangerous" 9% dividend is nothing of the sort, what the business is actually worth across three scenarios, and nine attempts to blow up my own Buy call. You are one click from all of it. Upgrade, and read the verdict.

Read more

Company: Kardex Holding AG · Ticker: KARN (SIX Swiss Exchange) · ISIN: CH0100837282 · Price: CHF 237 (13 Jul 2026) · Mkt cap: approx. CHF 1.83bn

Regular readers will remember Kardex from The Giant Vending Machine Company, published here in March at CHF 250. Short version, for anyone who was busy: Kardex builds the enclosed, room-height machines that fetch inventory out of a warehouse and hand it to a human in under twelve seconds.

Boring, essential, dominant, debt-free, and compounding.

I liked it.

I still like it.

What I said, in as many words, was that I wanted to see the half-year results confirm that margins were holding before I would call it a high-conviction buy.

Management has now saved me the wait. On 8 June, six weeks ahead of the scheduled report, they issued a profit warning. The stock fell as much as 23% during the day and closed down 12%. I want to walk through exactly what changed, why the margin evaporated, and, because this is the part everybody skips, what would actually have to happen for it to return. That last question is where I have spent most of my time, so that is where this note spends most of its words.

What happened on 8 June

Between the annual meeting and the half-year report, in the quiet part of the calendar when companies hope nobody is looking, Kardex published an ad-hoc “business update.” The word “update” is carrying a great deal of weight there. The market read it, did the arithmetic, and removed roughly a fifth of the company’s value before lunch.

Here is what made it interesting rather than merely bad. Management did two contradictory things in the same sentence. They raised the outlook for full-year orders and revenue to growth of 15-20%, which is faster than the plan. And they cut the outlook for the full-year EBIT margin to 8-10%, well under the roughly 12% the market had been carrying, and under the 11.9% the company itself delivered in 2025. First-half operating profit, they added, would land at about 60% of last year’s.

Selling more and earning less is a genuinely unusual thing to announce, and it is worth being precise about why it happened, because the reason is the entire investment case in miniature. In the company’s own careful phrasing, the culprit is an “elevated cost base to enable the growth trajectory combined with the temporary lower volume for Automated Products.” Allow me to translate from the corporate. They hired a lot of people and built a lot of cost in 2024 and 2025 to chase a bigger future. The high-margin part of the business that was supposed to pay for all that then went soft. Costs showed up on time. The profitable revenue did not. That is the whole of it.

The margin question, taken seriously

This is the section you came for, and it is the section I would have wanted before the warning rather than after. It runs four questions and one reality check.

1. Why was this predictable?

2. What actually broke?

3. Is this even a Kardex problem, or does the whole industry have it?

4. When, realistically, does the margin come back? And what if it does not?

I will take them in order, and I will try to give you numbers rather than adjectives.

1. Why nobody sensible should have been surprised

Kardex is not one business. It is two businesses wearing a single share price, and they could hardly be less alike.

1. The first, Automated Products (the Remstar vertical lift modules), is the crown jewel: it earned a 16.1% EBIT margin on CHF 572.8m of 2025 revenue.

2. The second, Standardized Systems (the Mlog high-bay warehouses, the AutoStore integration work, and the newly acquired Rocket shuttle business), is the growth engine, and it earned all of 5.0% on CHF 278.1m.

The group number you see reported, 11.9%, is simply a weighted blend of a lovely 16% business and a thin 5% one.

Now hold that picture and add one fact: the thin 5% business is growing far faster than the fat 16% one. In the second half of 2025, Standardized Systems orders grew 66% year on year, while Automated Products revenue actually fell 1% on weak US demand. When the low-margin half of a company expands and the high-margin half stalls, the blended margin has exactly one direction it can go, and it is not up.

This is not a subtle, hindsight-only insight.

It was the central tension I flagged in March, it was risk number four on my own list, and it was sitting in plain sight in the segment tables.

The mix was always going to press on margins. The only open questions were how hard and how soon.

2. The tell hiding in the 2025 accounts

Mix drift is slow and structural. It does not, by itself, produce a one-day 12% air pocket. For that you need the second ingredient, and it was disclosed months ago for anyone who bothered to read past the headline.

In late 2024, Kardex launched what it grandly calls a “strategic growth initiative,” which is corporate for hiring a great many people and asking you not to look too closely at the margin while they settle in. The initiative is a real and defensible idea: spend now on salespeople, marketing, IT, and R&D to reach CHF 1.5bn of revenue by 2029-2031. The trouble is the phasing. Look at what the 2025 accounts actually recorded. Revenue grew 7.5%. Headcount grew 10.4%, to 2,957 people. Operating expenses climbed to CHF 188.7m on “significantly higher sales and marketing expenses, as well as R&D and digitalization costs.” When your payroll grows half again as fast as your sales, you are not compounding, you are pre-committing. You are betting that the revenue arrives before the accountants do.

So … the 8 June warning was not a bolt from a clear sky. It was the meeting of a known structural drift (mix) with a known, self-inflicted timing problem (a cost base built ahead of the revenue), triggered by a soft patch in exactly the segment I had flagged as the one to watch. The only people entitled to be shocked were the ones who had not been paying attention.

Which, based on where the consensus margin sat on 7 June, was most of them.

The analysts spent March typing “12%” into their models because the company told them to, and spent June retyping “9%” because the company told them to. Somewhere in between, the actual reading of the accounts was skipped.

And here is the detail that should sharpen your view of management, not the business: at the March results, management themselves said the medium-term margin target of 10-14% “should apply for 2026.” Twelve weeks later they cut 2026 to 8-10%, below the very range they had just endorsed. A guidance range is supposed to have a longer shelf life than a carton of milk. This one did not survive the quarter. The business did nothing dishonest; it simply demonstrated that its own near-term forecasts are worth roughly what you paid for them.

3. Now zoom out: is this Kardex, or the whole neighborhood?

A margin problem reads very differently depending on whether your competitors have it too, so I went and checked the neighbors. The answer is clarifying. Kardex is not an outlier having a bad year. It is a company being dragged along by the physics of its own industry, and once you can see the shape of that industry the whole episode makes more sense and, frankly, reads far less like a scandal.

Intralogistics profitability is bimodal, which is a polite way of saying there are two kinds of company and almost nothing in between. Own the product or the intellectual property and you earn a lovely margin: Interroll runs a 16.6% operating margin, Japan’s Daifuku 15.2%, and AutoStore, which licenses the cube-storage grid, an eye-watering 32%. Integrate other people’s kit into big bespoke systems, or sell forklifts, and you earn a thin one: KION makes 6.4%, Jungheinrich 4.4%, and Symbotic, the US automation darling that grew revenue 26% last year, contrives to lose money outright.

Share

Now find Kardex on that chart, because it sits in both camps at once. Its Remstar business, at 16.1%, belongs with Interroll and Daifuku among the aristocrats. Its Standardized Systems arm, at 5.0%, belongs with KION and Jungheinrich among the strivers. The group number you fret over is just the weighted average of an aristocrat and a striver sharing a balance sheet. This reframes the whole worry. Kardex is not bad at systems integration. Systems integration is a 5% business for everybody who does it. The real question was never “can Kardex fix its systems margin,” it was “how much of Kardex would you like sitting in the 5% half of its own industry,” and since that half is the one growing fastest, the honest answer is “a little more every year.” That is the mix drift, drawn for you in six other companies’ accounts.

There is a wry footnote worth pausing on. AutoStore earns 32% because it owns the product. Kardex, as AutoStore’s integrator, captures only the thin integration slice of that same sale, never the fat product margin. Kardex does the labor while someone else banks the rent on the intellectual property. That, in a sentence, is why the company bought Rocket Solution (to finally own a product of its own instead of forever installing everyone else’s), and why I put the AutoStore dependency at the top of my risk list in March.

The margin structure of the industry and the strategic case for Kardex are the same fact wearing two hats.

The second piece of outside context is the cycle, and it is genuinely reassuring. The whole warehouse-automation sector had a pandemic boom and a long hangover after it. Industry revenue grew roughly 1% in 2024 as customers, spooked by high rates and a limp industrial economy, sat on their hands, and order intake is only now forecast to recover around 7%. If that pattern sounds familiar it should, because KION just reported 2025 revenue down 1.8% while order intake rose “considerably”, which is the identical shape to Kardex: orders up, revenue soft. The “temporary lower volume for Automated Products” that Kardex confessed to is not a Kardex-specific sin. It is the entire sector exhaling after a capex binge, and it has just started to breathe in again.

So what does the neighborhood tell us about when Kardex’s margin heals? Two things, one hopeful and one sobering, and they map precisely onto the timelines below. The hopeful part: the volume half of the problem is cyclical and industry-wide, and the cycle has already turned up, so the revenue that fills the cost base is plausibly on its way. The sobering part: the structural half, the mix, is set by the same iron industry economics that cap every integrator at single digits, and no quantity of management confidence repeals arithmetic. Which brings us, at last, to the question everyone actually opened this email to have answered.

4. When, if ever, does the margin come back?

This is the question that matters, and the honest answer has three separate timelines living inside it. Let me give you all three, with the arithmetic, and let you weight them yourself.

Timeline one: the deliberate trough (2026). The most charitable and, I think, most likely reading is that 2026 is the bottom of a J-curve the company chose to dig. The growth spending is now largely in the run-rate. It does not have to be spent again. Management insists Automated Products bookings have been rising since March, and the record Standardized Systems backlog of CHF 345.6m has to convert into revenue eventually. If the high-margin volume simply normalizes against a cost base that is already built, the margin mechanically improves, because you are adding revenue without adding much cost. That is the definition of operating leverage, and it is the entire bull case in one sentence.

Timeline two: the cyclical base rate (history). Zoom out and the panic subsides a little. Kardex margins have always been cyclical. They sat in the low teens through 2019-2021, collapsed to 9.6% in the 2022 supply-chain shock, and were back above 12% within two years. The 2026 dip to roughly 9% is, on this view, simply the third trough in a decade, this time self-administered rather than imposed by the world. Reversion to the low-teens is the base rate for this company, not the exception. The balance sheet (zero debt, roughly CHF 150m of net cash) means it has all the time in the world to let the cycle turn. Nobody is forcing this hand.

Timeline three: the structural cap (the uncomfortable one). Here is the caveat the bulls gloss over. Even if both segments hit their own targets, the mix has permanently changed. Do the blend: put Remstar at the middle of its 14-17% range and Standardized Systems at the middle of its 5-8% range, then let Standardized Systems keep gaining share, and the group settles nearer the bottom of that 10-14% band than the top. In other words, “recovery” most likely means a return to 11-12%, not to the 13.1% peak of 2024. The lovely 13% print that helped justify a premium multiple may simply not be available again at this mix. That is not a disaster. But if you are underwriting a re-rating on the assumption that the old peak margin returns, you are underwriting the wrong number.

Put the three together and my honest conclusion is this. The margin very probably recovers, because the cost base is built and the volume is coming and the history says troughs are temporary. But “recovers” means back into the low-teens, not back to the top, and the timing is a 2027 story at the earliest, entirely contingent on a second-half 2026 turn that, as of today, exists only in a press release.

The single most important sentence in the whole warning is management’s promise of a “materially stronger and more profitable” second half.

They always say that.

The second half is where corporate hope goes to live. I will believe it on 30 July, when I can see it, and not a day sooner.

Does the thesis change?

Let me steelman the bear first, because that is the honest order. The bear says this is a quality de-rating in slow motion: a company awarded a 25-30x multiple for “elite, resilient margins” has just shown that its margins are neither as high nor as resilient as advertised the moment the mix turns, and that its management will cheerfully cut its own guidance inside a quarter. On that reading, Kardex is a good-but-cyclical mid-cap that got priced like a serene compounder, and the price has some way still to fall toward reality.

The bull, to which I lean, says the market is confusing a timing problem for a quality problem. The machine is unchanged. Demand is strong enough that management raised the growth outlook. The balance sheet is a fortress. The service flywheel on 140,000 installed machines keeps turning regardless of the order book. The entire miss is a self-inflicted, front-loaded investment that will annualize away, and the mid-term targets were explicitly reaffirmed. Nothing here says the business is worse. It says the schedule is worse, and the market, quite reasonably, has stopped paying in advance.

The business did not get worse on 8 June. The timetable did. And a market that spent two years paying for certainty has abruptly remembered that it was only ever buying a forecast.

So the thesis is not broken. It is delayed, and it is de-risked in one specific and useful way: we no longer have to wonder whether the half-year will confirm the margin inflection. It will not, because management has told us so. That moves the real question off the business and onto the price, which is convenient, because the price is where the genuine surprise is hiding.

Subscribe now

My Valuation Ramblings

Every so often the market hands you a small lesson in why a falling share price and a cheaper share are not the same thing, and Kardex has just delivered a textbook example. Follow along, because it is almost funny.

The stock fell 12% on the warning. A reasonable person, seeing a 12% drop on a business they already admired, thinks: good, it got cheaper, let me look.

But the shares have since clawed back to CHF 237, which is only about 5% below where I wrote them up in March.

Meanwhile, the analysts have cut their 2026 earnings estimate from roughly CHF 10.23 to CHF 8.12, a haircut of about 21%.

When the price falls less than the earnings, the multiple does not contract. It expands. The bad news made the stock more expensive.

Run the tape at today’s CHF 237. You are paying about 29 times this year’s earnings, on a number the company has openly labeled depressed. You are paying about 20 times next year’s estimate, which is only reasonable if the recovery I described above actually lands on schedule, and which puts every chip on 2027. On enterprise value you are at roughly 15.6 times trailing EBITDA and a bit over two times sales, which are full, confident, growth-company multiples for a business that has just guided to a single-digit operating margin. The 2.7% dividend, covered and backed by net cash, is the one genuinely comforting number in the paragraph, and it is comforting precisely because it tells you the downside is contained, not that the upside is cheap.

Here is where I land, and it is the same place my March self was standing, only with more evidence.

This is not a deep-value situation and I am not going to insult you by dressing it up as one. There is no fat margin of safety in the multiple. The margin of safety, such as it is, lives entirely in the quality: the debt-free balance sheet, the net cash, the 140,000-machine service annuity, the genuine market leadership.

That is a real floor.

It is not a reason to overpay for the ceiling.

And at 29 times a knowingly poor number, two weeks ahead of a report management has already warned will be ugly, with the forward multiple having gone up rather than down since the last time I looked, you are being asked to pre-pay for a recovery that has not started, at a price that has barely acknowledged the problem.

I decline. Not forever. Just not here, and not yet.

The beautiful thing about this particular decision is how cheap patience is. The half-year report lands on 30 July. Waiting two weeks for it costs me almost nothing and removes almost all of the guesswork. If you must own something before then, own the question, not the stock.

What would move me to buy

• The 30 July report confirms the turn. Automated Products bookings genuinely re-accelerating, the 8-10% margin floor held rather than cut again, and hard evidence the cost base has peaked. Show me the inflection, not the adjective.

• Or a real capitulation in the price. A wash-out back toward the June low and below, call it CHF 200 or perhaps 190, would finally price in the reset and hand me the margin of safety that CHF 237 does not.

• Either way, the print comes first. Two weeks of patience against a pre-flagged bad number is the easiest edge on the table. I intend to take it.

Sincerely,

The Boredom Baron

Subscribe now

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Disclaimer:

The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments.

While I strive for accuracy, the information presented may contain errors or omissions, or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented.

This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice.

This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment decisions.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Sources and key data. Kardex ad-hoc, “Business update: Kardex adjusts its EBIT forecast for 2026,” EQS-News, 8 Jun 2026 and TradingView. FY2025 results and segment margins: Kardex Financial Results 2025 and second-half order-growth coverage. Original deep-dive: The Boredom Baron, 16 Mar 2026. Prices, fundamentals, and consensus EPS from EODHD (KARN.SW, retrieved 14 Jul 2026); half-year and annual figures from Kardex Holding AG reporting via its investor relations page.

Not investment advice. The

Boredom Baron publishes editorial research and opinion for information and entertainment. “Buy / Watchlist / Discard” are editorial coverage labels reflecting one writer’s view, not personalized financial advice or a recommendation to transact in any security. Small and mid-cap shares are volatile and can be illiquid, and you can lose money. Figures are drawn from third-party data providers and company filings and may contain errors or become stale, so verify everything against primary sources before making any decision, and consult a licensed adviser. The author may hold positions in the securities mentioned. Do your own homework.

The one-line answer, up front

TP ICAP goes on the watchlist, not into the book, at 350p. The business is far better than its dreary label, the hidden value is real and I have measured it, and I want to own it. Just not here: not at a 52-week high, not sitting bang on the average analyst target, and not while management keeps “reviewing options” on the one event that would unlock the value.

Here is the whole thesis in a breath. The market prices TP ICAP as what it mostly is: the world’s largest interdealer broker, a mature, people-heavy, agency middleman that arranges over-the-counter trades between banks for a commission. On that reading it is cheap but dull, 10x forward earnings, a 4.8% dividend, buying back its own shares. What that reading skates past is that roughly a fifth of the group’s profit comes from Parameta Solutions, a subscription data business with a 37.6% margin, 97% recurring revenue and an estimated 70% share of a market nobody else can supply. Value Parameta as the data company it is, value the broker as the broker it is, and the sum is worth meaningfully more than the whole. The market applies one multiple where it plainly should apply two. That is a textbook Confession Lag, and there is even a defined catalyst, a potential US listing of Parameta, to force the confession.

So why is it only a watchlist name? Because our edge is buying hated things at insulting prices, and this is neither hated nor insultingly priced. The stock is at its 52-week high. It trades on the analyst target, not at a discount to it. At roughly £2.5bn it is over our usual size ceiling and followed by seven brokers, which is about seven more than we like. And the catalyst has been “coming soon” for two years. None of that makes it a bad company. It makes it a good company at a fair price, which is a lovely thing to admire and a poor thing to overpay for. Below, I earn every word of that, and I give you the two triggers that would move it from the watchlist into the portfolio.

First, why this one and not the other.

Two ways to rent flow, and why only one is an investment

Both names make money from the flow of trades, and both look cheap. They are opposites in every way that matters to us.

Flow Traders is a principal market-maker: it quotes two-sided prices on exchange-traded products and pockets the spread, on its own book, at high frequency. It is well run, optically cheap (a forward P/E in the 7-9x range), genuinely under-covered, and comfortably inside our size band at about €1.2bn. On the screen it is exactly our kind of name. On the process, it fails almost every test we care about. Market-making has no customer switching costs; liquidity is fungible and awarded on price. There is nothing specced in, no qualification moat, no recurring revenue, just a capital-and-speed arms race. And Flow is a thoroughbred in a race Jane Street and Citadel finished several laps ago: its net trading income crawled to €486m in 2025, while Jane Street’s trading revenue went from roughly $10bn to nearly $40bn in two years. Flow’s earnings are a leveraged bet on a volatility level nobody can forecast, dressed up as a compounder. Cheap, yes. Cheap for a reason a five-year-old could read off the page.

TP ICAP is the opposite animal: a plodding agency intermediary with a genuinely embedded asset buried inside it. It fails our screen (too big, too followed) but it passes the process. And when the screen and the process disagree, the process wins, because the screen only tells you where to look; the process tells you what is actually worth owning. So I put the pretty screen fit down and picked up the ugly franchise. Here is what it actually is.

What you are actually buying

Figure 1. Left for dead as a voice broker in 2022, the stock has quietly risen about 20% in the last year to a 52-week high. The re-rating from the lows has already happened, which is precisely why this is a watchlist name and not a buy today. Source: EODHD end-of-day price data (TCAP.LSE).

TP ICAP runs four businesses. The FY2025 results lay them out cleanly:

• Global Broking, the voice-and-hybrid interdealer core, arranging OTC trades in rates, credit, FX and equities. £1,376m of revenue (58% of the group) and £241m of adjusted EBIT, up a chunky 18% on a record year for volatility.

• Energy & Commodities, broking in oil, power and gas. £449m of revenue, but adjusted EBIT down 27% to £41m in a deliberate broker-hiring investment year.

• Liquidnet, agency equity execution and block trading, a network business. £365m of revenue, £56m of adjusted EBIT.

• Parameta Solutions, OTC market data. £202m of revenue, £76m of adjusted EBIT, a 37.6% margin. This is the one that earns the whole company a second look.

Figure 2. Parameta is 9% of revenue but 22% of profit, and it earns a margin the three broking businesses can only dream about. The non-broking businesses (Liquidnet plus Parameta) are now 38% of group adjusted EBIT, up from under 30% two years ago. Source: TP ICAP FY2025 results.

Zoom out … and the group is a boring compounder wearing a boring label, which is the most Boredom Baron sentence I will write all week. Adjusted EBIT has grown from £233m in 2021 to £348m in 2025, roughly 9% a year, on revenue that has climbed steadily past £2.35bn. This is not a melting ice cube. It is a franchise that quietly gets a little bigger and a little more profitable most years, and gets absolutely no credit for the habit.

Figure 3. The unglamorous truth: adjusted EBIT compounding about 9% a year since 2021. Source: TP ICAP results and consensus history.

The catch, and the reason the market shrugs, is that this is a people business with a razor-thin margin. Of £2,353m of revenue, the overwhelming majority walks straight back out the door as front-office broker compensation. Only £348m survives as adjusted EBIT, a 14.8% margin, and only £186m lands at the bottom as earnings attributable to shareholders. Voice broking is labour-intensive and slowly electronifying, so the market files the whole company under “structurally-challenged intermediary” and moves along without looking inside. That incuriosity is the opportunity.

Figure 4. Where every pound of revenue goes. Broker pay dominates and the margin is thin. This is why the market prices the group like a commodity broker, and why it misses the one business inside it that is nothing of the sort. Source: TP ICAP FY2025 results (front-office/management cost split estimated on industry norms).

The business the market refuses to price

Parameta sells proprietary OTC price data, and here is why that is different in kind from everything around it. Over-the-counter markets are opaque by construction: no exchange tape, no public print. The only people who know where a rates swap or a credit instrument actually changed hands are the brokers who arranged the trade. Parameta is the exclusive data arm of TP ICAP’s broking brands (ICAP, Tullett Prebon and PVM), which means it sells data that, quite literally, exists nowhere else. Clients wire that data into valuation engines, risk systems, price-discovery tools and regulatory-compliance plumbing. Once it is in those workflows it does not come out: 97% of Parameta’s revenue is subscription, and management puts its share of the OTC interdealer data market at around 70%.

That is the embeddedness I hunt for, wearing a pinstripe instead of a hard hat: mission-critical, hard to replicate, specced into the customer’s own processes, with high switching costs. It is also, for once, genuinely AI-resistant, because you cannot train a model to reproduce a dataset that was never public to begin with.

Now the part a promoter would leave out. Parameta is not a rocket. In FY2025 revenue grew a mere 5% at constant currency (2% reported), and the margin actually fell, from 41.9% to 37.6%, as the division spent on its sales force and new products. This is a high-quality subscription utility that grows a touch faster than GDP, not a hyper-grower, and anyone selling you the second story is selling you something. It matters enormously for how much you can honestly pay, and I will not pretend otherwise when we reach the valuation.

Figure 5. The jewel, warts and all: 97% subscription and about 70% share, but revenue grew just 5% and the margin slipped from 41.9% to 37.6% last year as Parameta reinvested in its sales force and new products. Source: TP ICAP FY2025 and FY2024 results.

The catalyst, and why it keeps slipping

A hidden asset only closes the gap if something forces the market to look at it. Here that something has a name: a US minority listing of Parameta, floated by management to “establish a baseline value” for shareholders while the group keeps a long-term majority stake. About 93% of Parameta’s revenue is US-dollar-denominated and most of its listed comparables are American, so the venue makes sense.

The timing, less so. It was first floated in August 2024. By the FY2024 results in March 2025 management reckoned a listing “could occur as early as Q2 2025.” Q2 2025 came and went and produced precisely nothing. By the FY2025 results in March 2026 the language had wilted to a review that “remains challenging.” Two years of “strategic options” is not a catalyst; it is a support group. This is the single biggest risk to the thesis, and I am not going to bury it in a footnote: you cannot underwrite a catalyst that management keeps quietly moving to next year.

Figure 6. Two years of “we’re thinking about it.” The next hard checkpoint is the H1 2026 results on 6 August 2026, and the listing paragraph is the only one that matters. Source: TP ICAP RNS announcements.

Two things keep the name on the list despite the dithering. First, the business is not waiting for permission: Q1 2026 delivered record revenue of £689m, up 13%, and the board pronounced itself “comfortable with the outlook.” Second, even if the listing never comes, the sum-of-the-parts gap is real at today’s price, not just at the lows, as I will now show. Real value plus no catalyst is a waiting game. That is exactly what a watchlist is for.

The rest of this note is where the money is: the eight numbers that define the name, the sum-of-the-parts arithmetic that measures exactly how much hidden value sits in the stub, the three-point scenario that frames the return, the bear case stated at full strength, and the two triggers that would take this off the watchlist and into the book. If you remember one picture from this piece, make it the one two scrolls down: what you pay versus what the parts are worth.

Read more

Read more

So I put the numbers under scrutiny, which is the part the briefing outsources to me. What follows is what the machine got right, and the rather large thing it got catastrophically wrong.

A deep-dive into GMM, the Bavarian maker of truck seats and car interiors that trades on Xetra at roughly eight cents on the euro of sales. On the morning of 10 July 2026 it doubled its second-quarter operating profit, confirmed a €1.9-billion revenue year, and the stock jumped 14.8%. The screener will tell you this is one of the cheapest industrials in Europe: a €1.9-billion company priced at €150 million, “1.5 to 2 times EV/EBIT,” almost too cheap to be real. It is too cheap to be real, in the specific sense that it is not real. There is €477 million of net debt standing between you and those sales, an 86% owner who paid €60 a share for this company and now runs it while sitting on an 83% loss, and a dividend that has been dead since 2019. There is also, and this genuinely surprised me, a real turnaround. Spoiler in the first section, because I respect your time more than the briefing respects mine.

The one-line answer, up front

Here is the thing I want you to hold in your head for the next several thousand words.

The number that got this stock into my inbox, “a €1.9-billion industrial at a €150-million market cap, 1.5 to 2 times EV/EBIT,” is a mirage, and not a subtle one.

GRAMMER’s enterprise value is not €150 million. It is about €627 million, because the screener forgot to carry the €477 million of net debt that ranks ahead of the equity you would be buying. The honest multiple is roughly 7.8 times this year’s operating-EBIT guidance, which is to say four times the number the tip sheet quoted. That is still cheap for a European auto supplier. But “cheap industrial” and “almost-free claim on €1.9 billion of sales” are entirely different securities, and only the first one is for sale. What you would actually be buying is a thin, heavily geared equity stub perched on top of a large, cyclical enterprise, majority-controlled by a financially stressed Chinese parent, that has just, genuinely and verifiably, doubled its quarterly profit.

My answer, directionally and before I earn it: this is a small speculative starter at the very most, a deliberately tiny lottery ticket for people who can watch it go to zero without needing a lie-down, and for most of you, frankly, a watchlist name rather than a buy today.

It is exactly the sort of hated, ignored, structurally cheap thing this publication exists to root around for, and the operational recovery is the real article, not the usual restructuring theater. But it carries three warts I cannot polish away: leverage so heavy that the equity behaves like a call option rather than a share (the bear case here is not a bruise, it is a burial), an ownership structure that offers minority holders roughly the protection of a paper umbrella, and a business, automotive supply, that has lost money in three of the last six years. The valuation section prices all three, in euros, with the working shown. The arithmetic lands on “own a little, or watch it like a hawk,” not “reverse the truck up to it,” whatever the price-to-sales line is whispering.

Now let me earn that, because the story of how a €67 stock became a €5 orphan, and how that orphan quietly rebuilt its profit while precisely one analyst could be bothered to watch, is the most instructive thing I have read in a German filing this year.

The setup

Let me describe a business you have quite literally sat on, and then ask you to care about the balance sheet underneath it.

When you climb into the cab of a long-haul truck, a tractor, a forklift, a train, or a great many ordinary cars, there is a decent chance the seat beneath you, along with the headrest, the armrest, and the center console, was made by GRAMMER. Founded in 1880 as a Bavarian saddlery in the town of Amberg, GRAMMER AG is today a €1.8-billion-revenue maker of seating systems and interior components, run across two divisions. Automotive (headrests, armrests, consoles and interior parts for passenger-car makers, €1,157 million of 2025 revenue) is the bigger and the weaker. Commercial Vehicles (driver and passenger seats for trucks, buses, off-road machinery, agriculture and rail, €664 million) is the smaller and the prouder, because in it GRAMMER is one of the world market leaders. It runs 42 production and logistics sites across 20 countries and employs roughly 11,900 people (GRAMMER 2025 Annual Report).

This is a real, physical, load-bearing industrial that makes things out of metal and foam. It is also one the market has quietly written off.

GRAMMER is a capital-hungry, cyclical, heavily indebted business at a price that looks absurd right up until you count the debt, and the job is deciding whether a genuine profit recovery can outrun a balance sheet and an owner that both cut against you. That question runs through a takeover brawl, a pandemic, an energy shock, a Chinese acquisition, and a restructuring program, so the only honest way in is chronological.

A century and a half, and then the fall

For 138 years GRAMMER was a textbook German Mittelstand success: family-rooted, engineering-obsessed, floated in Frankfurt in 1996, the quiet sort of company that supplies the world and never makes the news. Then, between 2016 and 2018, it made the news for all the wrong reasons, as the target of one of Germany’s uglier corporate-control fights. The Bosnian Hastor family, through their Prevent group, already infamous for weaponizing a supply dispute with Volkswagen, built a stake and started agitating for the board. GRAMMER’s management, casting around for a white knight, found one in China. Ningbo Jifeng Auto Parts, via a German vehicle called Jiye Auto Parts GmbH, launched a takeover at €60.00 per share, won the fight, and walked away with control. GRAMMER kept its listing and its Amberg headquarters. It gave up its independence.

What followed was a masterclass in the perils of buying the top. The Chinese parent took control at the peak of the auto cycle, and the cycle promptly disintegrated underneath it:

• 2019: the last dividend, €0.75 a share, paid in July. Then the taps closed, and they have stayed welded shut ever since.

• 2020: COVID gutted global vehicle production. Revenue fell 16% to €1.71 billion and the company posted a net loss of roughly €65 million.

• 2021 to 2022: first the semiconductor shortage, then the European energy shock and raw-material inflation. 2022 delivered another loss, around €78 million, with the chronically hopeless Americas division doing its usual bit for morale.

• 2023 to 2024: a restructuring-heavy purgatory. 2024 was the kitchen-sink year, with €35.7 million of restructuring charges dragging reported EBIT down to a pitiful €8.1 million and the group to a net loss (roughly €48 million on the group’s continuing-operations basis).

A warning for anyone tempted to build a model here, because it is the kind of thing that separates the diligent from the embarrassed. GRAMMER’s historical figures are not like-for-like across report vintages. The company reclassified operations under IFRS 5 (discontinued operations and disposals), so FY2023 revenue shows up as €2,055 million in the FY2024 accounts but €2,305 million in the original 2023 report, and 2023 operating EBIT appears as either €57 million or €83 million depending on which document you happen to have open. Splice figures from different reports and you will conjure a decline or a recovery that never happened. I have anchored everything below to the most recent continuing-operations vintage, and I would gently suggest the tip sheet did not.

Now the business mix, because the recovery is not being shared out fairly.

Sit with that Americas number, because it is the operational crux and the one lever nobody wants to pull. It has been loss-making for years, and its revenue fell 19% in 2025 alone, which is one way to shrink a loss but not a good one. Every euro of the group’s recovery is being generated by EMEA and APAC while the Americas quietly hemorrhages in the corner. Fixing that division, or having the nerve to exit it, is the single largest operational prize GRAMMER has left, and the single biggest thing that could shove operating EBIT toward the bull case I will lay out later.

The catalyst: the profit line that moved the stock

Here is why this piece exists this particular week. On the morning of 10 July 2026, at 10:28 CET, GRAMMER released an ad-hoc via EQS titled, in the original German, “Result in the second quarter 2026 significantly above prior year” (there is an onvista mirror if the first link ages out). The headline numbers, and they are good:

• Q2 2026 revenue: €499.5 million, up 7.1% from €466.3 million a year earlier.

• Q2 2026 operating EBIT: €23.4 million, against €11.7 million in Q2 2025. That is a clean doubling.

• H1 2026 operating EBIT: €41.7 million, up 17.2% year on year.

• Full-year 2026 guidance confirmed: revenue of around €1.9 billion, operating EBIT of around €80 million.

This is a genuine turnaround, and it even has a name: the “Top 10” program, a set of ten strategic measures spanning restructuring, efficiency initiatives, passing input-cost rises through to customers, and refocusing on the core, concentrated in EMEA and grinding away since 2024 (GRAMMER 2025 Annual Report). The proof is in the trajectory rather than the press release: full-year 2025 operating EBIT of €75.1 million (a 4.1% margin, up from 2.2% in 2024), a Q4 2025 that leapt to €25.1 million from €3.6 million, and now a first half of 2026 running ahead of last year again. The company turned a net profit in 2025 (€23.5 million), its first in the Ningbo Jifeng era, with earnings per share from continuing operations of €1.40. The German small-cap press noticed, which for a stock this ignored counts as a ticker-tape parade.

I want to be unusually blunt here, because it is rare for me to hand a compliment to anything in the bargain bin: the operational story checks out. The margins are climbing, the EBIT has doubled, the guidance was just reaffirmed after a strong first half, and the “Top 10” is a coherent, disclosed programme rather than a mood board. If this were an all-equity company, you would be reading a much cheerier essay.

It is not an all-equity company. Which brings us to the two large objects standing between that improving profit line and your wallet.

The catch, part one: who actually owns this

Ningbo Jifeng owns 86.2% of GRAMMER, 13,135,660 of the 15,237,922 shares, held through Jiye Auto Parts GmbH (GRAMMER 2025 Annual Report; the briefing’s breezy “~80%” undercounts it by six points, which is the difference between “large holder” and “owns the whole thing”). Add 330,050 treasury shares and the free float is about 11.6%, roughly 1.78 million tradeable shares in the entire world. This single fact explains the whole tableau: the neglect, the lonely “Hold”-rated analyst, the total absence of institutions, the illiquidity that lets a 15% move happen on twenty thousand shares, and the cheapness itself. Institutions do not, cannot, and will not build positions in a company where 86% of the register belongs to one strategic owner and the float would barely fill a single fund’s coffee budget.

Now the nuances, because they cut in every direction and a value investor is paid to hold all of them at once:

The good news for minorities: there is currently no domination-and-profit-transfer agreement (Beherrschungs- und Gewinnabführungsvertrag, and yes, the Germans have a single word for it) in place, and no squeeze-out or delisting has been filed. The 2018 business-combination agreement even committed the bidder not to pursue a domination agreement, delisting, or squeeze-out without board support. So nobody is formally expropriating you this morning.

The bad news for minorities: the flip side of “no domination agreement” is that there is no guaranteed compensation, no floor dividend, no Ausgleich, no Abfindung protecting you either. You ride entirely on the operating results and the goodwill of an 86% owner, and goodwill is not a line item you can enforce. A future squeeze-out or delisting, at a price of the controller’s choosing on a day of the controller’s choosing, is a permanent, un-hedgeable feature of this security. The one crumb of comfort is arithmetic: Ningbo Jifeng paid €60 a share for control. Squeezing out minorities anywhere near today’s €10 would invite years of German appraisal litigation (Spruchverfahren) and look grotesque set against its own entry price. But “the controlling shareholder would feel a bit awkward” is not a covenant, and I would not underwrite capital on it.

The genuinely worrying news: the parent is not well. Ningbo Jifeng (Shanghai 603997) is itself a heavily geared business, with debt-to-equity around 147% and an Altman Z-score parked in the distress zone, running on margins thin enough to read a newspaper through (2024 revenue of roughly CNY 22 billion, net income of only about CNY 216 million). GRAMMER is the majority of the parent’s revenue. A distressed parent that controls 86% of a subsidiary, and that also lends that subsidiary roughly €130 million through subordinated shareholder loans, has both the motive and the machinery to make decisions that flatter the parent at the expense of the 11.6% minority. Exhibit A is the December 2024 purchase of the parent’s own European business (the “JAI” assets) for about €44.4 million, a related-party transaction that moved cash from GRAMMER to a Ningbo Jifeng subsidiary. It may have been an immaculately fair deal at an independently blessed price. It may also have been a cash-strapped parent using a listed subsidiary’s balance sheet as a handbag. You are a passenger either way, and nobody has offered you a seatbelt.

The free section has given you the business, the century-and-a-half arc, the three crisis years, the genuine Q2 profit-doubling catalyst, and the ownership structure that explains both the neglect and the discount. The paid section does the buying math, and corrects the number that put this stock in front of both of us. The eight numbers, the enterprise value your screener gets spectacularly wrong, what the €477 million of debt does to the profit before a euro of it reaches you, why the equity behaves like an option rather than a share, three scenarios with probabilities attached where the bear case is a funeral rather than a haircut, the steelmanned bear case, the monitoring dashboard, and the exact verdict with position sizing. Subscribe to read whether I would touch it with your money, let alone mine.

Read more

This week the Fear Gauge has climbed 9.7 points straight back into the cautious band, and the Sentiment Gauge has settled onto a dead-neutral reading that would look serene if you did not open the hood and see what is bolted underneath. Because the real story this week is not the level of either gauge. It is the fact that both of them are sitting quietly in the middle of their ranges while, beneath the surface, two powerful and opposite forces are pulling in opposite directions at once. The smartest money in the world spent the week writing billion-dollar checks to buy European assets, and the real economy that produces those assets spent the same week cracking in slow motion. Two stories, one market. Let us be good students and read them together, because separately they will mislead you.

At a Glance

Fear Gauge: 48 out of 100, Cautious. Up 9.7 from last week, which pushes the needle back across the line from the green calm band into amber. The rise is real, but the composition of that rise is the interesting part, and it is not what you would expect from a market that is actually frightened.

Sentiment Gauge: minus 0.6, Neutral. A slip back from the green flicker of last week to a reading that is neutral only because two strong opposing dimensions cancel each other out almost perfectly. A gauge can read zero because nothing is happening, or because a great deal is happening in both directions at once. This week it is emphatically the latter.

If you have only a minute this morning, here is the takeaway. Nothing in the arc has bent this week. The macro story has continued in exactly the direction it has been traveling for months, with fresh evidence stacking up on all three of the running theses. The discipline, as ever, is to stay positioned for what is actually happening rather than for what the middle of a gauge is telling you.

Where We Are in the Arc

For new readers, and as a standing reminder for the rest of us, three connected theses have been building in this briefing across the life of the Hormuz Arc. They are not getting less true. They are getting more true, and this week added a brick to each.

1. Thesis One, the Fragmentation Thesis. The post-1990 globalization equilibrium is coming apart at the seams. The cost of operating a business across geopolitical spheres is rising faster than corporate models have priced it, and the structural beneficiaries are European industrials with deep regional supply chains, regulatory entrenchment, and the balance-sheet strength to absorb energy shocks. Status this week: hardening. A diesel supply crunch, a fresh Hormuz flare-up, a fractious NATO summit, a live threat to halt trade with an EU member, an anti-dumping probe over Chinese poultry, and a fiscal fight over joint borrowing are six surface readings of the same tectonic shift. Read them as one thing.

2. Thesis Two, the Broken Safe-Haven Mechanism. The textbook crisis playbook (gold rallies, the dollar rallies, Treasuries are bid, volatility stays elevated) has been misfiring for the entire arc, and it misfired again this week. The mechanism that protected diversified portfolios for two decades has been corrupted by central-bank balance-sheet management, the politicization of Treasury holdings, and official-sector gold buying that crowds out private flows. Status this week: confirmed once more. Safe-Haven Demand is scoring 22 out of 100, near the floor of the gauge, in a week when the geopolitical dimension of sentiment reads minus 4. That is the most internally inconsistent pair of numbers on either dashboard, and it is telling you something important.

3. Thesis Three, the Three Trigger Conditions. The portfolio posture stays defensive (cash-generative, low-leverage, energy-pass-through, single-sphere industrials) until three specific conditions flip at the same time: energy premium compression, a genuine credit thaw, and an earnings recovery that broadens beyond energy. Status this week: still off. One of the three is flashing green on the readout, but I am going to show you in the paid section why I am marking it amber anyway. The full scorecard, as always, is behind the paywall.

The one-line version: the arc has not turned. It has continued, and the job is patience.

The Week in Context: Two Stories, One Market

Start with the good news, because there was a genuinely remarkable amount of it, and it all pointed the same way. Private capital spent the week treating Europe as a clearance sale. Apollo gatecrashed a prior bid for a budget airline with a cash offer for easyJet worth 5.7 billion pounds, or 715 pence a share, sending the shares up 14% as a genuine bidding war broke out. The same firm bought a 3 billion euro stake in Bayer’s contraceptives arm, a deal Bayer is doing not out of strength but to help pay its endless Roundup litigation bill. Carlyle sold a data-center power unit to EQT for a fivefold return, and French billionaire Xavier Niel spent around 6 billion dollars to become Vodafone’s largest shareholder. Four separate transactions, one message: sophisticated allocators look at European public-market valuations and see money on the ground.

That is the story the equity market wants to believe, and it is why the Sentiment Gauge’s Capital Flows dimension is the brightest thing on either dashboard this week. It is also, I will argue in a moment, exactly the wrong lesson to draw. But hold that thought.

Now turn the page, because the same week produced a very different set of headlines. Volkswagen, the single largest industrial employer on the continent, confirmed a restructuring that its own union describes as risking a major conflict, with as many as 100,000 jobs on the line, roughly 16% of the global workforce, and four German plants under threat. The four-year plan the company unveiled the next day left more questions than answers about which jobs and which plants survive, and a separate report has management studying a cut of up to 50% in the model lineup. This is not a car-company story. It is a demand-destruction event for the hundreds of Tier 2 and Tier 3 suppliers that populate the German small-cap universe, the precision machiners, the coatings and adhesives chemists, the just-in-time logistics operators whose order books are downstream of Wolfsburg. When the biggest customer halves its product range, the effect cascades through the tiers for two to four quarters, and no analyst has that in their model yet.

Layer the energy picture on top. Ukraine’s drone campaign has now damaged enough Russian refining capacity to produce a growing diesel supply crunch across Europe, and it arrived in the same week a renewed Iran flare-up drove a steep drop in traffic through the Strait of Hormuz. Two supply shocks, one in refined product and one in crude and LNG, stacked on the same energy-intensive industrial base. The commodity market’s response tells you how the professionals are playing it. Gold merely steadied as traders weighed the fighting against the rate outlook, and copper actually headed for a weekly gain as traders looked past the flare-up entirely. The market is not hedging this geopolitical tail. It is looking through it. That is either wisdom or complacency, and the arc has taught me to bet on the second.

The fragmentation bricks kept coming. The NATO summit in Turkey saw the alliance’s own Secretary-General lavishing praise on President Trump in a posture that underscored Europe’s strategic dependence. Washington made clear that even with the Supreme Court having struck down the IEEPA tariffs, it believes it retains the power to halt trade with Spain specifically. Brussels opened an anti-dumping probe into Chinese Pekin duck imports even as it negotiates a broader trade truce with Beijing, and a Dutch blueprint urged European banks to pool their buying power against US technology giants to reduce dependence on foreign cloud and AI providers. And the continent’s answer to all of this, a Spanish proposal for 850 billion euros of joint EU borrowing to build a new safe asset, was promptly met with skepticism from the bloc’s largest economies. Fragmentation, in other words, is not only external. It is internal, and it is showing up precisely when a coordinated fiscal response is most needed.

One last piece of texture, because it frames the whole picture. The week’s dominant market event outside Europe was SK Hynix’s record Nasdaq debut, a journey from near-collapse to a trillion-dollar valuation that could hand Wall Street nine figures in fees. One clear-eyed columnist called the jumbo share sale a sign of overheated times, and I would gently agree. When the memory-chip mania is minting record listings and a sustainable-fashion IPO is being framed as an acid test for a whole category of troubled offerings, you are looking at a market where the froth is concentrated in growth and AI, and the boring cash generators are being left on the shelf. That is not a coincidence. It is the same setup the private-equity buyers are exploiting, and we will come back to it.

Against the recent run of weeks, the tone has shifted from cautious optimism to something more honestly bifurcated.

The credit and private-equity markets are bullish.

The real-economy signals are weakening.

That divergence has a long history, and it almost always resolves in favor of the real economy, with a three to six month lag. Which side of the divergence you position for is the whole game.

The Central Banks: A Hawkish Hold and a Quiet Hike

I want to spend real time here this week, because the monetary picture is more important than the quiet gauge readings suggest, and because both of Europe’s major central banks are now leaning against precisely the energy-driven inflation the market spent the week looking through.

Start with the European Central Bank, which did something at its June meeting that would have been unthinkable a year ago. After cutting rates eight times between June 2024 and June 2025 and then pausing, the ECB raised its main rates by a quarter point, lifting the deposit rate to 2.25%, and it was explicit that the Middle East conflict and the inflation pressures it generates were the reason. This is a hiking central bank now, not a cutting one. Its next meeting concludes on July 23. And instead of using this week to guide markets on the rate path, President Lagarde spent it insisting in a Euronews interview that the digital euro will not replace cash, which tells you the ECB is in manage-public-trust mode rather than signal-a-pivot mode. Meanwhile the cost-push channel keeps loading. The diesel crunch is a fresh inflation vector the ECB cannot influence but cannot ignore, especially for an energy-intensive economy like Germany, and the fact that Vanguard is buying inflation-protected bonds on an oil-market oddity tells you institutional money is quietly hedging for stickier prices than consensus assumes. The read-through for the boring end of the market is simple and it matters: do not position aggressively for rate relief in the second half of the year. The ECB’s easing path is narrower than the equity market believes.

Now the Bank of England, because a good number of us hold London-listed names, and the UK picture has a live catalyst attached to it. At its June meeting the Bank held Bank Rate at 3.75% by a margin of seven votes to two, with the two dissenters voting to hike to 4%, and at least one further member signaling openness to an increase. That is not a dovish hold. That is a hawkish hold with a restless minority. UK inflation was running at 2.8% in May, above target, and the Bank’s own guidance is that it climbs back toward a little under 3% in the third quarter and a little over 3.25% in the fourth as the energy shock feeds through. The Bank continues to shrink its balance sheet through active gilt sales, and it has been unusually blunt that its job is to stop this supply shock from becoming embedded in wage and price setting, the dreaded second-round effects. The next decision lands on July 30, and it comes with a full Monetary Policy Report and a Governor’s press conference, which makes it a far bigger market event than a bare rate announcement. Some houses now see the possibility of a hike at that meeting. So while the diesel crunch is a European story on the map, it is a very specific UK monetary story in practice, because it is exactly the kind of cost pressure the MPC has told you it is watching.

There is a third central bank in the frame, and its silence is its own signal. Across the Atlantic, the new Federal Reserve chair has been conspicuously quiet through repeated bursts of market volatility. Put the three together and you have an unusual configuration: a hiking ECB, a hawkish-hold BoE, and a mute Fed, all of them wary of an inflation impulse the equity and commodity markets are busy discounting. When policymakers and markets disagree this openly about the direction of risk, the boring investor’s edge is to notice the disagreement and refuse to bet the portfolio on the complacent side of it.

You can see the same UK story reflected in the plumbing of the deal market. The froth that is drawing private equity into London is also drawing the regulators. The Financial Conduct Authority reported abnormal trading ahead of a record 41% of UK takeovers, the FRC opened a probe into accounting claims at the Battersea Power Station development, Parliament is pushing a permanent ban on crypto political donations, and the founder of a FTSE 100 energy distributor is publicly blasting his own board for backing a private-equity takeover on the cheap. A market this active at the top of the cycle, with informed money positioning ahead of announcements and insiders complaining that assets are being carried off below fair value, is a market where discipline about what a business is actually worth pays for itself.

The Contrarian Corner

The consensus reading of this week is comfortable and, I think, wrong on four separate levels. Let me take them in order.

First, and most importantly, the private-equity buying spree is not the valuation all-clear the equity market is treating it as. It is the opposite. When Apollo pays a premium for an airline and buys a pharmaceutical minority stake in the same week, and Carlyle and EQT and Xavier Niel all deploy at scale into European assets in the same five trading days, the signal is not that European equities are fairly valued. It is that they are priced for distress, and that sophisticated capital is exploiting that mispricing before the public market wakes up. Private equity does not buy out of generosity. It buys because it can model cash flows the market is ignoring, or because it is deploying cheap debt ahead of a refinancing window while the door is still open. The tell that informed money has been positioning for months is sitting right there in the FCA’s record 41% suspicious-trading figure. The crowd sees confirmation. The contrarian sees front-running.

Second, the Fear Gauge’s benign credit reading is not a thaw. It is a Confession Lag. Euro Credit Stress is scoring a placid 38 this week, a dramatic improvement from the panic levels of the arc’s worst weeks, and if you take it at face value you would conclude the funding stress has healed. But look at what happened inside private credit, where the gauge cannot see. UBS helped trigger an investor exodus from a Blue Owl private credit fund it had itself been instrumental in setting up. The stress did not disappear. It migrated to the private channel that no public spread index measures, which is precisely why the readout looks calm. The true structural position and the printed number have diverged, and that gap is where the mispricing lives. I would not trust the credit all-clear on the strength of a public spread when the private-credit plumbing is visibly leaking.

Third, the safe-haven mechanism is still broken, and this week gave the cleanest evidence yet. Gold will not bid. Safe-Haven Demand is at the 22nd percentile in a week of genuine geopolitical escalation, and the market’s chosen insurance policy is not the metal at all. It is inflation-protected bonds and, by implication, the dollar. If your portfolio is built on the twenty-year assumption that gold rallies when the world gets scary, the arc has been quietly informing you that the assumption has expired. Plan your hedges around the mechanism that actually works now, not the one in the textbook.

Fourth, and this is the constructive contrarian read, the froth is in the wrong place. The mania this week was in memory chips and AI infrastructure and IPO acid tests, all the glamorous corners of the market, while the unglamorous, asset-heavy, cash-generative businesses were being quietly hoovered up by private equity at premiums. Growth-oriented institutional money is chasing the shiny thing and leaving the boring thing on the floor. That is the entire premise of this newsletter, restated by the market itself in a single week. The real contrarian bet is not to chase the announced deals, where the premium is already paid. It is to work out which unloved second-tier and third-tier equivalents are next on the shopping list precisely because everyone else is fixated on the Volkswagen doom loop.

Risk and Opportunity

Key Risk. The single largest risk this week is the compounding energy supply shock and its transmission into industrial input-cost inflation that consensus has not yet modeled. The mechanism is specific and it is worth stating plainly. Ukraine’s drone strikes have materially reduced Russia’s diesel export capacity at the same moment Middle East fighting has cut Hormuz tanker traffic, producing a double supply shock in transport fuel and heating oil. For energy-intensive European industrials, the operators whose cost structures carry heavy diesel exposure, this is a direct threat to second-half operating margins that no analyst estimate reflects, because the shock is weeks old and margins report with a lag. The second-order risk sits in the rate market. The same institutional hedging via inflation-protected bonds, together with a hiking ECB and a hawkish-hold BoE, means the relief in refinancing costs that leveraged small-caps are praying for may simply not arrive this year, and it may not arrive at the worst possible moment, when their operating margins are already under pressure. Cost-push inflation and higher-for-longer rates are the pincer, and the leveraged, energy-exposed end of the market is caught between the jaws.

Key Opportunity. The most actionable opportunity is the mirror image of the risk, and the market handed us the template this week. Asset-heavy, cash-generative small and mid-cap companies in genuinely defensive sectors, environmental services, specialty waste processing, niche industrial distribution, are being acquired by private equity at premium multiples in the large-cap arena while their smaller equivalents sit ignored. The DCC founder’s complaint that a FTSE 100 business is being taken out on the cheap confirms that even the buyers’ targets think the buyers are getting a bargain. The opportunity is not to buy the announced deals, where the premium is spent. It is to identify the second and third-tier equivalents with contracted revenue, hard assets, and the cash-conversion profile that makes a private-equity acquisition model work: the unloved waste operators, the regional logistics businesses, the niche specialty distributors. These are precisely the companies that a strategic or financial acquirer could pay a 30 to 40% premium for and still generate an acceptable return. The re-rating is happening in large-caps first. It usually does. The small-cap follow-through is where the patient reader gets paid.

For Paid Subscribers

Everything above is the free half of this week’s briefing: what happened, and how to think about it. What follows is the working half, where I decompose both gauges component by component, tell you what each internal reading actually means, run the trigger scorecard, and walk the read-through into the names on the coverage list. If you find this useful, the paid tier is what keeps the lights on and the coverage names off the public internet.

Read more

Eighteen weeks ago, this briefing was born in a panic. The Fear Gauge jumped 38 points in a single week, every sentiment dimension went negative, and I spent the following four months documenting a crisis in weekly installments: the Hormuz closure, the selective blockade, the LNG squeeze, gold’s capitulation, the credit stress that kept climbing while the headlines got numb. For seventeen consecutive weeks, at least one of my two gauges told you to keep your helmet on.

This week, for the first time in the life of this arc, both needles are green. The Sentiment Gauge printed its first positive composite since the crisis began. The Fear Gauge dropped into the Calm band for the first time in eighteen weeks. The Strait of Hormuz is genuinely reopening, with tanker transits quadrupling over the past week as the US-Iran ceasefire holds, and oil has steadied as supply gushes back through the waterway.

And yet the single loudest event of the week was Russia launching a massive missile and drone strike on Ukraine, forcing Poland to scramble jets and Finland to restrict its airspace. The war we have all been watching for four months is winding down. The war Europe stopped watching is heating up. That split screen, I would argue, is the most important thing on your desk this week, and it is why I have never trusted my own green lights less.

Let me show you what I mean. As always, we will be good students about it.

At a Glance

Sentiment Gauge: +1.2, 🟢 Slightly Bullish (up from -1.4 Slightly Bearish, the first positive reading of the arc) Fear Gauge: 38/100, 🟢 Calm (down 3.7 from 42 Cautious, the first Calm reading of the arc)

The two gauges have disagreed with each other for most of this arc, and the disagreement was usually the story. This week they agree, and the agreement is the story. When the qualitative gauge (what the press is saying) and the quantitative gauge (what markets are doing) both turn green in the same week, you are being told the storm has passed. Which is precisely the moment a careful sailor checks the anchor.

The Week in Context

The dominant theme of this week is a quiet but meaningful rebalancing of risk, with the geography of European anxiety migrating from the Gulf to the eastern flank. Start with what went right. The Hormuz reopening is not a rumor anymore, it is tanker traffic: transits through the strait have quadrupled in a week, Japan is already rebalancing its power mix as LNG flows normalize after months of disruption, and the energy premium that has sat on every energy-intensive European income statement since March is compressing in real time. There is even a certain dark comedy in the FT publishing a podcast this week asking why the Iran war did not cause a recession. Four months ago that question would have been unaskable.

Now the macro. The most underappreciated data point of the week is the transatlantic labor divergence: US job growth is plummeting while eurozone unemployment holds at a record low. Read that again, because the consensus narrative has it exactly backwards. The global financial press spends its column inches on European industrial malaise and American exceptionalism, and yet the labor market data says the eurozone is at full employment while the US engine sputters. Full employment means wage income, which means domestic demand, which means a floor under European industrial order books that almost nobody is pricing. Meanwhile the weak US jobs data has pushed gold toward $4,200 as rate-hike odds fade, and copper is climbing with industrial metals on the softer dollar. A softening dollar, a Fed described by strategists as sitting in a “goldilocks situation”, and a full-employment eurozone is, historically, the recipe that sends capital flowing east across the Atlantic.

Capital is indeed moving, though not in a straight line. The AI trade wobbled hard this week, with South Korean stocks swinging nearly 10% down and then 5% back up in three sessions as scrutiny grows over whether the boom is sustainable, and US stocks rebounding only after two days of tech-led losses. The FT reports that surging Wall Street profit forecasts are fueling fears of an earnings bubble, with S&P 500 estimates rising at the fastest rate since the post-Covid rebound. Money leaving hyper-valued growth names has to go somewhere, and boring European value industrials are the anti-AI trade, attractive not because they are exciting but because they are not the thing being sold.

Then there is the thing that went wrong. Russia’s massive strike on Ukraine put NATO’s eastern members into active emergency response, and the political psychology is spreading: Lithuania is moving to scrap its ban on nuclear weapons, following Finland’s vote to do the same, with officials saying plainly that the situation is getting worse. This is not a crisis in the market sense, there was no risk-off convulsion, but it is a structural regime signal. Europe’s security architecture is in a multi-year realignment that permanently raises defense spending, and the capital markets are already voting: Renk Group is nearing a deal to buy the UK’s David Brown Defence for naval exposure, Lockheed is in the lead to buy naval tech group Ultra Maritime for $3.5 billion, and autonomous drone startup Quantum Systems just raised $1.2 billion as investors pile into defense.

Germany, as ever, remains the fly in the ointment. The FT ran both a piece on Germany’s twin crises in football and the economy and a longer examination of VW as the faltering engine of the German auto industry, while the EU car industry clashes over local content rules in the Made in Europe bill. I will have more to say about the German question in the Contrarian Corner, because I think the market is making a category error with it.

Compared to recent weeks, the tone shifts from cautious to selectively constructive. The geopolitical noise is louder, but it has changed address, and the macro fundamentals underneath are holding better than the consensus expected.

The Arc, Extended

Regular readers know this briefing tracks three named theses across the arc. Here is where each one stands after week eighteen.

The Fragmentation Thesis. The core claim, running since week one, is that this crisis would not resolve back to the old world but would institutionalize a more fragmented, higher-friction, more regionalized global economy. This week delivered the cleanest evidence yet that fragmentation is a condition, not an event. The Gulf front is de-escalating, and yet: Canada unveiled plans for a new oil pipeline to Asia explicitly to break its dependence on the US amid trade hostilities. CMA CGM deployed the world’s largest LNG-powered container ship on the Asia-Europe route, with Euronews framing maritime sovereignty and supply chain resilience as strategic priorities. India and Japan are deepening economic and defense ties as Tokyo’s relations with China fray. The war that started the fragmentation is ending; the fragmentation is not. It has simply stopped needing the war.

The Broken Safe-Haven Mechanism. This is the thesis I have been calling “The Dog That Didn’t Bark” since March: the old reflexes that sent capital into bonds and gold during stress have decoupled from stress itself. This week handed the thesis its most institutional confirmation yet. AMP, one of Australia’s largest asset managers, has cut bonds from some of its pension funds outright, saying sovereign debt no longer offers the diversification investors relied on for decades. When a pension manager formally abandons the bond hedge, the broken mechanism has moved from market anomaly to asset allocation policy. And notice what gold did: it rallied toward $4,200 this week, but on fading rate-hike odds, not on fear. Gold is now trading as a real-rates instrument, not a haven. The fear channel and the haven channel have been severed, and this week’s data (which paid subscribers will see decomposed below) shows the signature clearly.

The Three Trigger Conditions. The framework that governs when this portfolio rotates from defense back to offense. Last week, for the first time in the entire arc, one of the three conditions flipped green, on probation. This week the probation continued to run in the right direction, and a second condition did something more interesting than its label suggests. The full scorecard, as always, sits in the Founding Member section, because it is the closest thing this publication produces to a positioning instruction.

Contrarian Corner

The consensus this week says European industrials face a prolonged demand drought, anchored by Germany’s twin crises, VW’s structural decay, and the reflexive assumption that German weakness equals European weakness. The data says something different, and the gap between the two is where the money is.

Here is the category error. Germany’s problem is concentrated, brutally, in the auto complex and its supply chain. That is real, and I am not asking you to buy VW suppliers. But the market is applying a Germany discount to the entire universe of European niche manufacturers, waste processors, specialty chemicals producers, and logistics operators, most of whom do not sell a single euro of product into an auto plant. Meanwhile the eurozone labor market is tighter than at any point in the common currency’s history. Record employment means industrial services demand, consumer resilience, and order book stability for the Germany-agnostic operator. You are being offered non-auto European industrial cash flows at auto-crisis prices, and the mispricing exists because indexes and headlines do not distinguish between the two. Fund managers rebuilding non-US allocations after this week’s AI wobble will eventually make that distinction. You can make it first.

The second contrarian angle is the defense trade, where the consensus is right about the theme and wrong about the expression. Defense primes are a crowded consensus long, re-rated and owned. But rearmament is an industrial supply chain phenomenon, and the precision engineers, specialty materials processors, and secure logistics operators who feed the primes are still, in many cases, priced on peacetime multiples with civilian-market analyst coverage, which is to say almost none. The Renk and Lockheed deals this week are the primes buying capability because they cannot build it fast enough. When the acquirer class starts shopping in the supply chain, the supply chain re-rates. Each week of escalation on the eastern flank raises the floor under that thesis, uncomfortable as it is to write that sentence.

And a third, smaller one, because I cannot resist: the energy cost relief now flowing through Hormuz is arriving at the exact moment the consensus is most pessimistic about energy-intensive European SME margins. Margin surprises in the second half will come from the boring names whose biggest input cost just fell while nobody was updating their models.

The free section ends here. Below the paywall: both gauge images with the full component decomposition, the dimension-by-dimension sentiment read with key signals, the week’s risk and opportunity with transmission mechanisms spelled out, and, for Founding Members, the Three Trigger Conditions scorecard (which recorded its first double-move of the arc), three named companies from the coverage universe that this week’s signals run straight through, each with an embeddedness read and an honest bear case, and the tactical sleeve note. What sits behind the wall is the part that tells you what to do, not just what happened. The reason to trust it is eighteen weeks of a documented, unflattering scorecard I have kept whether it made me look smart or not. And the cost asymmetry is unchanged: a year of this costs less than one rotation made one week too early. If the work helps, the way to support it is to upgrade.

Read more

The one-line answer, up front

Here is the thing I want you to hold in your head for the next six thousand words.

You are not being asked whether Tristel is a good business.

It is a good business.

You are being asked whether it is a good investment at this price.

Those are different questions, and the gap between them is the entire point of this piece.

My answer, directionally and before I earn it: this is a genuinely high-quality compounder and a watchlist-to-small-starter name, not a back-up-the-truck buy at 400 pence. The business is excellent. The balance sheet is clean. The growth runway in the United States is real. And the price already pays for most of that, which means the thing most likely to hurt you here is not the company failing, it is the multiple compressing. That is a very different risk from the cheap, hated industrials this publication usually picks over, and it deserves a very different kind of discipline.

Now let me earn that, because the case both for and against is more interesting than the soundbite.

The setup

Let me describe the most boring business I can think of, and then I am going to ask you to get excited about it.

A small company in a village called Snailwell, just outside Newmarket in the flat green nowhere of Cambridgeshire, makes foam. Specifically, it makes a foam that kills germs. You squirt it onto a medical instrument that is too delicate to throw in an autoclave, an ultrasound probe, an endoscope, an eye-pressure gauge, you wipe it, you wait two minutes, and the bugs are dead. The active ingredient is chlorine dioxide, a chemistry the company has built its entire 30-year existence around. It employs around 270 people. It pays a dividend it has raised almost every year. It sits on net cash. And as I write, it trades at roughly twenty-four times earnings, the kind of multiple you normally pay for software, not for disinfectant wipes.

Welcome to Tristel plc.

This is the inversion of almost everything I usually write about. The typical Boredom Baron pick is cheap, hated, and ignored, and the job is to work out whether the cheapness is a gift or a trap. Tristel is the opposite animal. It is admired, well covered, owned by quality-growth funds, and expensive. The job here is not to find the hidden value. It is to pressure-test whether a wonderful business is wonderful enough to justify paying up, and to be honest about what could go wrong when you do.

So let us do the unglamorous thing and actually understand it, because there is a real investment question buried under the 81% gross margin and the glossy investor deck.

What you are actually buying

Strip Tristel down and it is, at heart, a single chemistry sold three ways.

The chemistry is chlorine dioxide, which the trade shortens to ClO2. Tristel generates it on demand at the point of care by mixing two stable components, a sodium chlorite base and a citric acid activator, which react to produce a small, potent dose of the gas dissolved in foam (Tristel’s own chemistry page explains the mechanism). It kills by oxidation, ripping electrons away from the proteins and DNA of whatever microorganism it touches, which is why it works against the hard targets, bacterial spores and mycobacteria, not just the easy bugs. The company was founded in 1993 specifically to give hospitals a safer alternative to glutaraldehyde, the nasty, sensitizing chemical that endoscopy units used to reprocess scopes with, and that founding purpose still describes the business.

It sells that chemistry in three buckets, and you can see the shape of the company in how lopsided they are.

The first and overwhelmingly largest bucket, 87% of the £46.5 million of revenue in the year to June 2025, is the Tristel brand: high-level disinfection of medical devices. Foams and wipes for ultrasound probes (the Duo ULT product), for ophthalmic instruments (Duo OPH), for surgical and endoscopic kit. This is the engine. The second bucket, 8%, is the Cache brand, sporicidal surface and floor disinfection for hospital environments, including a semi-automated washer called Stella. The third, a residual 5% labeled Other, is the rump of older lines. Tellingly, management has already pruned the weeds: the veterinary brand (Anistel) and a clean-room and personal-care line (Crystel) were both non-chlorine-dioxide, low-margin and UK-only, and were discontinued by 2022 with a £2.4 million impairment (FY2022 annual report). A management team that voluntarily kills its own low-margin revenue is a management team worth a second look.

If you understand nothing else about Tristel, understand this. It does not really sell machines. There is barely any razor. What it sells, more than 98% of revenue, is a consumable that gets used up, every single procedure, and rebought forever.

That brings us to the word every bull uses.

The razor-and-blades engine, and the chlorine dioxide moat

“Recurring revenue” is one of those phrases that does enormous work in an investor presentation and very little in a spreadsheet, so let us actually take it apart.

Classic razor-and-blades economics sell you a cheap razor to lock you into expensive blades. Tristel barely bothers with the razor. A hospital department adopts a Tristel protocol, which mostly means training, paperwork, and a validated process rather than a big capital machine, and from then on it buys foam. Forever. Here is why those blades are genuinely hard to dislodge, and I am going to give you the strong version before I knock it down.

• First, the absolute cost is trivial. We are talking a few pounds per procedure. Nobody in a hospital procurement office is going to risk a patient infection to shave pennies off a disinfectant wipe. The spend is too small to fight over and too important to cut.

• Second, it is compliance-driven. Infection control is the one budget line where a hospital does not want to be clever. The disinfection of an endocavity ultrasound probe (the kind used internally) is a regulated, audited, validated process. You cannot casually swap in a cheaper generic, because the moment you do, you have to re-validate the entire protocol and own the clinical and legal risk if it fails. The friction is not the price of the product. It is the cost and risk of changing it.

• Third, the chemistry itself is good at the hard jobs. Chlorine dioxide is sporicidal and mycobactericidal in minutes, which not every wipe can claim, and because it kills by oxidation rather than by a mechanism bugs can adapt to, resistance is not really a concern.

Now the part the bulls skate past, and it is the most important paragraph in this section.

The moat is real, but it is narrower and more regulatory than the pitch deck implies, and I want you to hold three corrections in mind.

1. The often-repeated claim that Tristel is “on the NHS formulary” is simply the wrong frame. It is procured through NHS Supply Chain framework agreements as a medical device, which is a competitive procurement process, not a protected drug listing.

2. The patents. Tristel does hold granted patents, but they largely cover the dispensing and generator hardware (a UK patent from 2018, a European equivalent, US patent 9,718,686), not obviously the underlying sodium-chlorite-plus-citric-acid chemistry, which is decades old and not exotic.

3. This is the big one, Tristel’s prized FDA clearance was granted through a pathway called De Novo, which creates a brand-new device category. Being first into a new category is a genuine advantage. But a De Novo classification explicitly lets competitors follow you in through the cheaper 510(k) door using your product as the predicate. It confers first-mover status. It does not confer exclusivity. A UV-C rival, Germitec, already holds its own FDA De Novo clearance in the adjacent space.

So … how sticky is sticky?

Sticky enough that the recurring revenue is real, defensible, high-margin, and recession-proof, attached to a market (hospital procedures) that grows rather than shrinks. That is genuinely better than the melting-ice-cube annuities I usually pick through. It is just not the unbreachable fortress the multiple seems to assume. It is a strong, narrow, regulatory-and-habit moat around a growing pond, not a moat around an ocean.

Which brings us to the pond that matters most, and the one doing the most work in the share price.

The United States, where the growth lives and the binary risk sleeps

Every premium-rated small cap has one slide that justifies the premium. For Tristel, that slide says “America.”

The logic is simple. The United States is the largest healthcare market on earth, and for years Tristel was effectively locked out of it, because the FDA regulates high-level disinfectants far more demandingly than Europe’s CE marking regime. Cracking the FDA was the whole game. And after a long slog, Tristel cracked it.

Here is the timeline, stripped of adjectives. Tristel filed its ultrasound foam, Tristel ULT, with the FDA in June 2022. The FDA cleared it on 2 June 2023 through De Novo, creating a new device category for “foam or gel chemical sterilant/high-level disinfectant” (FDA classification DEN220041). A second product, the ophthalmic Tristel OPH, was cleared via 510(k) in May 2025 (company RNS). Tristel sells into the US not directly but through an exclusive partnership with Parker Laboratories, a well-established American ultrasound-gel company with a real salesforce. And the catalysts have kept coming: the American Institute of Ultrasound in Medicine added chlorine dioxide to its guidance in November 2025, and a national purchasing agreement with Premier, one of the big US group purchasing organizations covering some 4,400 hospitals, went live on 1 June 2026.

That is a genuinely impressive sequence, and it is why the bulls are excited.

Now the part the excitement skates past.

The US is still, in revenue terms, almost nothing. In the half year to December 2025, US revenue was around £262,000. The company described that as up “542%”, which is technically true and also exactly the kind of percentage you get when you grow from a rounding error to a slightly larger rounding error (and the precise base for that 542% is murky enough that I would not lean on it). Management’s own near-term ambition is more than two million dollars of US sales by the end of FY2026. The total addressable US ultrasound disinfection market is cited at around 206 million dollars. So the prize is large, the progress is early, and the entire bull case rests on a single proposition: that clearance, a guideline mention, and a GPO contract will convert, hospital by hospital, into a real adoption curve against an entrenched incumbent. Clearance is permission to compete. It is not revenue. Anyone who tells you the US is “done” is selling you the slide, not the business.

I will name that entrenched incumbent, and the rest of the genuine risks, on the other side of the paywall, along with the numbers, the five-step decomposition of that 20% return, the valuation done properly, and the exact price and catalyst that would turn this from a watchlist name into something I would actually buy.

The free section taught you how razor-and-blades consumable economics work inside regulated healthcare, why chlorine dioxide plus an FDA category is a real if narrow moat, and why the United States is both the growth engine and the binary risk. The paid section runs the numbers, decomposes the return on equity into its five honest components to prove the quality is earned and not borrowed, values the thing properly, steelmans the case against paying up, gives you the green-amber-red monitoring framework and the position size, and tells you the exact price that flips it from watchlist to buy. Subscribe to read the verdict.

Read more

A short note, because you should always know what is coming before anyone else does. The dashboard is live, and as of today it is yours, a full week before it opens to the rest of the partners.

Your way in is dashboard.boredombaron.com, and this month’s password is founding-june (it rotates at the start of each month, and I will al…

Read more

Divergence watch: the European financial press leaned more bearish this week, yet the quantitative fear indicators actually eased. That gap, between what the headlines say and what the market is pricing, has been with us for several weeks now, and it is still the most important thing on this page. A souring narrative sitting on top of a calm tape is either a market that has not yet caught up to the story, or a press corps that has run out ahead of the facts. Working out which one you are looking at is most of the job.

The Week in Context

Here is a small puzzle to open with, because I think it teaches the whole week.

On Wednesday and Thursday, investors around the world did precisely what frightened investors are supposed to do. They sold technology stocks hard enough to trip a circuit breaker in Seoul for the second time in a single week, they dragged Asian indices down to two-week lows, and they pushed volatility higher. And in the middle of all that fear, gold, the one asset every textbook tells you to run toward when the lights flicker, slipped back below $4,000. Our Fear Gauge scores Safe-Haven Demand at 5 out of 100 this week, which is almost the floor of the range. Read that number twice. The world reached for the emergency exit and found it bolted shut.

If you have been reading this briefing through the spring, you will recognize the pattern immediately, because it is the single thread that has run through the entire Hormuz arc since the conflict erupted in late February, now more than four months ago. I have been calling it the Broken Safe-Haven Mechanism, and this week handed us the cleanest illustration of it we have had yet. More on that below.

The trigger this week was not European at all. It was American and Asian. Apple raised MacBook and iPad prices by 20 percent, shed roughly $263bn in market value, and blamed the move squarely on an AI-driven memory shortage. Microsoft followed with Xbox price increases for the same reason, and the read-across into Asian suppliers was instant, with the selloff explicitly traced to memory cost concern. For a European small-cap value investor the temptation is to file all of this under “tech-sector problem, not mine,” and that would be a mistake, because the transmission lines are real and they run in two directions at once. On one side, the cost-push impulse buried in those memory prices is an inflationary signal that complicates the ECB easing story and keeps the cost of capital high. On the other, a tech-led risk-off is exactly the kind of episode that historically seeds a rotation into boring, profitable, cash-generative industrials. The catch this week is that the rotation has not arrived cleanly, because the marginal flow is not switching seats, it is leaving the building, a point the Ares private credit fund made for us by capping redemptions.

Against that imported backdrop, two genuinely European stories stood out, and both cut against the comfortable consensus. Germany agreed to take a 40 percent stake in tankmaker KNDS, another step in the slow nationalization of European defense strategy that will reshape procurement supply chains for years. And a ship was struck by an unidentified projectile in the Strait of Hormuz, the first reported attack since the interim US-Iran peace deal, landing on the very same day that Brent crude fell back below the $72.48 it traded at before the conflict began. Hold those two facts next to each other, because the rest of this briefing is largely about the space between them.

The way I see it, the market is currently pricing three things simultaneously:

1. a smooth ECB easing cycle,

2. a durable Hormuz de-escalation, and,

3. contained AI cost inflation.

The signals this week suggest it may be wrong on all three at the same time. That is the setup.

Where We Are in the Arc

For newer readers, this briefing tracks the Hormuz crisis through three running theses, and the discipline is to check each one every week rather than restart the narrative from scratch. Here is where the three stand after this week, and how that has shifted from where we were.

The Broken Safe-Haven Mechanism strengthened, and it is no longer subtle. Gold fell during a genuine risk-off episode, Safe-Haven Demand printed 5 out of 100, and EUR/USD Pressure sits at 96 out of 100, almost pinned. The dollar absorbed the safe-haven bid, climbing on Fed rate-hike expectations while the Hong Kong dollar hit a 10-month low. For a euro-based investor this is the uncomfortable part of the whole arc: when the next real shock arrives, there is no domestic safe harbor waiting. The euro weakens, gold is not cooperating, and you import inflation on top of the drawdown. This thesis has done nothing but harden since we first flagged it.

The Fragmentation Thesis gained several bricks this week. Binance is exiting the EU after failing to secure a MiCA license, which is regulatory fragmentation of capital markets made concrete, the same story told from the Brussels side as a multi-market pullout. The FT laid out a blueprint for European monetary autonomy, an explicit ambition to desynchronize from the dollar system over time. The KNDS stake is defense-industrial consolidation along Franco-German lines. France leaned on the Hormuz energy crisis to defend strict car climate rules, energy security reshaping industrial policy in real time. And the trade plumbing kept rearranging as the Philippines, the UAE and Indonesia opened CPTPP accession talks. The world is re-bundling into blocs across finance, energy, defense and trade all at once. For boring European industrials this is not abstract theory, it is the slow construction of a more regional, more protected, more strategically minded European supply chain, and over time that favors the embedded domestic supplier over the globally sourced commodity one.

The Three Trigger Conditions are the framework for knowing when the crisis has graduated from a contained, range-bound event into a systemic one that finally reaches European value stocks. The notable thing this week is that all three flashed a warning at once, for the first time in a while, even though none has actually triggered.

The first condition, energy re-interdiction, got its clearest ping yet. The ship strike is the first attack since the interim deal, and while Brent is still below the pre-war $72.48, the tail risk that had been quietly closing has reopened. The supply side is plainly trying to normalize anyway, with empty LNG tankers massing outside Qatar as exports tick up and Iraq pressing OPEC to let it pump more. Tankers queuing for normal exports while a cargo vessel takes a projectile in the same water are not compatible signals, and that incompatibility is the whole point.

The second condition, credit transmission into Europe, is the subtle one, and it deserves a careful read. Our Euro Credit Stress component is still benign at 24 out of 100, sitting in the 76th percentile of calm, which on its face says all clear. But the Ares flagship fund just capped redemptions after 14 percent withdrawal requests. The public credit gauge is calm precisely because the stress is showing up first in the private-credit channel that the gauge does not measure. That is a textbook case of what I call Confession Lag, the printed indicator and the structural reality pointing in opposite directions. Do not watch the spread here. Watch the private channel.

The third condition, the monetary path breaking, stayed latent but warmed. There was no ECB move this week, only a digital-euro essay from the board, but EUR/USD Pressure at 96 and a firmer dollar on Fed expectations are the exact mechanism that would eventually force the ECB to hold rather than cut. Not triggered, but no longer cold.

The reason the framework matters is that you do not wait for all three conditions to trigger before you act on the portfolio, because by the time all three are confirmed it is already in the price. You position around the pings.

Share

The Contrarian Corner

This is where I want to spend a little extra time this week, because the contrarian setup is unusually clean.

The consensus read is that oil back at pre-war levels signals a durable Hormuz de-escalation and that energy-cost relief for European industrials is now effectively locked in. The contrarian read is sitting right there in the same news cycle: a ship was struck in that exact waterway on that exact day. LNG tankers are lining up in anticipation of normal exports at the same moment a projectile finds a cargo vessel. These two facts do not belong inside the same stable peace. The market is discounting the attack as noise. The arc says treat it as signal, and price the energy tailwind for European specialty chemicals and waste processors as conditional rather than banked.

There is a second contrarian layer, on the value rotation that everyone keeps waiting for. The textbook says a tech-led risk-off rotates capital into boring, profitable value, and plenty of commentators are leaning on that script. But the Ares redemptions tell a different story about the marginal flow right now. It is not rotating, it is de-grossing. Liquidity is leaving, not changing seats. The contrarian patience here is to refuse to assume the rotation arrives on schedule, and to prefer balance-sheet strength and genuine energy-cost pass-through over the kind of deep-value optionality that only works when the funding market is friendly. The companies that look cheapest on a screen are often the ones that most need a benign credit backdrop to realize the value, and that backdrop is the thing in question.

The third contrarian point is the boring tell hiding in plain sight. Gold did not protect, which is the Broken Safe-Haven Mechanism again. Aluminum is on its fourth straight weekly drop, iron ore is heading for its seventh, and China’s crude imports keep falling. That is not the commodity backdrop of an overheating, broadly inflationary world. It is the backdrop of softening real demand with a cost-push problem bolted on top, and the cost-push is coming from chips, not from an economy running hot. The contrarian conclusion is that the inflation the ECB is genuinely worried about is increasingly a supply-side, energy-and-components story rather than a demand story, which matters a great deal for the question of which European companies can actually hold price into next year. The ones with real pricing power earned from embeddedness keep it. The ones with merely cyclical pricing do not.

The Gauges, Decomposed

The Fear Gauge composite is 42 out of 100, Cautious, and it actually eased by 1.6 from last week. The headline number is the least interesting thing here. The story is in the spread between the components, because two of them are screaming and four of them are calm.

EUR/USD Pressure at 96 is the heaviest tail this week, even though it carries only a 10 percent weight. The euro is under real strain as the dollar mops up global risk-off flows, and this single number is the Broken Safe-Haven Mechanism expressed quantitatively. Global Vol Spillover at 72, on a 15 percent weight, is the imported turbulence from the US and Asian tech rout reaching European screens through the volatility channel. Then the picture flips. Euro Equity Volatility at 50, which carries the single heaviest weight at 25 percent, is merely middling, which tells you European volatility has not actually spiked, and that is the main reason the composite stays only Cautious rather than Anxious. Euro Equity Momentum at 24 and Euro Credit Stress at 24, on 15 and 20 percent weights, are both benign and both sitting around the 76th percentile of calm. The credit one is the Confession Lag flag from earlier, calm on the surface precisely because the stress is in the private channel it cannot see. And Safe-Haven Demand at 5, on a 15 percent weight, is the floor and the tell of the week.

The shape of this gauge, then, is a market importing fear through the currency and volatility channels while its own equity and credit internals stay composed. That composure is the thing to respect and the thing to distrust in equal measure, because it is exactly what a calm-before tape looks like and also exactly what a genuinely resilient one looks like, and this week the data alone cannot tell you which.

Subscribe now

Dimension Breakdown

The Sentiment Gauge composite is -1.4, Slightly Bearish, and it decomposes into five dimensions, four of them negative and one green.

Geopolitical Risk, scored -4, is the most negative dimension and the engine of the bearish read. The ship strike in Hormuz is the acute signal, the first attack since the interim deal and a direct threat to the de-escalation narrative that let oil fall back below pre-war levels. Layer on Ukrainian drones forcing Moscow residents into shelters for the first time, a genuine escalation in the Russia-Ukraine conflict, plus the KNDS stake as an expression of structural defense-industrial mobilization, plus France citing the Hormuz energy crisis to harden climate rules, plus the Binance MiCA exit as interventionist regulatory posture. For energy-intensive European industrials the net effect is a persistent energy-price risk premium that is genuinely difficult to hedge at the company level.

Capital Flows and Rotation, scored -3, is predominantly risk-off, driven by the tech selloff that began in Asia and rolled west. The Korean trading halt and the Asian two-week lows are real risk-appetite deterioration. The Ares redemptions are the canary for European leveraged mid-caps, because if private-credit funds are forced into defensive positioning, refinancing conditions for the mid-market companies that lean on them will tighten in the second half. Gold below $4,000 says even traditional havens are under pressure, the stronger dollar is a headwind for European exporters with dollar revenue and euro costs, and while Apple supplier Lingyi rose in a $1.1bn Hong Kong debut, showing Asian primary markets are partly open, the European small-cap IPO window remains effectively shut.

Consumer and Economic Confidence, scored -2, is deteriorating modestly, and the deterioration is forward-looking anxiety more than hard data. The Apple and Microsoft price hikes are a direct purchasing-power signal, since flagship goods jumping a couple hundred dollars per unit pressures discretionary spending across the income range, and the memory-chip cost-push is a source of European goods inflation that is not yet sitting in ECB models. Iron ore on a seventh weekly loss and aluminum on a fourth point to softening goods demand globally, which historically correlates with weaker European export orders, particularly for German specialty manufacturers selling into Asian construction. The heat wave is a double-edged consumer signal, boosting HVAC and energy spend in the near term while squeezing real incomes through utility bills. Notably, there was not a single positive PMI or GDP print in the week’s coverage to offset any of this, and the absence of good news in a week of stress is itself a quiet signal.

ECB and Monetary Policy, scored -1, offered only one direct signal, the digital-euro essay, which is institutionally important but says nothing about the rate cycle. The broader context, though, is quietly hawkish. The stronger dollar and Fed rate-hike expectations constrain the ECB’s room to cut without triggering euro weakness and imported inflation. The Hormuz energy volatility is precisely the upside inflation shock the ECB has been vigilant about, and France treating energy security as a structural rather than monetary problem reinforces the point. With no decision and no guidance, the signal is neutral-to-mildly hawkish by omission, and the implication for small-cap industrials is unchanged: floating-rate debt stays expensive, discount rates are not falling as fast as hoped, and multiples on capital-intensive businesses stay suppressed.

Corporate Earnings Tone, scored +2, is the one green dimension, and it is nuanced rather than uniformly bullish. The most actionable European signal is VW’s sale of its Everllence division, which revealed the hidden value tucked inside ailing carmakers, a real argument for hunting sum-of-the-parts discounts across asset-heavy European industrials trading below book. Bending Spoons running an earnings-only model on distressed tech assets is a niche but relevant template for neglected digital businesses. On the cautionary side, Ryanair scrapping family seating fees under regulatory pressure shows margin risk when regulators intervene, and Ferrari’s marketing chief departing after a troubled EV debut flags brand and execution risk in the luxury-to-EV transition. Micron’s blockbuster results are a positive read for semiconductor-adjacent suppliers, even as the Apple price hikes introduce demand-destruction risk at the device end. The heat-wave rally in air conditioning and building-efficiency stocks is a genuine catalyst for the efficiency niche, while UK housebuilders warning of shockwaves as steel tariffs double is a margin warning for construction-adjacent material producers.

Read more

Is it a buy, or is it a watchlist name wearing a buy’s clothes?

Spoiler in the first section, because I respect your time.

The one-line answer, up front

This is, in my mind, a watchlist candidate, not a buy at €1.44. It is a genuinely interesting, genuinely cheap-looking, genuinely improving business sitting on top of a €605 million pension anchor and a free cash flow line that has gone the wrong way for five straight years. The deal is smart. The price is not yet cheap enough, and the cash is not yet clean enough, to back the truck up. Put it on the list, set an alert, and read on for why.

Now let us earn that conclusion.

The setup

Let me describe the most boring business I can think of, and then I am going to ask you to get excited about it.

A 175-year-old German company makes enormous metal machines that put ink on paper. The machines cost millions of euros each, they live in industrial sheds for two decades, and they exist to serve an end market (printed matter) that has been in polite, well-mannered decline since roughly the day Steve Jobs walked on stage with the first iPhone. The company is headquartered in a town called Wiesloch. It pays no dividend. Its stock has lost roughly half its value in the past twelve months. Its trailing price-to-earnings ratio is 28, the kind of multiple you normally pay for software, not for ink-on-steel.

And on 25 June 2026, a research house looked at all of that and said: Buy.

Welcome to Heidelberger Druckmaschinen.

This is exactly the sort of name that makes value investors lean in and everyone else reach for their phone. So let us do the unglamorous thing and actually read the numbers, because there is a real question buried under the press releases. Heidelberg just bought the lifecycle (read: service and spare-parts) business of its insolvent arch-rival, Manroland sheetfed, out of a German insolvency process.

• The bull case is that this bolts a chunk of sticky, high-margin, recurring revenue onto an installed base that cannot easily switch suppliers.

• The bear case is that you are buying a slightly larger piece of a melting ice cube, and paying for the privilege with a balance sheet that has a very large skeleton in it.

Both can be true at once. That is what makes it interesting.

Subscribe now

What actually happened (and what the spin left out)

Here is the catalyst, stripped of adjectives.

On 24 June 2026, Heidelberg announced it had signed a purchase agreement to take over the worldwide lifecycle business of the manroland sheetfed Group: the service operations, the spare-parts business, the related intellectual property, around 35 sales and service market organizations across the globe, selected assets, and roughly 600 employees. Manroland’s printing-press manufacturing in Offenbach am Main, the part that actually loses money, is not part of the deal. That plant is being wound down. No price was disclosed.

The following morning, Warburg Research upgraded the stock from Hold to Buy and lifted its price target from €1.60 to €1.80, calling the deal “strategically sensible.” The shares popped about 3.6% to €1.44. That implies roughly 25% upside to the Warburg target, and the broader analyst consensus target sits higher still, around €2.10.

Now the context the upgrade note was a touch quiet about.

Manroland sheetfed, owned by Britain’s Langley Holdings, filed for protective insolvency proceedings (the German Schutzschirmverfahren) in March 2026 and tipped into open insolvency on 1 June. Langley’s own accounts pegged Manroland’s 2025 losses at €43.2 million. So this was not a competitive coup in any normal sense. Heidelberg’s closest direct rival in sheetfed offset did not lose a price war. It collapsed. Heidelberg then walked into the wreckage and picked up the one part of the carcass that throws off cash: the service and parts arm that supports more than 3,000 installed Manroland presses worldwide.

That is the deal. It is clever. It is also, let us be honest, the corporate equivalent of buying the dead man’s tool drawer at the estate sale.

Profitable, sensible, and not exactly a sign that the neighborhood is thriving.

What you are actually buying

Before we judge the deal, we need to understand the company, because Heidelberg in 2026 is not the Heidelberg of investor memory.

Strip it down and there are two businesses living inside this ticker.

The first is the press business. Heidelberg designs and builds sheetfed offset and digital printing presses, the flagship being the Speedmaster line. This is the part everyone pictures: heavy, cyclical, capital-intensive, exposed to the capital-expenditure budgets of commercial printers and packaging converters around the world. When the global economy is good and printers feel flush, they buy a new Speedmaster. When it is not, they wait another year, and another, and they call the service guy instead. New-equipment revenue is lumpy, low-margin, and structurally challenged, because the world simply does not need more printing capacity than it already has.

The second business is the interesting one. Heidelberg calls it Lifecycle, and it is the aftermarket: spare parts, consumables, service contracts, software, remote diagnostics, performance subscriptions, the whole annuity stream that flows from a press for the fifteen-to-twenty years it sits on a customer’s floor. This is the razor-and-blades half of the company. The press is the razor, sold at thin margin to win the floor space. The parts, the service, the consumables, the contracts: those are the blades, and the blades are where the money actually lives.

If you understand nothing else about Heidelberg, understand this. The investment case has almost nothing to do with selling more presses and almost everything to do with squeezing more, stickier, higher-margin revenue out of presses that are already installed. The Manroland deal is a direct expression of that strategy. Heidelberg did not buy a factory. It bought 3,000 customers who now have nowhere else to go for genuine parts and service.

Which brings us to the word the bulls keep using.

How sticky is “sticky,” really?

“Sticky” is one of those words that does a lot of heavy lifting in pitch decks and very little work in spreadsheets. So let us pressure-test it.

There are genuinely good reasons the aftermarket here is sticky, and they are not marketing fluff.

A sheetfed offset press is a precision machine that runs for the better part of two decades. Over that life, the cumulative spend on parts, service, and consumables comfortably exceeds the original purchase price. The owner cannot realistically go to a generic third party for critical components, because the tolerances, the firmware, the safety certifications, and the warranty all point back to the original manufacturer. Downtime on a press that anchors a print shop’s entire production schedule is catastrophically expensive, which means customers pay for reliability and fast parts availability without much haggling. And there are only two names that ever truly mattered at the high end of sheetfed offset: Heidelberg and Manroland. One of them just died.

So when Heidelberg absorbs Manroland’s service book, it is not winning customers in a competitive bake-off. It is becoming the only adult in the room for those 3,000 installed presses. Their owners need genuine parts and support, the original supplier no longer exists as a going concern, and the spare drawer now has Heidelberg’s name on it. That is about as captive as an industrial customer gets. Warburg is right that this strengthens the recurring revenue stream, and right that recurring service revenue carries far better margins than selling a new press at a knife-fight price.

Now the part the bulls skate past.

Sticky is not the same as growing. The installed base of sheetfed offset presses is, in aggregate, shrinking. Commercial print (catalogs, magazines, marketing collateral, the stuff that competes directly with screens) is in slow structural decline, and that decline does not reverse. Every year, some presses come off the floor and are not replaced. The service annuity attached to those machines retires with them. So what Heidelberg has bought, and what its own core aftermarket represents, is a high-margin, captive, beautifully defensible revenue stream attached to a slowly deflating balloon.

The honest way to describe it: a melting ice cube with a very slow melt rate and exceptional margins on the meltwater.

There is one important nuance that keeps this from being a pure liquidation story, and it is the reason the company is not uninvestable. Packaging. Folding cartons, luxury packaging, pharma packaging, and food packaging are not in decline. They are flat-to-growing, propped up by e-commerce, regulation, and the simple fact that a box still has to be a physical box. Heidelberg has spent years tilting its mix toward packaging customers, who keep buying, keep printing, and keep needing service. The commercial-print balloon is deflating; the packaging segment is roughly holding its air. The blended result is a business that is not dying so much as slowly, grindingly stabilizing at a lower altitude.

So: how sticky is sticky? Sticky enough that the recurring revenue is real, defensible, and worth paying something for. Not sticky enough to grow on its own. The Manroland deal does not change the trajectory of the industry. It changes Heidelberg’s share of a shrinking-but-cash-generative pie, and it does so at what was almost certainly a distressed price, because you do not pay full freight for assets pulled out of an open insolvency. On the merits, the deal is a good one. Just do not confuse “good deal” with “growth story.” They are different animals.

The numbers, which are where the romance goes to die

Let me walk you through the financials, because this is where you find out whether the turnaround narrative survives contact with an income statement. Heidelberg runs an April-to-March fiscal year, so “FY2026” means the year ended 31 March 2026.

Start with the top line.

Take a moment with that.

Revenue peaked at €2.47 billion in FY2023, the post-Covid restocking snapback, and has drifted down to around €2.29 billion since. Call it flat-to-gently-declining, hovering in the low €2.3 billion range. The most recent quarter showed revenue down about 11% year-on-year, so the softness is not ancient history.

This is not a company growing into anything. It is a company defending a top line.

Now look at the net income column, and try not to get seasick. Heidelberg earned €91 million in FY2023 and €0.30 per share. Two years later it earned €5 million and €0.03 per share. That is not a rounding error. That is earnings power evaporating by more than 90% in 24 months. FY2026 clawed back to €15 million and €0.05 per share, which counts as progress only because the prior year was nearly breakeven.

This matters enormously for the valuation. When earnings are this thin and this volatile, the price-to-earnings ratio becomes almost meaningless. Heidelberg’s trailing P/E of 28 is not telling you the stock is expensive. It is telling you the denominator collapsed. On the forward estimates the multiple drops to roughly 8 to 11 times, which is a completely different story. Both numbers are “true.” Neither is useful on its own. That is the trap with cyclical near-breakeven industrials, and it is why the lazy screens flag this as either wildly overvalued or absurdly cheap depending on which E they grab.

Now the part that actually matters: cash.

Here is the honest synthesis, and it is more nuanced than the version I would have given you from a quick screen. On the company’s own definition, Heidelberg generated positive free cash flow in FY2022 through FY2025, in a range of roughly €50 to €88 million. So this is not a perennial cash incinerator. But two things are true at once. First, that free cash flow has fallen in a straight line every year, from €88 million to €72 million to €56 million to €51 million, and then to negative €19 million in FY2026. Second, the company’s definition is generous: strip out proceeds from asset disposals and look at the cruder operating-cash-flow-minus-capital-expenditure figure, and the underlying number is far lumpier and frequently hovers around breakeven or below. Either way you cut it, FY2026 was a cash-burn year, as severance payments and accelerated investment in the new defense venture cleared the bank before the savings landed.

A business whose entire bull thesis rests on “high-margin recurring revenue” should be a cash machine. This one is not, yet. The annuity is real. The owner’s cash it is supposed to produce keeps getting consumed by the cost of running, and restructuring, a large fixed German industrial base. That gap is the single most important thing to watch.

Subscribe now

The skeleton in the balance sheet, now with a precise weight

The headline balance sheet looks reassuring, which is precisely why you should read past the headline. The bulls love to quote it. At 31 March 2026, Heidelberg held a net financial position of positive €39 million. Net cash. On a sub-€500-million company, that sounds like a fortress.

Then you open the annual report to the provisions note, and there it is.

The precise figure, from the audited FY2025/26 accounts published on 10 June 2026: provisions for pensions and similar obligations of €605 million as of 31 March 2026. That is actually down from €650 million a year earlier, and the decrease is not because Heidelberg paid anything down. It is because the German pension discount rate rose from 3.8% to 4.2% over the year, which mechanically shrinks the present value of the obligation. Higher rates flatter the number; they do not make the pensioners go away. Total provisions, including restructuring and warranties on top of pensions, come to €770 million.

Sit with the scale of that. The net pension provision is more than fifteen times the celebrated net cash position, and it is larger than the company’s entire book equity of about €563 million (an equity ratio of 27%). The “net cash” headline is technically accurate and almost completely beside the point. The real obligation hanging over this enterprise is the pension, and it dwarfs everything else on the right-hand side of the balance sheet.

This is not a scandal. It is normal for a century-old German industrial with a long, loyal, and now largely retired workforce. The plan is partly funded through a dedicated pension trust, and the company is not about to be sunk by it. But it has two very real consequences that the soundbite valuation ignores, and they are the reason this stays on the watchlist rather than jumping into the buy column.

The first consequence is a cash and earnings drag that never shows up in EBITDA. The net interest cost on those pension obligations ran about €24 million in FY2026. Look at what that does to the income statement: operating income of roughly €50 million, and then nearly half of it is eaten by the pension’s financial unwind before you even get to tax. That is a structural reason the net line is so thin. The pension is quietly taxing the equity holders every single year, and it will keep doing so.

The second consequence is what it does to enterprise value, which is where the “cheap” thesis quietly falls apart.

Valuation, part one: the cheapness goes to hide

The bull pitch leans on a delicious-sounding number: Heidelberg trades at roughly 3 times EV/EBITDA. Three times! For a profitable industrial with a captive aftermarket! Surely that is a giveaway.

It is, until you remember what enterprise value is supposed to include.

A net pension obligation is debt in everything but name. It is a senior, non-negotiable, cash-consuming claim that sits ahead of shareholders. Load it into enterprise value, where it belongs, and the picture changes completely. Take the roughly €438 million equity value (304 million shares at €1.44), add the €605 million pension, subtract the €39 million of net cash, and the true enterprise value is about €1.0 billion. Against FY2026 adjusted EBITDA of €151 million, that is not 3x. It is closer to 6.6x, and on the lower statutory EBITDA it is nearer 8x.

Six to eight times EBITDA for a structurally declining, thin-margin, cyclical industrial is not expensive. But it is not cheap either. It is fair. The whole “deep value on an enterprise basis” story evaporates the moment you treat the pension as the liability it plainly is. What is genuinely cheap here is the equity optics: 0.78 times book, 0.18 times sales, a single-digit forward P/E. And those equity metrics are cheap precisely because the equity sits behind a €605 million pension wall. The market is not being stupid. It is pricing the anchor.

This is the single most important correction to the bull case, and it is why I keep using the word “watchlist.”

The turnaround: real surgery or interpretive dance?

To the company’s credit, management is not sitting still, and the actions are more concrete than the usual investor-day vocabulary.

Heidelberg is in the middle of a genuinely aggressive cost program. It is moving production of its flagship Speedmaster CX 104 entirely to China, and building a new facility in North Macedonia, both classic plays to drag the cost base out of expensive German labor and into cheaper geographies. It has already signed more than 550 severance agreements with German employees, which is real, painful, balance-sheet-affecting restructuring rather than a slide that says “efficiency.” The CEO and CSO had their contracts renewed early, back in April 2026, which signals the supervisory board wants continuity through the program rather than a reset.

And then there is the curveball. Heidelberg has stood up a new division, HD Advanced Technologies, and is pushing into defense, trying to repurpose its precision-engineering and metalworking know-how toward the one end market in Europe currently swimming in government money. Whether this becomes a meaningful third leg or a rounding-error distraction is genuinely unknowable today, but as free optionality on a stock this cheap, it is not nothing. A company that can build a Speedmaster to micron tolerances can plausibly build other precise metal things, and Europe is rearming.

The trouble is that the surgery is costing exactly what it was always going to cost, in exactly the place it hurts most.

Here is the catch, and you knew there would be one. The adjusted EBITDA margin did not improve in FY2026. It fell, from 7.1% to 6.6%, against a guidance that had called for the opposite. Management blamed a weaker product mix and the accelerated, upfront cost of standing up the defense business. Restructuring and new ventures are cash and margin events before they are benefits. So in the near term you get the worst of both worlds: the savings have not fully landed, the severance checks and defense investments have already cleared, the margin slipped, and the free cash flow turned negative. The plan is sensible. The question is whether the margin actually arrives on the far side of all this spending, and whether the structural decline of the core market eats the savings before they reach the bottom line. That is a real and open question. Anyone who answers it with confidence is selling something.

What about EPS and the long term?

Let me address the question directly, because it is the right question. What is happening with EPS, and what are the long-term prospects?

EPS is recovering off a near-breakeven trough, and the analysts modeling this company expect that recovery to continue. The consensus has FY2027 EPS around €0.13 and FY2028 around €0.175. Run those against today’s €1.44 share price and you get a forward P/E falling from roughly 11x to under 8x. If those estimates are even approximately right, the stock is cheap on forward earnings. That is the entire foundation of Warburg’s Buy.

The phrase doing all the work there is “if those estimates are right.”

Look again at the seismograph in Figure 3. The historical EPS path reads minus 1.08, minus 0.12, plus 0.11, plus 0.30, plus 0.13, plus 0.03, plus 0.05. Now tell me, with a straight face, how much confidence you place in a smooth glide to plus 0.18. The analyst model is a clean upward staircase. The actual history is a heart monitor. For the estimates to be met, three things all have to go reasonably well at once: the cost program has to deliver the targeted margin, the Manroland service book has to integrate cleanly and accretively, and the underlying market cannot deteriorate faster than the savings accrue. None of those is implausible. All three landing together, on schedule, is a more demanding ask, and FY2026 (margin down, cash negative, mix weak) is a reminder of how easily one of them slips.

Long term, the realistic picture is this. Heidelberg is not going to become a growth company. The end market will not allow it. What it can plausibly become is a smaller, leaner, higher-margin, cash-generative survivor: the last credible manufacturer standing in high-end sheetfed offset, harvesting a captive aftermarket across both its own and Manroland’s installed base, anchored increasingly in packaging rather than dying commercial print, with a cost base relocated to cheaper geographies and an option ticket in defense. That is a perfectly respectable thing for a stock to be. It is a “re-rate from distressed to merely cheap, then collect the cash” story, not a “compound at 15% for a decade” story.

The Manroland deal fits that story precisely. It does not bend the growth curve upward. It thickens the annuity and removes the only other service provider for a few thousand captive presses, at a distressed price. That is value accretion, not growth. For a value investor, that distinction is the whole game, and it should temper the enthusiasm without killing it.

Valuation, part two: the three-point probabilistic view

Now the part you came for. Let us put a number on it, the usual way, with three scenarios, explicit assumptions, and probabilities, then weight them. I am anchoring on a blend of a normalized earnings multiple and a pension-adjusted EV/EBITDA, sanity-checked against book value, because no single lens is trustworthy on a near-breakeven cyclical with a pension anchor. Current price for reference: €1.44.

Share

Bear case: €0.95 (probability 35%). The structural decline in commercial print accelerates, or the macro turns and printers freeze capital spending again. The Manroland integration proves messier and costlier than billed (insolvency carve-outs usually do). The cost program slips further, the 7% margin target is missed again, free cash flow stays negative into FY2028, and the pension drag keeps grinding the net line toward zero. The market loses patience and re-rates the stock toward distressed metrics: roughly half of book value, or a low-single-digit pension-adjusted EV/EBITDA on a declining EBITDA base. That gets you to around €0.95, roughly a third below today’s price. This is not a bankruptcy scenario, the net cash position and the real aftermarket annuity guard against that, it is a “value trap that keeps trapping” scenario. I weight it heavily, because thin-margin cyclicals in declining end-markets with large pension overhangs disappoint more often than they delight, and FY2026 already gave us a preview.

Base case: €1.75 (probability 45%). The turnaround grinds out roughly as planned. The cost program delivers most of the targeted margin, adjusted EBITDA recovers back toward and through €160 million, the Manroland service book is modestly accretive, and EPS recovers toward the €0.13 to €0.15 range. The market re-rates the stock from “distressed” to merely “cheap declining industrial”: call it about 11 to 12 times those normalized earnings, or a still-modest pension-adjusted EV/EBITDA. That lands you right around €1.75, which, not coincidentally, is essentially the Warburg target. About 22% above today’s price. This is the “management does what it says, the industry behaves, nothing heroic happens” outcome, and I give it the highest single weight because the plan is coherent and already substantially underway.

Bull case: €2.80 (probability 20%). The cost cuts land in full, the relocated production structurally lifts gross margin, the Manroland annuity proves more profitable than expected, packaging momentum holds, and the defense optionality starts to look like a real third leg rather than a press release. EPS pushes toward €0.18 to €0.20 and the market, starved for cheap industrial cash flow, re-rates the whole thing to 14 to 15 times earnings. That carries you back toward €2.80, the 52-week intraday high the stock literally printed less than a year ago, so it is not a fantasy number, just a demanding one. It is roughly a double from here. I cap the probability at 20% because it requires several good things to compound, and Heidelberg’s recent history is not one of several good things compounding.

Now weight them:

(0.35 x €0.95) + (0.45 x €1.75) + (0.20 x €2.80) = €0.33 + €0.79 + €0.56 = €1.68

A probability-weighted fair value of about €1.68, against a current price of €1.44. That is roughly 17% expected upside.

Sit with what that number is, and what it is not. It is positive. The skew is modestly favorable: the bull case (+94%) is a bigger move than the bear case (-34%), so the upside tail pays you more than the downside tail costs you. But the expected return is mid-teens, not a fat, mispriced, back-up-the-truck number. And it is built on a 45% base case that only just clears the analyst target, plus a hefty 35% chance of a one-third drawdown. This is not the kind of asymmetry that makes you mortgage the house. It is the kind that earns a name a place on the list and, at most, a small starting position, with room to add if the bear scenario shows up and hands you €0.95.

So, to be clear: watchlist or buy?

I told you the answer in the first section, but let me earn it properly now, because the user asked me to be unambiguous and I will be.

Watchlist. Not a buy at €1.44. Three reasons, in order of importance.

1. First, the pension changes the valuation verdict. The story the market tells about this stock (”net cash, 3x EBITDA, below book”) is the story of a deep-value giveaway. The story the audited accounts tell is of a fairly-valued enterprise carrying a €605 million pension that is larger than its equity, consumes €24 million of earnings a year through the interest unwind, and pushes the true EV/EBITDA to a perfectly ordinary 6.6x. The equity is cheap because it sits behind that anchor, not because the market missed something. That is a fine reason to own a stock at the right price. It is not a reason to pay up.

2. Second, the cash is not clean yet. The thing that converts a watchlist name into a buy, for me, is a credible inflection in free cash flow. Heidelberg’s free cash flow has fallen for five straight years and turned negative in FY2026. The bull thesis is “high-margin recurring revenue,” the proof of that thesis is owner’s cash, and the owner’s cash is currently going out the door. I want to see one, ideally two, clean periods where the recurring revenue and the cost savings actually drop through to positive free cash flow after restructuring. The moment that prints, the bear case weakens materially and the name graduates.

3. Third, the margin just went the wrong way. Management guided to a higher FY2026 adjusted EBITDA margin and delivered a lower one, 6.6% against 7.1% the year before. The entire turnaround rests on clawing back above 7%. I would like to see them actually do it before I assume they will.

What keeps it firmly on the list rather than in the bin? The deal genuinely is smart. Buying the only other sheetfed service provider’s captive customer base out of insolvency, at what was surely a knock-down price, with no new factory to feed, is precisely the kind of quiet, unglamorous, accretive move that does not move the needle in a single year but compounds the aftermarket annuity over many. The balance sheet, pension aside, is not stretched. The restructuring is real and already cutting. The packaging tilt is the right tilt. The defense angle is a free option. And the whole thing trades on single-digit forward earnings with not a single sell-side cheerleader in sight. That is the raw material of a Boredom Baron pick. It just needs one more thing, a better price or a cash-flow inflection, before it is cooked.

What flips me from watchlist to buy? Any one of three triggers.

1. A pullback toward the €1.20 to €1.30 area, which would widen the expected return to something genuinely fat and roughly match the lower end of the recent range.

2. Or a print of sustained positive free cash flow that validates the recurring-revenue thesis after restructuring costs.

3. Or hard evidence, in the first integrated numbers, that the Manroland service book is landing margin-accretively rather than just adding revenue and integration expense.

Get a cheaper price and a cash-flow inflection together, and this stops being interesting and starts being obvious.

And the liquidity reminder, because it is your kind of illiquid. Heidelberg trades on Xetra as HDD and over the counter in the US as HBGRF, and the HBGRF line in particular can be thin and gappy. The German line is more liquid, but this is still a sub-€500-million micro-cap where a few hundred thousand shares move the price 3 to 4% in a session, as we just watched on the deal news. Scale in patiently, use the German listing where you can, and mind the spread.

The Baron’s bottom line

Heidelberg Druckmaschinen is a 175-year-old company selling shrinking quantities of magnificent machines into a slowly dying market, and it has just made the smartest possible move available to a company in that position: it bought the captive service annuity of its dead rival, cheap, and skipped the factory. The strategy is coherent, the restructuring is real, and the equity looks cheap on every optics-based measure that fits in a headline.

It is also a thin-margin, cash-burning-this-year, structurally-challenged industrial whose earnings line looks like a heart monitor, whose margin just slipped when it was supposed to rise, whose recurring-revenue thesis has not yet shown up as recurring cash, and whose entire enterprise sits behind a €605 million pension obligation that the cheerful “net cash” headline politely forgets to mention. Load that pension where it belongs and the 3x bargain becomes a fair 6.6x.

“Sticky” is real here. It is just sticky around a slowly shrinking base. The Manroland deal makes Heidelberg’s slice of that base bigger and its margin on it richer, without bending the growth curve. That is value, not growth, and it should be priced as such.

So, to be unambiguous: this is a watchlist candidate, and a good one. It is not a buy I would chase at €1.44. The probability-weighted upside is a respectable-but-unremarkable 17%, the pension reframes the cheapness into mere fairness, and the cash flow is pointing the wrong way.

Put it on the list. Set the alert at €1.25. Read the next two cash-flow statements like a hawk, and watch for the first set of numbers that fold Manroland in.

When the free cash flow inflects, or the price comes to you, do not wait for the sell side to notice, because by then it will not be boring anymore, and boring is the entire point.

Sincerely,

The Boredom Baron

Subscribe now

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Disclaimer:

The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments.

While I strive for accuracy, the information presented may contain errors or omissions, or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented.

This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice.

This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment decisions.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Notes:

• Data sourced from the EODHD fundamentals and price feeds (HDD.XETRA / HBGRF) and the audited Heidelberg FY2025/26 annual report (consolidated financial statements, published 10 June 2026), with deal and restructuring facts linked inline throughout.

• Share price as of the 25 June 2026 close of €1.442. Fiscal year ends 31 March.

• This is analysis and opinion for a value-investing newsletter, not investment advice, and the author is describing a thinly traded micro-cap that can gap on low volume.

• Do your own work, size accordingly, and mind the spread.

The company is ATOSS Software SE, ticker AOF on Xetra, and I want to be honest with you from the first paragraph, because that is the entire arrangement here. By every rule I have ever written down for this newsletter, I am not supposed to be interested in ATOSS. It is not my usual attention desert and a supply-chain embeddedness story. It is a beloved, thoroughly modeled, nine-analyst SDAX quality name that the German small-cap faithful have adored for years, and my entire edge is built on finding the things nobody is looking at, in the languages nobody wants to read, in the corners of Europe where the research simply does not exist. ATOSS is the opposite of all of that. So why am I writing thousands of words about it?

Because the most useful thing I can teach you for free is not another obscure name.

It is the discipline of looking at a genuinely wonderful, genuinely cheap-for-once business and being able to say, calmly and without flinching, “lovely, and not for me.” That muscle is worth more than any single ticker. Let me show you how it works, using the best possible specimen.

The chart above is the whole emotional arc in one line. ATOSS compounded quietly from the low teens to an all-time high of EUR 140.37 in July 2025, split-adjusted, and has since given back almost exactly half of it, closing at EUR 71.30 on 22 June 2026. (If you have seen a write-up calling this a thirty-eight percent fall from the high nineties, that note is simply stale; the de-rating has gone further and the stock is cheaper than the consensus narrative has caught up with.) Nothing in the operating numbers explains a move of that size, which is precisely what makes it interesting. A drawdown like this is a re-rating of the multiple, not a verdict on the machine, and the first job of any honest analyst is to tell those two things apart.

The thesis in one paragraph, so you know where this is going

ATOSS is a debt-free, founder-built, cash-gushing workforce-management software business that has grown revenue at roughly fifteen percent a year for twelve years without a single down year, that earns a thirty-six percent operating margin and a fifty-percent-plus return on equity, and that the market has just put on sale at the cheapest valuation it has carried in a decade. That is the bull case, and it is a real one. The bear case is that even after the fall it still trades at twenty-three times earnings for low-teens growth, in a maturing home market, in a German economy that is shedding manufacturing jobs, with a founder who sold down half his stake near the top and a leadership handover landing at the turn of the year, all while the market re-prices every piece of application software it owns for the age of AI. My own verdict, which I will defend at the end, is that ATOSS is a textbook holding for the boring, low-maintenance, quality-compounder sleeve of a portfolio, the place where you put things that need no special insight to own, and that it is emphatically not a name where my particular edge does any work at all. Both of those statements are true at once, and learning to hold them together is the point of the exercise.

The 101 course: what ATOSS actually sells, and why it sticks

Before any number means anything, you have to understand the product, because the durability of the whole story lives in the answer. ATOSS sells workforce management software, which is a polite umbrella term for the deeply unglamorous business of figuring out who works when. Time and attendance, shift planning, demand-driven staffing, absence and vacation management, and, crucially, compliance with the thicket of European labor law that governs all of it. If you run a hospital, a logistics depot, a three-shift factory, or a supermarket chain, you have a non-trivial daily problem: you must put the right number of correctly qualified people in the right place at the right time, without breaking working-time directives, collective bargaining agreements, or the local works council’s hard-won rules, and without paying for idle hours you did not need. ATOSS is the software that solves that problem, and it has been solving it since Andreas Obereder founded the company in Munich in 1987.

Here is why it sticks, and why the stickiness is the real asset. Once a company embeds ATOSS into its operations, the software is wired into payroll, into the ERP system (typically SAP or Oracle), into the scheduling logic of every department, and into the compliance reporting that keeps the labor inspectorate and the union satisfied. Ripping it out is not a software migration, it is organizational surgery, and implementations that take three to eight months to stand up are not casually unwound. The company serves roughly 15,600 customers across more than fifty countries, managing the schedules of over four million employees, and the roster of references reads like a tour of the European real economy: Deutsche Bahn, Lufthansa, ALDI Sud, Coca-Cola, and a long tail of industrial names I will come back to. This is operational switching-cost stickiness, the kind that compounds quietly because the cost of leaving rises every year the system is in place. It is a genuine moat. It is also, and I will be equally honest about this, a completely different species of moat from the one I usually hunt, and that difference is going to matter later.

The structural tailwind underneath all of this is the least sexy and most reliable kind. Labor is getting scarcer and more expensive across Europe, shift-based operations are under permanent pressure to squeeze more output from the same headcount, and the regulatory burden around working time only ever grows. The European workforce-management software market was worth roughly EUR 2.7 billion in 2025 and is growing at around eight to nine percent a year. ATOSS does not need to win share to grow; it needs only to ride a structural demand pool that gets bigger whether the economy is good or bad. Tight labor markets make scheduling software valuable because every hour matters. Loose labor markets make it valuable because every euro matters.

That is the kind of demand profile that lets a company string together twenty consecutive record years, which is exactly what ATOSS has done.

The transition that turned a good business into a great one

If you want to understand why ATOSS earned its premium in the first place, you have to look at what happened to the shape of its revenue, because the company executed one of the cleaner software-business transformations in Europe and most people who own the stock could not tell you the details. ATOSS used to sell perpetual licenses, the old model where a customer pays a large one-time fee, you book it as a lumpy upfront sale, and then you pray for the next deal. Over the last several years it has methodically converted itself into a subscription business, where customers rent the software on a recurring basis and the revenue arrives every year like rent. This is the single most important thing that has happened to the company, and it is why the quality crowd fell in love.

The growth record speaks first. Revenue climbed from EUR 35.5 million in 2013 to EUR 189.3 million in 2025, a compound rate just under fifteen percent a year, and net income grew faster still, from EUR 3.0 million to EUR 48.4 million, because the model gets more profitable as it scales. There is not a single down year in the series, through a pandemic, an energy shock, two European recessions, and a German manufacturing slump. That is not luck. That is a business whose customers cannot easily stop paying.

Now look at the composition, because this is the part the headline growth rate hides. Recurring revenue, meaning cloud subscriptions plus software maintenance, has climbed from fifty-eight percent of the total in 2022 to seventy percent in 2025, and management is steering toward seventy-five percent by 2027. Cloud and subscription revenue alone grew twenty-eight percent last year to EUR 92.7 million, now nearly half of all sales, while the old one-time license line withered to EUR 8.8 million, down thirty-five percent, exactly as intended. The reason this matters for an investor is subtle and worth slowing down for: during a license-to-subscription transition, reported revenue growth understates the underlying progress, because a euro of upfront license revenue is being deliberately traded for a stream of smaller annual subscription euros that add up to far more over time. The optics get worse before the economics get better. A company doing this well looks like it is decelerating when it is in fact strengthening, and that gap between optics and reality is precisely the kind of thing that creates a mispricing.

The cleanest way to see through the optics is to ignore reported revenue entirely and watch the contracted recurring base instead. Cloud annual recurring revenue, the run-rate value of every active subscription, grew from EUR 58.9 million at the end of 2023 to EUR 101.3 million at the end of 2025, and reached EUR 109.8 million by the first quarter of 2026. Net revenue retention sits around 111 percent, which in plain English means the existing customer base spends eleven percent more each year even before ATOSS signs anyone new, and the cloud order backlog stands near EUR 109 million of revenue already contracted and waiting to be recognized. This is the engine under the hood, and it is still accelerating away from the headline. When a skeptic tells you ATOSS is “slowing,” ask them whether they are looking at reported revenue or at the recurring base, because the two are telling different stories and only one of them is the truth.

Share

Why the quality crowd was right about the business

Let me give the bull case its full due, because the quality is not an illusion and I have no interest in being contrarian for sport. This is, on the numbers, one of the cleaner compounders in European software, and the things that make it clean are exactly the things that are hard to fake.

Start with the margins, because they are the tell. ATOSS earned a thirty-six percent operating margin in 2025 and a net margin above twenty-five percent, and the operating margin has climbed steadily from the mid-twenties a decade ago. Margins that expand as a company scales are the signature of genuine operating leverage and real pricing power, the marks of a business selling something customers value rather than something they tolerate. The gross margin sits near seventy-nine percent, return on equity above fifty percent, and return on assets near twenty-eight percent, the sort of capital efficiency that only a software business with a sticky installed base can produce.

And here is the detail that earns ATOSS extra credit from anyone who has been burned by software accounting: the company expenses its research and development as it spends it rather than capitalizing it onto the balance sheet to flatter near-term profit. R&D ran about EUR 28.6 million last year, roughly fifteen percent of revenue, and it is already fully absorbed in that thirty-six percent margin. The profit you see is the profit there is. There is no hidden spending lurking off the income statement waiting to ambush you, which is more than you can say for a depressing number of “profitable” software companies.

Then there is the balance sheet, which is the part that lets you sleep. ATOSS carries no financial debt at all and sits on roughly EUR 121 million of net cash, and it generated EUR 46 million of free cash flow last year and EUR 58 million the year before, on capital expenditure of barely a million. This is a company that funds its own growth out of pocket, returns most of its earnings to shareholders, and would not notice a credit crunch because it has never needed a lender.

When people use the phrase “quality compounder” as a marketing slogan, this is the picture they are gesturing at without usually bothering to show you. The combination of high margins, high returns on capital, no debt, and conservative accounting is rare, and it is rare for the boring reason that it is genuinely hard to build.

It also pays you while you wait, which the growth crowd tends to forget a compounder can do. ATOSS has declared a EUR 2.28 per share distribution for 2025, up from EUR 2.13, which works out to a yield north of three percent at today’s price, and over the years it has topped up the ordinary dividend with occasional specials. The payout has run between roughly sixty and seventy-five percent of earnings, with the lumps in the chart marking the special years. There are no share buybacks, which is the German way, but the cash return is real and rising. A three-percent yield on a business growing the underlying earnings at low double digits is not a bond substitute; it is a compounder that happens to hand you some of the cash along the way, which is a perfectly nice thing to own if your nervous system is the kind that likes dividends.

The one thread that touches my actual turf

I promised honesty, so here is the single place where ATOSS brushes against the work this newsletter actually does, and I am going to be candid that it is a narrow thread rather than a load-bearing beam. My franchise is built on operations and supply chains, on understanding how physical value chains hang together and where the embedded, hard-to-displace suppliers sit. ATOSS is software, so on the face of it there is no overlap. But look at who actually runs ATOSS’ software, and a connection appears.

The customer base is heavily weighted toward shift-based, physically intensive, supply-chain-exposed operations: manufacturing and logistics above all, then healthcare and retail. The named references are a roll-call of the industrial economy I spend my time thinking about: DB Schenker in logistics, Barry Callebaut in food processing, and a cluster of automotive and components suppliers including Pierburg, Knorr-Bremse, Federal-Mogul, EBM-Papst, and Fronius. In these businesses, labor scheduling is not a back-office nicety; it is the layer that translates a production plan or a freight schedule into actual humans standing at actual stations, and it flexes in real time as order volumes swing. You can squint and see ATOSS as the workforce-scheduling layer of the physical supply chain, the software that decides how a shift-heavy industrial operation actually deploys its people against demand. There is a real thesis in that framing, and it is the one strand of the ATOSS story where my way of thinking earns its keep.

But I am going to be the one to tell you it is a narrative bridge and not a rigorous application of my toolkit, because if I do not say it, the framing flatters itself. Much of my analysis work is about embeddedness in physical value chains, about qualification cycles and design-in and the specific relationships that make a components supplier impossible to replace.

ATOSS sells horizontal software into many industries; its moat is software switching costs, which is a real and well-understood thing, but it is the same analytical frame that a hundred better-resourced software specialists already apply to every SaaS company on earth. I bring no special tool to it. The supply-chain customer base is a nice color, a way to make the business feel familiar to me, but it would be intellectually dishonest to dress it up as the kind of edge that justifies a marquee deep dive. So I am declining to do that, on the record, which brings me to the uncomfortable part.

Why this is not, and should not be, a Boredom Baron name

Everything I do rests on two pillars. The first is the attention desert, the structural reality that the names I write about are under-researched because of language barriers, research-unbundling economics, and the simple fact that most European small-cap money never leaves its DACH-and-Nordic comfort zone. The second is the supply-chain read, my particular way of seeing physical value chains. ATOSS fails the first test outright and only grazes the second, and a name that misses on both is, by definition, not where my edge lives.

Consider the attention question with actual data rather than vibes. ATOSS is followed by roughly nine sell-side analysts with a consensus Buy rating, including Berenberg, Warburg Research, Hauck Aufhauser, Deutsche Bank, and a more cautious Jefferies. This is not a desert; it is a well-tended garden with a tour guide. If I write the ATOSS report, I am the eighth or ninth voice on a name that quality-growth funds have modeled to the decimal place for the better part of a decade, and I arrive with no informational advantage and no privileged angle, just an opinion. As a tell of how crowded this already is, while I was researching it I tripped over an independent write-up built on the exact “the forty-something-percent fall makes ATOSS worth a look” thesis I would have been tempted to write. When the angle you think is yours is already a published headline before you have typed a word, that is the market telling you the desert is, in fact, a city.

This is the discipline I actually want to teach with this piece, and it is worth more than the name itself.

The temptation, when you find a wonderful business on sale, is to convince yourself you have an edge because the edge would be so convenient to have. You reach for a framing, you find one that half-fits, you talk yourself into it. The honest move is to ask coldly whether you know something the nine analysts and the quality-growth funds and the substack writers do not, and if the answer is no, to file the business in the right drawer and move on without bitterness.

A wonderful business you have no edge on is not an opportunity; it is a distraction wearing an opportunity’s clothes.

Knowing the difference is most of what keeps a research process honest over a career.

Subscribe now

The bear case, in its strongest form, because token risk sections are an insult

If I am going to talk you out of treating this as one of my names, I owe you the genuine reasons it could disappoint even the people who do own it, stated as forcefully as I can manage rather than as the obligatory paragraph of throat-clearing that most write-ups bury at the bottom.

Start with valuation, because a forty-nine percent fall is not the same thing as cheap. At EUR 71 the stock trades around twenty-three times trailing earnings and roughly fourteen times enterprise value to EBITDA, for a business now guiding to low-double-digit revenue growth. That is a perfectly defensible multiple for a compounder of this quality, but it is not a bargain in any absolute sense; comparable European SaaS names change hands at twenty-one to twenty-four times, so at twenty-three times ATOSS now sits squarely inside the peer band, the decade-long quality premium finally compressed away rather than discounted below it. The de-rating took the stock from absurd to merely fair, not from fair to cheap, and anyone telling you a great company at twenty-three times is a screaming buy is selling you the word “great” and hoping you do not check the “times.”

The valuation chart is genuinely two-faced, and you have to read both faces. Yes, twenty-three times is the lowest ATOSS has traded in a decade, well below its ten-year average near forty times and a world away from the eighty-two times it touched in 2021. That is the bull’s chart, and it is real. But notice what it also tells you: the entire history above was the era of free money and software euphoria, the period when investors paid any price for recurring revenue. “Cheap relative to its own bubble” is not the same as “cheap,” and the danger in anchoring to a 2021 multiple is that you are anchoring to a regime that may simply not return. The honest reading is that the multiple has normalized, not collapsed, and normal is the right price for a slowing compounder, not a discount to it.

Then there is the macro and the maturity problem, which is the proximate cause of the fall and not a trivial one. The reason the stock cracked is that German and Austrian sales cycles lengthened through 2025 as customers, especially in manufacturing and automotive, delayed software budgets amid a genuinely grim German industrial backdrop in which the economy was shedding well over ten thousand manufacturing jobs a month. ATOSS earns roughly eighty percent of its revenue in the DACH region and holds around a twelve percent share of that core market, which means its home turf is both mature and macro-sensitive at exactly the wrong moment. The growth-from-here story therefore leans heavily on international expansion, and international is barely six percent of revenue and entirely unproven at scale. A company can be wonderful and still spend three years growing into a multiple because its home market stalled, and that is a real path for ATOSS, not a tail risk.

Now the governance wrinkle, which is the detail that the stale write-ups get wrong and that I find genuinely telling. The old story on ATOSS was that founder Andreas Obereder controlled roughly half the company, the classic aligned-owner-operator setup that quality investors love. That is no longer true. Obereder’s vehicle, AOB Invest, sold a large slice to the New York growth-equity firm General Atlantic in mid-2023, and a further accelerated placement in September 2024 cut the founder’s stake to around twenty-two percent. Read that sequence against the price chart. The man who knows this business better than any analyst alive, and a growth-private-equity firm whose entire profession is timing software multiples, were both reducing exposure into the strength that preceded a forty-nine percent fall. I am not going to tell you that is dispositive, founders diversify for a hundred innocent reasons and Obereder remains the largest holder and the CEO, but I am also not going to pretend it is nothing. Insider selling near a top is exactly the sort of fact a disciplined reader notes out loud rather than explaining away.

Stack the rest on top. The founder is handing the CEO role to chief operating officer Pritim Kumar Krishnamoorthy at the turn of 2026 into 2027, a planned and orderly succession but a key-person transition all the same, in a company that has been run by its founder for thirty-nine years. The free float is thin, around nine million shares on the SDAX, which means liquidity is poor and institutional positions are hard to build and harder to exit. And the competitive frame is not static: the global human-capital giants, UKG with its twenty-seven percent slice of the workforce-management market, along with Workday, SAP, and Ceridian, are increasingly bundling workforce management into full suites, and while ATOSS wins on European labor-law depth today, “bundled and good enough” has killed better specialists than this one. None of these alone breaks the thesis. Together they are why the stock is not, and arguably should not be, back at eighty times.

But I have saved the largest question in software for last, because skipping it would be cowardice dressed up as concision: in 2026, doesn’t AI simply eat a business like this? The challenge has teeth and it deserves them. The dominant market story of the year is that artificial intelligence dismantles application software from the inside, that agents and near-free code generation collapse the moats SaaS spent two decades building, and the sell-off has been violent enough that investors gave it a name, the “SaaSpocalypse”, a software-sector rout driven by exactly this fear. ATOSS, however undeserving, was standing in the blast radius, and part of its de-rating is not about Germany at all; it is every investor re-asking whether they want to own any vertical software at all, at any multiple. If an enterprise can soon have an agent assemble its own shift logic on demand, why rent the Munich specialist forever? You have to sit with that question, not wave it off.

Here is why ATOSS is, of all the software I might be looking at, close to the worst possible target for that thesis. The work that survives, on the most credible reading of where the durable moats now sit, is the regulated system of record built on proprietary data that cannot be cheaply reproduced; S&P now frames software durability in precisely those terms, and even the disruption bulls concede that agentic AI hollows out workflow tools long before it touches the authoritative source of truth. ATOSS is that source of truth for a brutally specific problem: who is legally permitted to work which shift, under which collective-bargaining agreement, blessed by which works council, auditable for which labor inspectorate. A model that hallucinates a working-time breach is not a feature, it is a liability, and no operations director hands the legal exposure of a homegrown compliance engine to an LLM because it demoed well. Regulatory complexity only grows and the appetite to own that risk in-house only shrinks, which makes the compliance depth I walked through in the 101 course the rare kind of moat that AI thickens rather than dissolves. Nor is ATOSS standing still and praying. It already ships AI-based workforce forecasting as a paid tailwind, reached five AI services in general availability by late 2025, and in May 2026 opened an AI technology hub in Bengaluru built explicitly for multi-agent systems, reinforcement learning, and real-time work orchestration. Inside its own walls it looks far more like an AI beneficiary than an AI casualty.

So is the AI bear case nothing? No, and I keep the bear the two points that genuinely survive the counter. The first is sentiment rather than fundamentals: the market can de-rate the entire application-software category on the AI narrative regardless of which names deserve it, and the real-world impact will be uneven and slow to sort the survivors from the casualties, so ATOSS can wear a structurally lower multiple for years simply for the crime of being software. The second is sharper and loops straight back into the bundling worry, because AI is the accelerant under it: the same human-capital giants are racing to bolt autonomous scheduling onto suites a customer already owns, and “bundled, good enough, and now AI-assisted” is a quicker killer of the international-growth story than plain bundling ever was. The compliance moat defends the installed base beautifully. It defends the next decade of new logos, the ones that have to be won outside the regulated DACH heartland where the whole growth case lives, considerably less completely than the bulls assume. The honest shape, then, is this: the lazy “AI kills software” line is unusually weak against ATOSS in particular, the company is closer to an AI beneficiary than an AI victim inside its own walls, and yet the AI era still rationally caps the multiple and narrows the runway, which is, conveniently, the very same verdict the rest of the bear case reached by other roads.

I will leave the valuation argument with the most honest chart in the piece, and note what it is and is not. It plots the published fair-value estimates other people have put on ATOSS against today’s EUR 71, and the spread is enormous, from a consensus analyst target around EUR 126 and bullish broker numbers stretching to EUR 157, all the way down to a multiples-based model that pencils in EUR 45, well below the current price. I am showing you other people’s numbers deliberately, because putting my own probability-weighted fair value and a buy level on this would cross the line into the work that lives behind the paywall, and this is a free teaching piece. The lesson in the chart is not “which target is right.” It is that when serious models disagree by a factor of three on the same set of facts, the honest position is humility about the multiple, not conviction, and the way you express that humility is position sizing, not a price target you defend to the death.

To put arithmetic on that spread rather than just admire it, here is a transparent three-point cut, built on the same two-stage discounted-cash-flow engine the data services use, ten years of growth fading over a further ten to a four percent terminal rate, discounted at ten percent, so you can check every figure yourself. Start with the trick actually worth teaching, the reverse DCF: at EUR 71 the market is paying for roughly fourteen percent annual earnings growth from here.

Sit with that number, because ATOSS has compounded earnings at better than twenty percent a year for a decade. The market is not pricing a wonderful company at a wonderful price; it is pricing a decelerating one, and almost the entire debate collapses into a single question, whether fourteen percent is too pessimistic (the bull case) or about right (the bear's). The three scenarios below just turn that one question into a fair-value range. I am deliberately not collapsing them into a single probability-weighted number with a buy level stapled to it, because that weighting is the real work and it lives behind the paywall; what is free, and far more useful to a learner, is seeing exactly which assumption each price is quietly making.

NB: Trailing EPS ≈ €3.05; €3.26 expected for 2026. The bear lines up with the €45 multiples-floor in Figure 9; the bull with the broker fair values clustered at €105–€126. Reverse-DCF implied growth at €71 is ~14%, versus a realized ~20% over ten years and ~22% over five … the market has priced a clear deceleration, which is the whole asymmetry: you win if ATOSS slows by less than feared, you lose if it slows by more.

My Value Ramblings

So where does that leave us, after all the kind words and all the cold ones? Pretty much where intellectual honesty usually leaves you, which is somewhere less exciting than either the bull or the bear would like.

ATOSS is a wonderful business. I mean that without irony. Twenty straight record years, a thirty-six percent operating margin, no debt, a fortress of net cash, a subscription engine still compounding at high-twenties percent under a headline that flatters to deceive on the downside, and a moat made of the most durable material there is, which is the sheer organizational pain of ripping out the system that decides who works when. If you want a low-maintenance compounder for the part of your portfolio that exists precisely so you do not have to think about it, the part where you put quality and let time do the work, ATOSS at twenty-three times after a forty-nine percent fall is a thoroughly reasonable thing to own, and you need no special insight from me or anyone else to own it well. That is the whole appeal: it is a good decision that requires no edge.

But it is not a core Boredom Baron idea, and the gap between those two statements is the entire lesson I wanted to leave you with. My edge is the attention desert and the supply-chain read, and ATOSS is a crowded, beloved, nine-analyst name whose moat sits in a software frame that better-resourced specialists already own. I could write you a competent ATOSS report. It would be indistinguishable from the several that already exist, it would leverage not one of the things that make this newsletter worth reading, and it would be, in the end, a generic quality-growth note with my name on it, which is the one thing I have promised never to hand you. The discipline of saying so, of declining to spend a marquee slot on a name where I bring no advantage no matter how lovely the business, is worth more to you over time than the note itself would have been. The boring possibility, as ever, is the under-priced one, and the boring possibility here is that the right move with a wonderful company you have no edge on is simply to admire it, file it in the compounder drawer, and keep your firepower for the deserts where the real mispricing lives.

If you love the business, and it is easy to, treat it as exactly what it is: a quality compounder the market briefly put on sale, a name worth your own research and your own homework, not a recommendation and not a pick. And then let the deep-dive slot, the one that costs me weeks and earns its keep only when my edge actually compounds, go to a genuine attention desert. There is a Polish nuclear-supply-chain name and a coverage-orphaned French auto-components supplier both waiting their turn, and neither of them has nine analysts, a tour guide, or a substack headline already written about it. That is where I am going next.

The boring possibility is, as I keep telling you, the under-priced one.

Having said this, I have added it to the growth sleeve of my portfolio and started a small position last week.

Sincerely,

The Boredom Baron

Subscribe now

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Disclaimer:

The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments.

While I strive for accuracy, the information presented may contain errors or omissions, or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented.

This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice.

This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment decisions.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

The members’ edition (dropping later this week) names the companies, scores the whole field, and builds a portfolio.

This is research and commentary, not investment advice, and certainly not a substitute for thinking.

1. A four-billion-euro price tag on a maker of metal boxes

The most revealing number in European industrials this month did not come from a company anyone has heard of. It came from SGB-SMIT, a transformer maker in Regensburg that ninety-nine percent of professional investors could not have identified in a police lineup three years ago, which is now reported to be testing the public market at a valuation north of four billion euros. Four billion. For a company whose entire reason to exist is to manufacture large metal boxes that make electricity a different voltage than it was a moment ago.

Read that again, because the instinct is to assume a typo. There is no typo. On a reported forward EBITDA of roughly 300 million euros, the talked-about price tags the business at around thirteen times earnings before all the things accountants like to add back. That is not a multiple the market hands out for making boxes. It is a multiple the market hands out for owning a chokepoint, and a transformer maker, it turns out, owns one of the best chokepoints in the industrial economy.

Here is the part the energy-transition brochures bury under photographs of wind turbines at golden hour. Transformer, switchgear and cable makers sit at the single narrowest point of three separate spending waves that have, with no coordination whatsoever, decided to arrive at the same time. The electrification of everything that currently burns fuel. The integration of wind and solar into grids that were designed by engineers who would have laughed you out of the room if you had described the modern energy system to them. And, the gatecrasher nobody invited, the bottomless electricity appetite of the data centers being built to run artificial intelligence. Each of those, on its own, would keep these factories busy for a decade. Together they imply a genuine, physical, years-long shortage of exactly the boring equipment these companies happen to make.

So the four-billion-euro question is not whether the demand is real. It plainly is. The question is the one the brochures never ask: is this a durable structural shortage you can own for years, or is it the precise moment a private-equity owner sprints for the exit while the public is still applauding? Both can be true at once, which is what makes this interesting. The free edition lays out the demand, the supply, the money and the catch. The members’ edition does the part that actually pays for itself: it names the businesses, scores them on how much of this theme they genuinely capture versus how much they merely gesture at in an investor deck, checks every valuation by hand, and builds a portfolio. Read this far and you will understand the sector. Read the second half and you will know what to do about it, which is a different and considerably more profitable thing.

Subscribe now

2. Three supercycles, one set of factories

Start with the demand, because for once the demand is not the usual analyst fan-fiction. It is arithmetic.

Electrification. The slow tectonic story is that the world is swapping things that combust for things that draw current: cars, heating, steelmaking, rail, whole industrial processes. All of it lands on the grid. The International Energy Agency, an organization not given to excitable language, puts it about as bluntly as it ever does: for every dollar spent on renewable generation, only about sixty cents goes to the grids and storage needed to make any use of it, and in every scenario it models that ratio has to climb toward one-to-one through the 2040s. Translation: for fifteen years the world has been enthusiastically building power stations and quietly forgetting to build the wires to carry the power anywhere. That bill has now come due, and it does not take a credit card.

Renewables integration. A grid built around a few hundred large, obedient power stations is a fundamentally different animal from one built around millions of small, weather-dependent ones that generate hardest precisely when nobody needs it. Connecting North Sea wind to southern German factories, or Spanish sun to French industry, demands high-voltage transmission, undersea cable, converter stations and a great deal of switchgear. ENTSO-E, the club of European grid operators, has costed a project portfolio worth roughly 328 billion euros to 2040, rising toward 863 billion of total electricity infrastructure by 2050, and helpfully notes that every euro spent returns more than two in system savings, which is the sort of return profile that usually requires a financial crime to achieve. Meanwhile the queue of renewable projects waiting to plug into the European grid runs to roughly 1,700 gigawatts, and curtailment, the polite phrase for switching off perfectly good clean power because the wires cannot carry it, cost the system an estimated 8.9 billion euros in a single year. We are, in other words, building wind farms we then pay to switch off. The wires, not the windmills, are the binding constraint, and have been for some time.

Artificial intelligence. And then, right on cue, the accelerant nobody had in their model. European data-center electricity demand is set to rise sharply by 2030, with credible estimates running from the IEA’s roughly 70 to 115 terawatt-hours up to McKinsey’s punchier near-tripling toward 150 terawatt-hours, or something like five percent of the continent’s power, from a rounding error. The binding constraint, yet again, is not the generation. It is the grid. In the established hubs of Frankfurt, London, Amsterdam, Paris and Dublin, the wait for a connection now runs seven to ten years against a build cycle of eighteen to twenty-four months. Ireland’s data centers already inhaled twenty-two percent of the entire country’s metered electricity in 2024 and are heading toward thirty. Great Britain’s connection queue has bloated past 700 gigawatts, which is several times what the country could conceivably need, a queue so absurd the system operator had to invent new rules to clear out the speculative tickets. Every one of those connections, when it eventually happens, needs transformers, switchgear and cable. This is not a demand forecast. It is a waiting list, and waiting lists do not get talked out of existence on an earnings call.

The point that ties the three together, and the one most thematic ETFs miss entirely, is that they share one set of factories. The transformer line serving a utility upgrading a substation is the same line the offshore-wind developer and the hyperscaler are both queuing for. They are fighting over the same scarce output. That fight is what turns a worthy infrastructure story into something far more valuable to an investor: a pricing-power story.

3. Why the supply side cannot simply answer

In a textbook, this is where the story ends. Demand surges, prices rise, capacity floods in, returns get competed away, and the analysts who wrote “structural” in their notes quietly delete it. The reason this cycle refuses to follow the textbook, and the reason a box maker can fetch thirteen times EBITDA without anyone calling security, is that the supply side physically cannot respond on anything like the usual timetable.

The wait for a large power transformer has gone from roughly fifty weeks in 2021 to about 120 to 128 weeks by 2025, with bespoke units quoted at up to four years, while prices have climbed on the order of seventy-five percent since 2019. When the customer is willing to wait the better part of three years and pay three-quarters more than they used to, you are not looking at a market about to be rescued by a wave of new supply. You are looking at a queue.

Three things keep the queue long. First, a critical ingredient, grain-oriented electrical steel, the specialized silicon steel transformer cores are wound from, comes from a handful of producers on earth and roughly doubled in price during the squeeze. You cannot conjure it. Second, the factories are slow and expensive to build and, more to the point, the people who know how to run them are genuinely scarce; the industry has announced well over twenty billion dollars of capacity expansion, but a new line takes three to five years to qualify and ramp, and a press release announcing a factory is not the same thing as a factory. Third, the genuinely hard end, the undersea cables and the high-voltage direct-current converters that link countries and bring offshore wind ashore, sits with three or four Western suppliers, and there is no express lane to becoming the fifth.

This is the entire difference between a trade and a cycle.

The weight of the evidence says this one is the second kind. Which does not, and I cannot stress this enough, automatically make the shares worth buying.

See Section 7, where the good news goes to get expensive.

4. The money: how big, and how long it lasts

The scale of the spending behind this is the part that turns a nice story into a structural one, and it is large enough to be genuinely difficult to keep in your head.

Global grid investment sat stuck near 300 billion dollars a year for over a decade, while generation spending nearly doubled around it, because building wind farms photographs better than burying cable and politicians have eyes. That neglect is now reversing in a hurry. The IEA reports roughly 400 billion dollars of grid spend in 2025, BloombergNEF counts it higher still, north of 470 billion and a record, and both agree it has to climb toward more than 600 billion a year by 2030 to keep the lights on and the targets credible. In Europe specifically, the Commission’s 2023 Grids Action Plan put the bill at 584 billion euros this decade, and by December 2025 it had stopped pretending that would be enough and sketched a modernization need of roughly 1.2 trillion euros through 2040. Roughly forty percent of the European Union’s distribution lines are over forty years old, which is a polite way of saying a good chunk of the continent’s electricity travels through equipment installed when the Berlin Wall was load-bearing. That is replacement spending, and replacement spending does not care about your views on the business cycle.

Now, a healthy skeptic will note that politicians announce trillions the way the rest of us announce diets, and that an EU communication is not a purchase order. Fair. So look instead at the people who actually take the orders, because order books do not lie the way press releases do. As of mid-2026, essentially every listed grid-equipment supplier is sitting on a record backlog. Hitachi Energy, the giant of the field, carries around 57.9 billion dollars of orders. Siemens Energy ended its half-year with a group backlog of roughly 154 billion euros, its grid arm growing orders more than forty percent. GE Vernova’s electrification orders are running at around two and a half times what it can actually ship. The cable specialists are sold out years ahead, locked in by frameworks such as TenneT’s roughly 30-billion-euro two-gigawatt program and National Grid’s 59 billion pound Great Grid Upgrade. When the whole industry’s book-to-bill sits comfortably above one, and above two at the sharp end, demand has stopped being the interesting question.

Execution has become it.

5. Where in the chain the scarcity actually lives

“Grid equipment” is not one business, and treating it as one is how investors overpay. It is a chain that runs from the heaviest, most specialized hardware at the top to the people who sell cable by the meter at the bottom, and the scarcity, the pricing power and the margin all pool at the top like cream. Where a company sits in this chain is the whole game, because two companies can both wave the word “electrification” at you while capturing wildly different amounts of the actual bottleneck, and only one of them deserves the multiple.

Node in the chainBottleneckMarginsWhat it actually isHVDC converters and high-voltage direct currentExtremeHighestThe kit that moves bulk power long distances and links countries; a three to four player clubLarge power and distribution transformersExtremeHighThe metal boxes; throttled by special steel and scarce laborHigh-voltage and subsea cablesExtremeBest-in-classThe wires for offshore wind and interconnectors; sold out for yearsHigh-voltage switchgear and gas-insulated gearHighHighThe protection and control that makes a substation more than a shedCable accessories and connectorsMedium-highHigh, asset-lightThe small parts a billion-euro project cannot finish withoutProtection, power electronics, componentsMediumHealthyFuses, surge protection, power-quality gear, busbarsGrid automation and digitalMediumHighest (software)The software that runs the networkGrid construction and installation (EPC)Medium-highThinThe people who actually dig the holes and stand up the steelElectrical distribution and wholesaleLowestThinnestThe merchants who stock it and sell it on

The single most useful idea in this entire report is that bottleneck severity and margin run in the same direction down that table, and that the companies the market most eagerly associates with “the grid” are frequently not the ones sitting highest on it. A diversified electrical giant may derive a surprisingly modest slice of revenue from the genuinely scarce top three rows, while an unfashionable mid-cap nobody covers may live almost entirely up there. Sorting the real bottleneck owners from the companies that merely sell into the general vicinity of a bottleneck is the work of the members’ edition. It is also, conveniently, where the cheap stock tends to be hiding.

Subscribe now

6. The tell: when the insiders start selling

There is a second reason the SGB-SMIT story matters, and it is the one the bulls would rather skip. SGB-SMIT is owned by a private-equity firm that has held it since 2017, tried and failed to sell it outright in 2025, mused about parking it in a continuation fund, and is now reported to be testing the public market instead. Note the sequence. The professional buyers were offered this asset and passed; the plan to sell it to itself was floated; and only then did the public become the preferred customer. Nothing says “ground-floor opportunity” quite like being the third choice.

It is not alone at the exit. Pfisterer, a maker of high-voltage cable accessories, listed in Frankfurt in May 2025 and has since multiplied several times over from its offer price, which has every other private-equity owner in the sector reaching for a prospectus. A cluster of flotations and sponsor exits arriving simultaneously, while order books are at record highs and multiples are full, is one of the most reliable patterns in finance, and it does not signal early innings. It signals that the people who know these businesses best, the ones with the audited accounts and the customer contracts in front of them, have decided that the public market will pay them a richer price than a strategic buyer will. They are, in the politest possible terms, selling you the top of their own knowledge. This does not mean the cycle is over; the order books say it has years left to run. It means you should treat the supply of shiny new paper with the suspicion it has earned, insist on a price that makes sense, and decline to pay a scarcity premium to the very people offloading the scarce thing. The sellers know more than the buyers. They almost always do. That is why they are the sellers.

7. The catch: the boom is already in the price

Here is where the cheerleading note you may have read elsewhere and this one part company, and it is the reason this report exists in two halves rather than as a single excitable “buy the grid” sermon.

The market, irritatingly, is not asleep. The marquee listed grid names have re-rated to roughly twice their ten-year median valuations on enterprise value to EBITDA. The cable champion trades near nineteen times against a long-run median below nine. A leading electrical major trades around twenty against a median in the mid-teens. Many of these shares have doubled, tripled or worse over two to three years. The cycle is real, the demand is structural, and essentially all of that good news is now sitting in the price with its feet up. Buy the obvious names here and you are paying full freight for a cycle you are quietly assuming will run without a single stumble for the rest of the decade. The market has a long and entertaining history of punishing that assumption.

This is exactly where a value discipline stops being a personality trait and starts being an edge. There is a quiet, consistent and frankly underexploited pattern across this sector: the companies with the cleanest, purest exposure to the genuine bottleneck are disproportionately the smaller, duller, less-followed names trading on sensible multiples, while the companies wearing the richest valuations are often the big diversified ones whose true grid exposure is a minority of the business dressed up for the occasion. Theme purity and price, in other words, tend to pull in opposite directions. The crowd has bought the story. The bottleneck, at a fair price, is still sitting there largely unbothered in the part of the market that does not get written up in the weekend papers. Which names, and at what price each one stops being interesting and starts being a mistake, is precisely what the second half is for.

8. What could go wrong

No thesis this fashionable deserves to be read without its objections, and these are not garnish. They are the reason the members’ edition is selective rather than a shopping list.

• The cycle is priced as though it is illegal for it to end. The largest risk is not that the demand fails to show up. It is that the demand shows up exactly as advertised, and shares already trading at twice their historical multiples deliver precisely what was promised and not one cent more. Re-rated cyclicals are merciless to companies that merely meet expectations.

• This industry has blown itself up before, and recently. Electrical equipment has a well-documented habit of building too much capacity at the top. After the post-2008 stimulus, transformer capacity was thrown up with abandon and utilization in some markets collapsed within a few years. Today’s mid-to-high-teens margins sit comfortably above the through-cycle norm, and capacity is being added from three directions at once, by the incumbents, by a flood of Chinese exports, and by the Koreans. When supply finally catches demand, those peak margins are the first thing to mean-revert, and management teams currently describing the situation as a “supercycle” will rediscover the word “cyclical.”

• The customers can simply stop. A great deal of this rests on rate-regulated utilities and on offshore-wind and data-center developers whose projects are exquisitely sensitive to interest rates, permitting and the political mood. Offshore-wind cancellations have already happened. A regulator squeezing allowed returns or a hyperscaler pausing to digest its own build-out would hit the order books that this entire thesis leans on.

• The hard projects are genuinely hard. High-voltage direct-current and offshore work is fixed-price, first-of-its-kind and dependent on a dozen counterparties behaving. The sector’s own history is littered with large warranty and execution losses on exactly these contracts. One troubled mega-project can vaporize a year of a division’s profit, and the press release announcing it always uses the word “isolated.”

• And a word on the data. A startling number of the headline figures in this sector mix transmission with distribution, different base years and different currencies, and a fair few of the rounder numbers come from press releases rather than anything audited. The members’ edition flags where the data is soft and corrects it where the public feeds are simply wrong, which, as we discovered, is more often than is comfortable.

The honest conclusion is that this is a genuine structural cycle wrapped in a partly delusional valuation. That combination is not an argument for avoiding the sector. It is an argument for being extremely particular about which slice of it you own and what you hand over for it, which is a value investor’s natural habitat and happens to be ours.

9. The one-paragraph version

Europe is about to spend more on its electricity grid than at any time in living memory, because three forces, the electrification of everything, the integration of renewables, and the gluttonous power demand of artificial intelligence, have arrived at once and all run through the same narrow set of factories that make transformers, switchgear and cable. The supply side cannot answer quickly, because lead times have tripled, a key steel is scarce, and the top end is a closed shop, so these companies have order books stretching years out and pricing power they have not enjoyed in a generation. The four billion euros being floated for one German transformer maker is the market pricing that bottleneck in public. The catch, and there is always a catch, is that the obvious names have already re-rated to roughly twice their historical multiples and the insiders are busy selling through new listings, which is the oldest late-cycle tell there is, so the easy money has been collected by people who are not you.

What remains is the part the crowd skipped: the cleanest exposure to the bottleneck sits in the smaller, cheaper, duller, less-followed names rather than the crowded large-caps, and exploiting that gap is the entire job description of a patient, valuation-disciplined investor.

Which is to say, it is our job.

10. What the members’ edition adds

This free edition hands you the map. The members’ edition hands you the territory, by name and with the receipts:

• The whole field, scored. Two dozen listed European names across the entire value chain, each rated on how much of the theme it genuinely captures, the quality of the business, and the value actually on offer today, in one ranked table that will annoy anyone who owns the sector through the biggest name they could find.

• Deep dossiers on the names that matter. Verified financials (every market cap and multiple recomputed by hand, because the public feeds are wrong on several, including one where the headline price was overstated by a fifth), order backlogs, ownership, the bull case and the bear case, and a blunt valuation verdict for each.

• The cheap-and-clean opportunities, including the two names we think offer the best risk and reward in the entire sector, both of which you can buy today without holding your nose.

• The names to avoid, including the one celebrated large-cap we think is priced for a perfection it has no chance of sustaining, and the statistically “cheap” names that are cheap for reasons that have precisely nothing to do with the grid.

• A suggested portfolio, seven names with position sizes, the job each one does, explicit entry discipline on the ones to buy only when the market does you a favor, and a clear list of what would break the whole thesis.

Founding members get it first. It is the difference between knowing the grid is the trade and knowing how to own it without overpaying for the privilege.

Not investment advice. Do your own work. The boring possibility is, as I keep telling you, the under-priced one.

Sincerely,

The Boredom Baron

Share

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Disclaimer:

The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments.

While I strive for accuracy, the information presented may contain errors or omissions, or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented.

This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice.

This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment decisions.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Sentiment Gauge: -0.5, 🟡 Neutral (up from -1.4 Slightly Bearish) Fear Gauge: 52/100, 🟡 Cautious (holding inside the cautious band)

⚡ Rotation alert: Two gauges, both parked politely in the middle of their ranges, both radiating the kind of serenity that should make you count your fingers after shaking hands. Read in isolation they say almost nothing, which is precisely the problem, because the entire week happened underneath them. Geopolitics went from the gauge’s biggest cheerleader to its biggest sourpuss, monetary policy did the exact opposite, and inside the Fear Gauge the funding plumbing is quietly flooding while the equity surface insists everything is fine. The thermometer reads the same as last week. The patient has been swapped out for a different one.

Where We Are in the Arc

For the newer arrivals, and as a standing reminder for those of us who have been here since the shooting started, three theses have been compounding in this briefing for sixteen weeks. They are connected, they are not subtle, and this week each of them got louder while everyone else was busy applauding the ceasefire.

Thesis One: The Fragmentation Thesis. The tidy post-1990 globalization equilibrium is coming apart at the seams, and the cost of doing business across geopolitical fault lines is rising faster than a single corporate model on the planet has bothered to price. The winners are European industrials with deep regional supply chains, regulatory moats, and the balance sheets to eat an energy shock without flinching. Status this week: confirmed, and in the most embarrassing form imaginable for the bulls. The Iran deal was supposed to be the week fragmentation went into reverse. Instead, the same five days the guns fell silent, industry was warned the accord clears the way for Hormuz transit charges. The war ends and the toll booth opens for business. Tehran has apparently worked out that the most dependable revenue stream is not selling your own oil but charging everyone else to move theirs, which is the single most on-brand development of the entire conflict. Set it beside the US trade probe into Germany’s drug pricing and the EU choosing to postpone rather than settle its China confrontation, and you have three separate cracks in the same wall.

Thesis Two: The Broken Safe-Haven Mechanism. The textbook crisis script (gold rallies, the dollar bids, Treasuries get hugged, volatility stays elevated) keeps fluffing its lines. The machinery that kept risk parity portfolios upright for two decades has been quietly gutted by central bank balance sheets, the weaponization of official Treasury holdings, and official-sector gold buying that elbows private flows out of the way. Status this week: fresh evidence at both ends of the gauge. Safe-Haven Demand is pinned at 10 out of 100, gold is being shown the door even as Goldman knocks 500 dollars off its target on the no-Fed-cuts thesis, and over on the other side of the same panel, Euro Credit Stress is howling at 83. The hedge that exists for exactly this kind of week has been made redundant during the week, which is a little like firing the lifeguard because the water looks calm from the deck chairs.

Thesis Three: The Three Trigger Conditions. The posture stays defensive (cash-generative, low-leverage, energy-pass-through, single-sphere-domiciled industrials) until three conditions flip together: energy premium compression, a credit thaw, and earnings broadening beyond energy. Status this week: energy flickering, credit firmly off, earnings off. For the first time in the arc, the energy condition is genuinely alive, with oil sliding toward a weekly loss and Hormuz reopening. The catch, and there is always a catch, is that the compression arrives via a deal that bolts a permanent toll onto the strait, so the relief comes pre-installed with a ceiling. The other two conditions have not so much as twitched. The honest scorecard reads one-and-a-fraction out of three, and the fraction comes with an asterisk and a footnote. Posture: preparation, not action, and anyone telling you otherwise this week is reading the headline instead of the gauge.

If you have sixty seconds, here it is. The composite numbers barely moved, but the machine underneath them was taken apart and reassembled this week. The discipline, as ever, is to watch what rotated rather than what printed.

The Week in Context

There is a particular noise a market makes when it has spent four months pricing the end of the world and abruptly decides the end of the world has been postponed. It is the sound of sixteen weeks of accumulated caution being heaved over the side in a single session, and it is almost never the sound of people thinking clearly. That was this week. The US-Iran interim deal took effect, Iranian ships turned for home in what one report breezily called business as usual, supertankers carrying eighty million barrels queued up to thread Hormuz, oil headed for a weekly slump, and jet fuel tumbled on the promise of renewed Gulf exports. For European industrials that have been swallowing energy costs since 2022, the bull thesis wrote itself in crayon: lower energy, fatter margins, cheap valuations finally bumping into a catalyst. It is a perfectly good thesis. It is also the thesis the market opened the week believing and spent the rest of the week quietly walking back.

The trouble, as always, is in the small print. A former Obama diplomat read the deal as a tidy win for Tehran, Trump spent his week swatting at critics over the concessions involved, and India was already being described as edging only slowly back toward Middle Eastern oil even as the strait reopened. This is what selling the news looks like, and it is the oldest trade in the book, which is exactly why it manages to ambush a fresh cohort of investors every single time it happens. The market bought sixteen weeks of geopolitical premium on the rumor of resolution, and it is now discovering, with the air of a man reading the terms of his own mortgage for the first time, that resolution has a price list attached. That, in one sentence, is why Geopolitical Risk swung from plus three last week, when the deal was a daydream, to minus three this week, now that it is a document with clauses.

The most useful voice in the entire week belonged to the one institution churlish enough to refuse the party invitation. The plain question the FT put on the table, why are bond yields not lower now that the war is over, is the most important sentence written about Europe in five days, and the fact that almost nobody wanted to answer it tells you everything. If peace were real and disinflationary, the long end would be rallying with the rest of them. It is sitting on its hands. Add a hawkish repricing in US rates that has upended global currency bets, garnished by Kevin Warsh’s hawkish debut at the Fed, and the bond market is telling you, in the flat monotone it reserves for important things, that it does not buy the clean version of the story. Equities are throwing the party. Credit is standing by the door, coat on, eyeing the exits. In my experience, credit is the one that has read the room.

And then, beneath all the geopolitical theater, the signals that actually matter for this letter lined up around the least glamorous object in the industrial economy. German transformer maker SGB-SMIT entered early IPO talks at a valuation reported north of four billion euros, the EU moved to dismantle barriers to cross-border bank capital, and global capital made plain that it likes the look of Europe but would like lighter regulation as the cover charge. Three years ago a maker of power and distribution transformers was the sort of company you mentioned only to clear a dinner party. This week it is the most interesting valuation on the continent, which tells you precisely where we are in the cycle and precisely what the herd is still ignoring while it watches the strait.

Share

Reading the Sentiment Gauge

The composite landed at minus 0.5, which the dial politely calls Neutral and which I would call the single least informative number the gauge has produced all year. A minus 0.5 is a Rorschach test. The bull sees a market shrugging off geopolitics and climbing the wall of worry, the bear sees conviction draining out of a relief rally, and both walk away convinced the gauge agrees with them. It does not. The headline is a weighted average of five dimensions that are pulling in genuinely opposite directions this week, and the only way to use it is to ignore the average and read the arguments underneath. So let us be good students and read them, with the source content attached so you can mark my homework.

Geopolitical Risk

The sign flip is the whole story, and it is a clean six-point reversal from last week’s plus three. Last week this was the gauge’s chief optimist, pricing the hope of a deal. This week it is the chief pessimist, pricing the substance of the deal that actually showed up. The arithmetic is brutal: the shooting war is winding down, but the accord opens the way for Hormuz transit charges, and a bargain a former US diplomat reads as favoring Tehran is not the clean Western victory a relief rally needs in order to keep a straight face. The deeper point for our purposes is that this is the Fragmentation Thesis confirming itself in real time and in public. Peace did not restore the old cost structure for European supply chains. It swapped an acute risk premium for a chronic structural toll, which is exactly the sort of permanent friction that rewards the regionally embedded operator and quietly bankrupts the globally stretched one.

Key signal: The market bought the rumor of peace and is now selling the news of its terms. The deal ends the war and installs a toll booth, which is fragmentation in a nicer suit.

Consumer & Economic Confidence

Soft signals stayed cautious-to-grim, and the fiscal cushion is thinner than the relief crowd assumes. The EU budget fight opened with Austria announcing that rich member states are not an ATM, which is roughly the noise a fiscal union makes when the bill lands on the table and everyone suddenly remembers a prior engagement. More quietly, and more usefully, BHP took a 2.3 billion dollar writedown on a Canadian fertilizer project. That is not a supply-relief story dressed up as bad news. That is demand destruction wearing a supply-relief costume, and the distinction is the difference between a healthy disinflation and a quiet recession. Falling input prices driven by customers who have stopped buying are not the unambiguous gift the headlines keep insisting they are.

Key signal: A meaningful slice of this year’s commodity relief is demand weakness in disguise, and EU fiscal squabbling means there is precious little policy cushion underneath the European consumer if that weakness deepens.

Corporate Earnings Tone

Hard European earnings were thin on the ground, but the texture was sour everywhere except two corners. The clearest canary was services spending: Indian software stocks tumbled after Accenture warned on growth, which is the market’s way of telling you that corporate IT and consulting budgets are being trimmed, and trimmed budgets are the overture, not the finale, of discretionary caution. Layer the BHP writedown on top, add the usual background hum of governance mishaps, and the picture is one in which demand, not cost, is the binding constraint. The two exceptions are energy, where falling prices help downstream margins, and grid infrastructure, where the SGB-SMIT process is a genuine bright spot in an otherwise overcast quarter. Everywhere else, the burden of proof on earnings has gone up, and the market has not noticed.

Key signal: Outside energy and the grid, the earnings texture is soft, and a services-spending warning plus an industrial writedown both point the same way: volume, not input cost, is the problem worth watching.

ECB and Monetary Policy

This dimension staged the week’s second great reversal, from minus four to plus one, and before anyone gets excited, the move is mechanical, not dovish. Last week the ECB’s first hike since 2023 detonated inside an energy-driven inflation scare. This week, with Hormuz reopening and oil sliding, the inflation threat that justified the hike is quietly evaporating, which makes the restrictive stance look far less like a policy error and lifts the score accordingly. But the Governing Council is conspicuously declining to take the win, and the agenda on display was the central banking equivalent of leaving a burning building but keeping your coat on, just in case. While the house smoldered, Cipollone delivered an address on the digital euro as the future of money, even as the FT pointed out that Europe still has no geopolitical strategy for digital money whatsoever. Nothing says confidence in the present quite like a detailed slide deck about the future. Falling energy prices, to be clear, are not being read as permission to cut anything.

Across the Channel, the Bank of England drew the genuinely hard hand, and it earns its place in this dimension this week on merit. The shock was political. Andy Burnham won the Makerfield by-election and opened a path to challenging Prime Minister Keir Starmer, and gilt traders were left to render their verdict on what a Burnham premiership would do to fiscal credibility. A political risk premium has been injected straight into the gilt curve at the precise moment the global rates backdrop turned meaner, and the gilt market, which has the institutional memory of a goldfish and the emotional regulation of a toddler, has reacted accordingly. That boxes the BoE neatly into a corner: a softening growth picture argues for easing, while fiscal and political risk in gilts argues firmly against it. The desynchronization theme grinds on, an ECB that hiked and now holds, a BoE pinned to the spot by domestic politics, and neither of them with the slightest room to ease into a peace that may not survive contact with its own terms.

Key signal: Falling energy prices ease the inflation case, but neither the ECB nor the BoE will read that as a green light to cut, so the financing squeeze on European industrial borrowers persists, now garnished in the UK with a fresh political risk premium in gilts.

Capital Flows and Rotation

The flow signals were the most consistently cheerful part of the gauge, powered by the peace-dividend revaluation that has Europe outrunning its US peers on the thesis that the continent’s battered industrial base has more torque to normalizing energy than its better-loved American cousin. Global capital is signaling appetite for Europe, the EU is filing the rough edges off cross-border bank capital in a way that should gradually shave the cost of capital for mid-market industrials, and risk appetite for growth remains frankly indecent, with SpaceX plotting a 20 billion dollar bond deal on the heels of a record IPO. The catch is that the rotation is huddled in energy-levered large-caps, and the appetite has a tell underneath it, with the FT asking whether insurers have become dangerously addicted to private credit ratings. They have, of course, and they will rediscover that those ratings are worth exactly as much as the people being paid to write them, a lesson the market relearns roughly once a decade at spectacular expense. Flows into Europe are real. Small-cap industrials will still have to earn their slice on cash generation, not on a free ride behind the peace trade.

Key signal: Rotation into European equities is genuine but crowded into energy-levered large-caps, and the late-cycle froth in private credit is a reminder that flow-driven moves are conditional, never structural.

Sector Spotlight

The standout sector development this week, and the one closest to where this letter actually does its work, is European electrical grid equipment. The anchor is SGB-SMIT entering early IPO talks at a valuation reported above four billion euros, an arresting number for a niche maker of power and distribution transformers, a category most investors could not have picked out of a lineup three years ago. The valuation is not a clerical error. Transformer and switchgear makers sit at a genuine bottleneck across three overlapping supercycles: the electrification of everything, the integration of renewables into grids that were designed by people who never imagined them, and now the surge in data center power demand from AI compute that nobody can switch off without unplugging the future. Each of those alone implies decades of grid spending. Together they imply a structural shortage of exactly the unglamorous metal boxes these companies happen to manufacture.

This is the thesis we have carried for weeks under a single deadpan line: the market is pricing the war and ignoring the grid. The SGB-SMIT process is the first proper public price-discovery event for the category, and it validates the valuation uplift available to companies with real bottleneck positioning in the energy-transition supply chain. There is a risk worth saying out loud, which is that IPO-grade enthusiasm has an unfailing talent for compressing the very discount that made early movers in adjacent listed names attractive in the first place. The secondary question is whether smaller private comparables now use this listing as a benchmark to rerate their own exit ambitions, which they will, because that is what private owners do the moment a public comp gives them permission. Either way, the price discovery is happening in public, in real time, and it is happening in physical supply chains rather than in software, which is precisely the kind of boring, durable, mispriced story this letter exists to dig up while everyone else watches the strait.

Subscribe now

Contrarian Corner

The consensus this week is clean, confident, and very nearly unanimous: the Iran deal is a structural positive for European equities via cheaper energy and a slimmer geopolitical risk premium, and the FT, Bloomberg, and the institutional flow chorus all signed the same hymn sheet. Unanimity in markets is not comforting. It is a smoke alarm. Here are four reasons to hold the consensus at arm’s length and check its pockets.

One, the peace dividend arrived with an expiry date stamped on the box. The entire bull case rests on energy relief, and yet the accord itself opens the way for Hormuz transit charges. The spot premium compresses while a permanent structural toll is bolted on in the background. Resolution is not restoring the pre-war cost base, it is converting an acute spike into a chronic friction, which means the most leveraged versions of the reflation trade are buying a recovery with a ceiling built into its own treaty. The bulls are pricing a return to 2019. What they are getting is 2019 with a turnstile.

Two, the bond market has declined to attend. The war is over, so why are yields not lower? If peace were genuinely disinflationary, the long end would already be rallying, in bunds and in gilts, and it is conspicuously not. Equities and the bond market are telling two incompatible stories this week, and the bond market is the one with actual money riding on the instrument that prices the disinflation thesis directly. When equity and credit disagree this openly, the historical base rate does not favor the optimists holding the equities. It favors the humorless people holding the bonds.

Three, the surface is glass-calm and the plumbing is flooding. The Fear Gauge composite of 52 is an average, and this week the average is a lie of omission. On the calm side, Safe-Haven Demand reads 10 and Euro Equity Momentum reads 1, which makes the tape look positively sedated. On the stressed side, Euro Credit Stress reads 83 and EUR/USD Pressure reads 90, both buried deep in the red. A market with strong momentum and zero flight to safety, perched on top of red-lining credit and currency stress, is not calm. It is a market that has not yet checked its own basement. Credit stress at 83 is the single most important number on the panel, because credit leads equity in every cycle ever recorded, and right now it is the number the equity rally is cheerfully pretending not to see.

Four, the fertilizer tell and the lifeguard who got fired. BHP’s 2.3 billion dollar fertilizer writedown is the kind of quiet signal that vanishes under a week of geopolitical fireworks, and it points the same direction as falling agricultural input prices in general: toward demand weakness, not benign supply normalization. That sets up a specific double squeeze for agricultural-adjacent specialty chemicals, with energy cost relief arriving at the exact moment volume demand walks out the door. Pair it with gold being dumped even as Goldman trims its target on the no-cuts thesis and gold executives warn of a smuggling crisis, and you have the one hedge built for a fragmenting world being marched out the door at precisely the wrong moment. This is not a reason to chase gold this afternoon. It is the cleanest contrarian hedge-rebuild setup the gauge has handed us in months, and the best setups always feel idiotic at the point of entry, which is the entire reason they pay.

Risk and Opportunity

This week the risk ledger and the opportunity ledger are unusually crowded, so let us run both at length rather than the usual single line apiece.

⚠️ Risk one, US trade aggression mutating into a new species. The most underpriced danger of the week is the metastasis of US trade policy from honest, legible tariffs into the murkier business of attacking foreign regulation directly. The US launching a trade investigation into Germany’s spending on new medicines is not a pharmaceutical story. It is a template. If Washington decides that a European reference-pricing or cost-containment regime constitutes an unfair trade practice, the identical logic can be swung at medical devices, at specialty chemicals with US revenue, and at any sector where European states set procurement prices, which in Europe is most of them. For small-cap European industrials with US distribution or US customers, the second-order effect is a chilling frost over investment in European manufacturing capacity and a slow reorientation of US procurement away from European suppliers. The danger is compounded by an EU that is currently arguing with itself over whether its rich members are an ATM, which is not the posture of a bloc ready to mount a coordinated negotiating response. A union that cannot agree on its own budget is unlikely to present a united front to a US trade representative who has clearly developed a taste for the work.

⚠️ Risk two, the credit market nobody is watching. Beneath a relief rally that has everyone feeling clever, Euro Credit Stress sits at 83 and EUR/USD Pressure at 90, and the appetite for risk is being expressed in precisely the places that tend to break first. Insurers leaning ever harder on private credit ratings is a slow-burning fuse, because private credit is where this cycle’s optimism has been quietly warehoused, marked at prices nobody has tested in a downturn. The risk is not that any single name detonates next week. The risk is that the funding plumbing is already stressed while the equity surface is calm, and that gap closes violently when it closes at all. Credit leads, equity follows, and the lead time is exactly long enough to lull the inattentive.

⚠️ Risk three, the peace that may not hold its own terms. The entire bullish revaluation is conditional on an interim deal that, within days of being signed, was read by serious people as a win for Tehran and defended by its own architect against a chorus of critics. Interim deals favoring the side with the most to gain from reopening hostilities are not famous for their longevity. If this one frays, the snapback in oil and the violent re-bid in the very hedges currently being dumped would catch a market that has comprehensively un-hedged itself, and it would do so against an ECB and a BoE with no policy room to cushion the blow. The most dangerous portfolios this week are the ones built on the assumption that the geopolitical chapter is closed. It is not closed. It has merely been given a toll booth and a press release.

✦ Opportunity one, the grid supply chain that survives every news cycle. The most compelling structural opportunity remains the European power infrastructure and grid-modernization supply chain: the niche manufacturers, component suppliers, and engineering firms positioned in transformers, switchgear, and grid integration. The SGB-SMIT IPO process is finally providing public price discovery for a category that private and small-cap public markets have systematically undervalued for years out of sheer boredom. The drivers here, AI data center power demand, renewables grid integration, and a multi-decade grid replacement cycle, are profoundly indifferent to whether Brent prints at 70 or 130 next Tuesday, which is exactly why they keep compounding through weeks like this one while the macro tourists are distracted by the strait. This is a sector-level call, deliberately, not a single name. Separating the genuine bottleneck operators from the also-rans dressed up in the same costume is precisely the work the deep dives exist to do, and it is work that does not survive being reduced to a ticker in a market briefing.

✦ Opportunity two, a cheaper cost of capital for the unloved middle. Quietly, underneath the noise, the EU moved to liberalize cross-border bank capital flows while global capital signaled it wants in, provided the regulatory burden lightens. Neither headline will trend on anyone’s feed, which is rather the point. Both push in the same direction: a gradually lower cost of capital for the mid-market European industrials that have spent the post-MiFID-II years starved of both analyst attention and cheap funding. A structurally cheaper cost of capital is the single most underappreciated tailwind a neglected small-cap can have, because it reprices the entire discounted cash flow without management lifting a finger. The orphans of the information desert do not need a miracle. They need a lower discount rate and someone bothering to look, and this week handed them the first while this letter supplies the second.

✦ Opportunity three, the hedge everyone is busy abandoning. Following directly from the contrarian corner, the precious metals complex is being marched out of portfolios at the worst possible moment, with Goldman cutting its gold target and Safe-Haven Demand pinned in the basement at 10. In a world where the safe-haven mechanism is structurally broken (Thesis Two, still compounding), a hated, beaten-down hedge being dumped by the consensus is not a thing to mock. It is a thing to start sizing into, slowly, while it is unfashionable, because the entire job of a hedge is to be there when nobody wanted it. For the income-focused readers, the regulated and infrastructure end of the grid theme is also where the most durable PRIIPs-compliant exposure tends to live, which means the same structural story serves both sides of this house. That is rare, and rare things are worth noticing.

Fear Gauge Components

EUR/USD Pressure reads 90 out of 100, which is the single highest reading on the entire panel, and it is also, in one of the gauge’s crueler jokes, the component that matters least. This one reads the euro against the dollar, and a 90 means the euro is being leaned on hard, the dollar is winning, and the currency market has plainly not received the memo about a triumphant European reflation. That is awkward, because a genuine peace dividend flowing into European assets is supposed to lift the euro, not pin it to the floor. Instead the dollar is being bid on the back of a hawkish repricing in US rates and Warsh’s hawkish arrival at the Fed, and Europe’s supposed moment is showing up in a weakening currency. The sting is in the weight. At 10 percent this is the smallest vote on the committee, so the most alarming number on the board barely nudges the headline. The scariest reading with the quietest voice is a recurring feature of this gauge, and it is worth remembering before you take any comfort from the composite.

Euro Credit Stress sits at 83 out of 100, and unlike its neighbor it carries a 20 percent weight, the second largest on the panel, which means that when it talks the composite actually has to listen. This component reads euro high-yield credit, the spread the market demands to lend to the companies most likely to come unstuck, and an 83 says those spreads are stressed even while equities are uncorking the champagne. This is the number I keep circling back to, because credit leads equity in every cycle that has ever been written down, and a credit market flashing red underneath a serene equity tape is the oldest warning in the book. The insurers leaning ever harder on private credit are a reminder of where this cycle’s optimism has been quietly warehoused, and the bond market’s flat refusal to let yields fall is the same message in a different instrument. If you read one number on this panel, read this one. The equity rally is doing its level best not to.

Global Vol Spillover comes in at 69 out of 100, carrying a 15 percent weight, and this one reads the VIX, the American volatility index that doubles as the world’s stress barometer whether the rest of us care for the arrangement or not. A 69 is not panic, but it is not calm either, it is the market keeping its coat on indoors, and the source of the draft is not hard to locate. The same hawkish turn in US rates that is leaning on the euro is keeping global volatility elevated, because when the Fed turns meaner the entire world stops to recalculate, and recalculation always shows up as vol. For European investors the lesson is the familiar and faintly humiliating one, which is that even in a week defined by a Middle East deal and a European energy story, the weather is still being made in Washington. The spillover is real, it is moderate, and it is leaning the wrong way.

Euro Equity Volatility reads 60 out of 100, and here is where the gauge’s split personality stops being an accident and becomes a structural feature, because this component carries the heaviest weight on the entire panel at 25 percent. It reads the VSTOXX, the implied volatility the options market is pricing into European equities, and a 60 is the very definition of middling, the options market bracing for a moderate amount of trouble, neither pricing catastrophe nor sounding the all-clear. The consequence of a bland 60 sitting on the heaviest weight is that it anchors the composite firmly toward the unremarkable middle, which is a very large part of why the headline printed a forgettable 52. The single most influential input on the gauge this week is, in effect, a shrug. When the loudest voice in the room is also the most noncommittal, you should be deeply suspicious of any tidy conclusion the headline tries to sell you.

Safe-Haven Demand sits at 10 out of 100, and while that is a hair above the basement reading we have lived with for weeks, do not mistake a hair for a recovery. This component reads gold, and a 10 means the metal is still being actively shown the door rather than merely ignored. For most of this sixteen-week crisis the number has refused to rise while everything around it screamed, and I have called that refusal the broken safe-haven mechanism for so long it has very nearly become the house motto. This week it did not heal, it simply stopped falling, with Goldman trimming its gold target and the consensus marching the one hedge built for a fragmenting world straight out into the street. As I argue at some length in the Contrarian Corner below, a beaten and abandoned hedge is not a thing to celebrate. The funeral everyone else is busy attending is precisely the event that makes me want to start quietly buying flowers.

Euro Equity Momentum reads 1 out of 100, which is about as close to zero fear as this gauge ever gets, and it is the component doing the most to flatter the headline into a false calm. It reads the trend in European equities, and a 1 means momentum is not merely positive, it is sitting in the top one percent of its entire recorded history, with emerging and European equities touching record highs on the back of the peace trade. On its own that reads as unambiguous good news, and on a 15 percent weight it pulls hard, dragging the composite down toward serenity. But set it beside credit stress at 83 and currency pressure at 90, and a momentum reading of 1 stops looking like strength and starts looking like the last guest dancing while the band plays on. Strong momentum perched on top of stressed funding is not a contradiction the market has resolved. It is a contradiction the market has not yet noticed, and in my experience those are the ones that close fastest.

Line the six up and the split personality is impossible to miss. Two of them are screaming about funding, credit at 83 and currency at 90, and between them they carry barely thirty percent of the weight. Two are middling, the two volatility measures, and the heaviest of them single-handedly anchors the whole thing to a bland 52. And two are basement-calm, gold abandoned and momentum euphoric, hauling the average down toward a serenity the plumbing simply does not support. The composite is not wrong, exactly. It is just an average doing what averages do, which is quietly euthanize the most important information in the set. The credit market is the one honest voice in this building, and this week it is being comprehensively out-voted by a shrug and a victory lap.

My Value Ramblings

The way I see it, this was a week designed to flatter people who read headlines and punish people who read footnotes. The peace dividend is real, the energy relief is real, and the European reflation thesis is not stupid. It is simply incomplete, because it has decided to celebrate the end of the war while studiously ignoring the toll booth, the credit stress, the demand-driven nature of half the price falls everyone is cheering, and the bond market sitting in the corner refusing to clap. The composite gauges, both planted in the bland middle of their ranges, are aiding and abetting the comfortable interpretation. Our job, as it has been for sixteen weeks now, is to be politely allergic to the comfortable interpretation.

So the posture does not change. Preparation, not action. We watch the energy trigger, which is finally flickering, while remembering it flickers behind a permanent toll. We watch the credit market, which is the loudest thing on the dashboard and the quietest thing in the financial press. We keep building the case in physical supply chains, in grid equipment and the unloved industrial middle, where the compounding happens slowly enough that the tourists never stay to watch. And we keep one eye on the hedges that everyone else is busy throwing overboard, because the day they are desperately wanted is rarely the day they are cheap.

None of this is exciting.

That, as you know by now, is rather the point.

Sincerely,

The Boredom Baron

This briefing was generated from an analysis of European financial press articles collected during the week to 2026-06-19. Sentiment scores reflect qualitative assessment of press coverage, not market prices. The Fear Gauge reflects quantitative market data.

Both are proprietary indicators of The Boredom Baron.

Subscribe now

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Disclaimer:

The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments.

While I strive for accuracy, the information presented may contain errors or omissions, or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented.

This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice.

This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment decisions.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

• Return on invested capital (ROIC) is after-tax operating profit (NOPAT) divided by the capital actually tied up in operations; it is the most leverage-neutral measure of business quality.

• ROIC only means something against the cost of capital: above WACC, growth creates value; below it, faster growth destroys value faster.

• A compounder earns a high ROIC and can reinvest large amounts of new capital at that same high rate; Kardex held ROCE near 33% while growing capital employed +64% over 2019-2024.

• A value trap earns a low ROIC, often below WACC, and looks cheap on purpose, Vodafone earned only ~2.5-3% on capital (negative in FY2025) against a ~5% cost of capital and cut its dividend in half.

• Reported ROIC lies on serial acquirers: strip goodwill and acquired-intangible amortization out of Equasens and the operating return roughly triples, from ~11-15% to ~34%.

• High returns fade toward the cost of capital; about 79% of excess return persists year to year on average, and a moat is what buys the slow fade.

• Small-caps fade faster than large-caps on average, which is exactly why finding the durable, embedded small-cap exception in the attention desert is the edge.

The worked examples below each have their own deep dives, referenced throughout:

• Kardex, the capital-light compounder (ROCE ~33%, +64% reinvestment)

• Equasens, the goodwill trap hiding a 34% operating ROIC

Let me put two stocks in front of you and watch your instincts betray you. The first trades at roughly two times earnings and pays an eleven percent dividend yield. Two times earnings. A yield that fat. Every value screen you have ever run, every dividend filter, every reflex Benjamin Graham bolted into your skull, is screaming at you to back up the truck. The second trades at something like thirty or forty times earnings and pays a yield so thin you need a microscope to find it. Expensive, obviously. Overpriced quality. The kind of thing you tell yourself you will buy on the next crash, which never comes. And in a great many real cases, you would be precisely, expensively wrong on both counts, because the cheap one is quietly setting fire to your capital while the dear one is compounding it at a rate that will make you wealthy if you simply sit still.

I know what you are thinking. How can a stock at two times earnings be the worse buy? That feels like a violation of natural law. So let us be good students and pull this apart, because the number that tells these two businesses apart, the single most important number in my entire process and the one my screen is built around, is return on invested capital. Get it right and you will understand why some cheap stocks deserve to be cheap forever, and why some expensive stocks are the bargains of the decade. Get it wrong and you will spend your investing life buying value traps and congratulating yourself on the low multiple right up until the dividend gets cut.

The Two-Minute Version (Read This Even If You Read Nothing Else)

Here is the whole argument in one breath. Return on invested capital measures how much profit a business generates for every unit of capital tied up in its operations, calculated as after-tax operating profit divided by invested capital. The number only means something when you compare it to the cost of that capital, because a business that earns more on its capital than the capital costs creates value as it grows, while a business that earns less than its capital costs destroys value as it grows. That single relationship, the spread between ROIC and the cost of capital, is the entire game, and it is why growth is a blessing for one company and a curse for another.

• A compounder is a business that earns a high return on capital and can reinvest large amounts of new capital at that same high return, so its intrinsic value snowballs.

• A value trap is a business that earns a low return on capital, often below its cost of capital, and looks statistically cheap precisely because the market correctly senses that its growth is value-destroying and its low multiple is deserved.

ROIC is also the quantitative fingerprint of a moat, because competition relentlessly drives returns down toward the cost of capital, and the only businesses that resist that gravity are the ones protected by something structural. That something, in my world, is supply chain embeddedness. This matters most in the European small-cap attention desert, because nobody is doing the work, so the market routinely misprices both the level and the durability of a small company’s returns on capital. My screen starts at a sustained ROIC above fifteen percent, comfortably above the seven to twelve percent that most businesses pay for capital, because that gap is where compounding lives.

That is the spine. The rest of this piece adds the meat, with a clean compounder and a textbook value trap from the real world, the canonical wisdom of Munger and the persistence research of Mauboussin, a comparison table you can actually use, and an honest tour of where ROIC lies to you. Casual readers, follow the main narrative and skip the clearly labeled deep dives. Serious readers, the weeds are where the edge lives, so wade in.

What Does ROIC Actually Measure? A 101 Course

Start with the definition, because most people who quote ROIC have never built it from scratch and it shows. Return on invested capital is net operating profit after tax, which we call NOPAT, divided by invested capital. NOPAT is simply operating profit (EBIT) with taxes taken out, EBIT multiplied by one minus the tax rate, and it represents the after-tax cash the operations throw off before any decision about how the business is financed. Invested capital is the money actually tied up in running the business, which you can build from the financing side as debt plus equity minus surplus cash, or from the operating side as net working capital plus net property, plant and equipment plus the intangibles the business genuinely needs. The two roads should arrive at roughly the same place. Divide the after-tax operating profit by that capital, express it as a percentage, and you have ROIC.

The reason I prefer ROIC to its more famous cousins is that it is honest about where returns come from. Return on equity, the number most investors reach for, can be inflated to the moon with debt, because piling on borrowings shrinks the equity base and flatters the ratio even when the underlying business is mediocre. A company can show a spectacular ROE and a pedestrian ROIC, and the gap between them is just leverage dressed up as quality. Return on assets has the opposite problem, dragging in idle cash and non-operating assets that have nothing to do with the operating engine. ROIC strips the financing decision out entirely and asks the only question that matters about the business itself: when this company puts a unit of capital to work in its actual operations, how many cents of profit does it get back? That is a leverage-neutral measure of operating quality, and it lets me compare a debt-light Swiss machinery firm with a debt-laden British telecoms giant on equal terms.

But here is the part that the textbook definitions bury, and it is the most important sentence in this entire course. The level of ROIC tells you almost nothing on its own. A ten percent ROIC is wonderful for a regulated utility and a disaster for an asset-light software company. What matters is the level relative to the cost of capital, the spread, and once you internalize that, everything else falls into place.

Deep Dive: How To Actually Calculate ROIC (And The Bits That Will Trip You Up)

For the serious reader, the devil lives in three adjustments, and getting them wrong will hand you a number that lies.

The first is what to do with cash. Operating cash that the business needs to run should stay in invested capital, but a large surplus pile sitting in money-market funds is not invested in the operations and should come out, otherwise you penalize a cash-rich company for hoarding and understate its true operating ROIC.

The second, and the most consequential, is goodwill and acquired intangibles. When a company buys another business, it records goodwill and writes up the acquired customer relationships and brands, and these sit in invested capital. Whether you include them changes what the ratio is telling you. ROIC including goodwill answers the question of whether the acquisitions created value, that is, whether management paid sensible prices, because it holds them accountable for the full purchase price. ROIC excluding goodwill answers a different question, the operating quality of the underlying business stripped of acquisition accounting. A serial acquirer can have a mediocre ROIC with goodwill (it overpaid) and a magnificent ROIC without goodwill (the businesses themselves are superb), and the difference between those two numbers is one of the most revealing things you can compute.

I will show you exactly this with a real name later.

The third trap is the denominator problem of old assets. A business with fully depreciated property, plant and equipment carries those assets at almost nothing on the balance sheet, which shrinks invested capital and inflates ROIC, making a tired old industrial look more capital-efficient than it really is. Operating leases, now mostly capitalized under current accounting, used to hide capital off the balance sheet entirely and still need care. None of this is busywork. Each adjustment changes the verdict, which is why ROIC is a judgment rather than a number you download.

Why Does The Spread, Not The Level, Create Value?

Now to the heart of the matter, the relationship that makes ROIC the master metric. A company funds itself with a mix of debt and equity, and that funding has a cost, the weighted average cost of capital, or WACC, which for most businesses lands somewhere between seven and twelve percent. When a company earns a return on its invested capital that exceeds this cost, every unit it deploys produces more value than it consumed, and so growth makes the business more valuable. When a company earns less on its capital than the capital costs, the logic flips with brutal symmetry: every unit it deploys destroys a little value, and so growth, the very thing investors usually cheer, actively makes shareholders poorer. This is the framework McKinsey’s valuation work (the Koller, Goedhart and Wessels canon) has hammered for decades, and it is captured in a single chart that every investor should tattoo somewhere visible: growth only creates value when ROIC is above the cost of capital, and below it, faster growth simply destroys value faster.

Sit with the implication, because it is genuinely counterintuitive and it is the whole reason value traps exist.

A business earning four percent on capital against a six percent cost of capital is a machine for converting shareholder wealth into corporate activity. It can grow revenue, win awards, employ thousands, and dominate headlines, and it will still leave its owners worse off every year it expands, because it is reinvesting their money at a loss relative to what that money costs. The market is not stupid about this. It prices such a business cheap on purpose, with a low multiple and a high dividend yield, because the cheapness is the market’s verdict that the growth ahead is value-destroying. The low multiple is not an opportunity. It is a warning label. And the investor who buys it because it looks cheap has mistaken the warning label for a discount tag.

This is also where I part company, gently, with the deepest of deep-value purists. Graham’s net-net world was a world of liquidation, of buying a dollar of assets for fifty cents and waiting for the gap to close. It worked, and in pockets it still does. But for a going concern that intends to keep operating, keep reinvesting, keep growing, the asset discount is a trap if the engine inside earns less than its capital costs, because every year the business keeps running it grinds a little of that discount away. Time is the friend of the wonderful business and the enemy of the mediocre one. ROIC versus WACC is simply the instrument that tells you which one you are holding.

The Compounder: High ROIC With A Reinvestment Runway

Flip to the other end. The most beautiful object in all of investing is a business that earns a high return on capital and has a long runway to reinvest fresh capital at that same high return, because such a business compounds its intrinsic value at extraordinary rates with almost no help from the investor. Charlie Munger put the whole philosophy into one passage in his 1994 talk on worldly wisdom, and I think about it constantly. His point was that over a long holding period, your return as a shareholder converges on the return the business earns on its capital, almost regardless of the price you paid. A business that earns six percent on capital for forty years will hand you something close to a six percent return even if you bought it at a deep discount, because the mediocre internal compounding eventually swamps your clever entry price. And the mirror, the part that converts value investors into quality investors, is that a business earning eighteen percent on capital for two or three decades will make you rich “even if you pay an expensive looking price,” to use Munger’s exact phrase, because the magnificent internal compounding eventually swamps your overpayment.

This is why I am willing to pay up for genuine quality, and why a low multiple has never once tempted me on its own. But Munger’s insight comes with a crucial condition that the quality-at-any-price crowd often forgets, which is the reinvestment runway. A high ROIC compounds your wealth only to the extent the business can plow earnings back in at that high rate. Warren Buffett drew the distinction perfectly when he described two businesses that both earn twelve percent: one lets you take the cash out every year, while the other must reinvest all of its cash just to stand still, so you never see a penny. The first is a fine investment and the second is a treadmill, and the difference is entirely about whether high returns come with somewhere profitable to redeploy capital. The arithmetic is simple and worth carrying in your head: a company’s intrinsic value compounds at roughly its ROIC multiplied by the fraction of earnings it reinvests. A business earning thirty percent on capital that reinvests all of it compounds intrinsic value at close to thirty percent, while an equally excellent business earning thirty percent that can only redeploy a tenth of its earnings, returning the rest as dividends, compounds the core at a far gentler pace and hands you cash you must find a home for yourself. Both can be wonderful. Only the first is a compounding machine.

Worked Example One: Kardex, A Compounding Machine You Can Actually Watch Work

Let me show you the ideal pattern in a real company from my universe, and I have chosen one where the data is almost a textbook illustration. Kardex Holding (SIX: KARN), the Swiss intralogistics group, makes automated storage and retrieval systems, the vertical lift modules and carousels and AutoStore installations that warehouses use to fetch parts efficiently, and it wraps that hardware in a growing, high-margin lifecycle service business. Crucially, it is capital-light: it runs only a handful of manufacturing facilities and assembles premium systems largely to order, so it does not need to sink enormous capital into plant to grow. And one housekeeping note before the numbers, because precision is the whole point of this article: Kardex reports in Swiss francs, not euros. Every figure below is in CHF.

Now look at the returns, drawn from the company’s FY2024 accounts, which you should of course verify against the annual report. For the year to December 2024, Kardex generated operating profit (EBIT) of CHF 103.8 million on capital employed of roughly CHF 316.4 million, total assets of about CHF 493.5 million less current liabilities of about CHF 177.1 million, which is a return on capital employed of around 32.8 percent. That figure is pre-tax, so the after-tax ROIC, applying a Swiss tax rate of roughly 22 percent, lands closer to 24 or 25 percent, but either way it sits at three or four times a typical cost of capital and roughly double the machinery industry average of around 15 percent. And here is the magic, the second half of the compounding equation. Over the five years to 2024, Kardex held that return on capital high while the capital employed in the business grew from CHF 192.6 million in 2019 to CHF 316.4 million in 2024, a rise of about 64 percent. Read that again. It did not earn high returns on a static pile of capital, which would make it a cash cow with no runway. It earned high returns while continuously deploying much more capital at those same high returns. That is Buffett’s ideal business made flesh: high ROIC and a long reinvestment runway, the rarest and most valuable combination there is.

I want to be honest about the shape of that curve rather than flatter it, because honesty is the brand. The return on capital did not march in a dead-flat line; it dipped to 23.3 percent in 2022 in a mid-cycle wobble before recovering. Trace the whole series and you get a business that held its returns in the high-twenties to low-thirties throughout (32.7 percent in 2019, 28.1 percent in 2020, 27.9 percent in 2021, 23.3 percent in 2022, 32.2 percent in 2023, and 32.8 percent in 2024) ending the period essentially where it began, near 33 percent, with one cyclical breath in the middle. That is not a fluke, and it is not a straight line either. It is a durable franchise absorbing a soft patch and reasserting itself, which is precisely the texture you want to see, because a return that never wobbles is often a return that has not yet been tested. Over the same window revenue grew from CHF 471.2 million to CHF 791.2 million, so the high returns were earned on a business that nearly doubled in size.

What does such a business cost? A premium multiple, naturally, because the market is not blind. As of June 2026 Kardex trades around CHF 231 a share, within a 52-week range of roughly CHF 202 to CHF 340, for a market capitalization near CHF 1.75 billion and a price-to-earnings multiple of about 46. Forty-six times earnings. Read that next to the two-times-earnings stock from the opening and feel your Graham reflex twitch. This is exactly where investors who anchor on the multiple go wrong, and exactly where Munger’s wisdom earns its keep. If Kardex can keep reinvesting in the high twenties for another decade, the entry multiple will prove almost irrelevant to your long-term return, swamped by the internal compounding, and the investor who refused to pay up because it looked expensive on a screen will have missed the compounding to save a few points on the purchase price. Whether the reinvestment runway truly persists is the real question to interrogate, which is what the embeddedness and persistence work is for, but the shape of the business is the shape of a compounder, and no value screen would ever have put it in front of you.

The Value Trap: Low ROIC With A Tempting Price

Now the cautionary mirror, and I want a real, recognizable name rather than a tactful composite, because the lesson only lands when it has teeth. Consider Vodafone (LSE: VOD), the European telecommunications giant, which for the better part of a decade was the value trap par excellence, the stock that looked irresistibly cheap on every conventional metric while quietly destroying the capital of everyone who fell for it.

The numbers tell the story with painful clarity. Telecommunications is among the most capital-hungry industries in Europe, forever pouring money into spectrum and network upgrades, and Vodafone’s returns never came close to justifying that capital intensity. By the company’s own admission in its 2023 full-year results, its return on capital employed had sat below its weighted average cost of capital for over a decade, with management bluntly conceding “our performance has not been good enough.” Rebuild the ratio from Vodafone’s own EODHD-reported accounts and the admission is borne out in cold arithmetic. Take operating profit, tax it at a normalized rate, and divide by invested capital of well over GBP 100 billion, and the return on invested capital comes out at only about 2.5 to 3.5 percent across the last several years … and it actually turned negative, around minus a third of a percent, in the year to March 2025, when operating profit briefly slipped into the red. Now set that against the cost of the capital, estimated from those same EODHD inputs rather than borrowed from anyone else: a cost of debt of roughly 4.5 percent (interest expense over total borrowings) and a CAPM cost of equity near 6 percent (on a reported beta of about 0.32), which blend to a weighted average cost of capital in the region of 5 percent. The verdict is unavoidable. The company has been earning perhaps two to three points less on its capital than that capital costs, year after year, which is the precise financial signature of a business that destroys value as it grows.

Now recall how cheap it looked through that decade. At one point in 2024 the shares changed hands at around two times reported earnings (a figure distorted by one-off asset-sale gains, with the adjusted multiple closer to eight) and offered a dividend yield north of eleven percent. Every screen on earth flagged it as deep value. And the ending was the one ROIC predicts: in 2024 the company cut its dividend in half, from nine cents to four and a half, and the share price spent years grinding lower, so that the fat yield was repeatedly an illusion erased by capital losses. One commentator looked at the two-times multiple and the double-digit yield and wrote, correctly, “beware the value trap.”

The capital destruction is not a matter of opinion, it is in the accounts. Run the numbers and the franchise has bled red ink in size: net income of roughly negative GBP 4.17 billion in FY2025 and negative GBP 0.39 billion in FY2026, with a trailing return on equity of about 0.11 percent … a rounding error away from zero. And the dividend, the very thing that lured the yield-hunters, has been quietly drained: dividends paid fell from about GBP 2.43 billion to GBP 1.79 billion to GBP 1.08 billion across the most recent years. The eleven-percent yield was never income. It was the market’s estimate of how much of your capital you were about to lose, paid back to you in installments out of the wreckage.

What makes Vodafone the perfect teaching case is that the cure proves the diagnosis. The company’s own remedy, under pressure, was to shrink out of its worst markets, and Morningstar notes that Vodafone divested its Spanish and Italian operations in 2024 precisely because of their low returns on invested capital. That is the ROIC discipline of this very article playing out in the boardroom: management finally accepted that growth and presence in low-return markets were destroying value, and the value-creating move was to exit them. The subsequent partial recovery of the shares into 2025 and 2026, helped by the UK merger and a German stabilization, came not from the cheapness that lured value investors years earlier but from the company belatedly attacking its return-on-capital problem. By June 2026 the stock trades around 111.85 pence, within a 52-week range of roughly 67.55 to 131.1 pence, with a market capitalization near GBP 25.8 billion and a post-cut dividend yield of about 4.17 percent, a far cry from the eleven percent that lured the unwary, and tellingly, the yield came down because the dividend came down, not because the price ran away. The cheap multiple was never the opportunity. The low ROIC was the truth, and the cheap multiple was simply the market pricing that truth correctly. An investor armed with nothing but ROIC versus WACC would have avoided a decade of pain that a P/E screen actively walked them into.

The Compounder And The Trap, Side By Side

Answer engines, and tired humans, both love a clean table, so here is the entire argument compressed into one. These two businesses are not subtle variations on a theme; they are opposite physics. Note in particular the column that matters most, the spread between ROIC and the cost of capital, and how it predicts everything downstream of it, the multiple included.

Stare at that for a moment, because rebased to a common starting point the two share-price paths tell the same story the table does, one curve climbing as the internal compounding does its quiet work, the other grinding lower as the negative spread bleeds the franchise. Over a long enough horizon your return as a shareholder converges on the return the business earns on its capital, and the chart below is simply Munger’s sentence drawn as a picture.

Deep Dive: Does High ROIC Last? Persistence, Fade, And Why Small-Caps Need A Moat

Here is the objection a thoughtful reader should now raise, and it is the right one. If high returns on capital are so wonderful, why does everyone not pile in until they are competed away? The answer is that they usually are competed away, and understanding the exceptions is the whole job. The essential research here is Michael Mauboussin's work, both his 2007 study on reversion to the mean and the more recent Counterpoint Global analysis, and it tells a nuanced story. The baseline is grim for optimists: ROIC reverts toward the cost of capital over time, in every period anyone has studied, because high returns attract competition and capital until the excess is bled away, exactly as microeconomic theory predicts. This is the gravity that pulls every great business back toward mediocrity.

But gravity can be resisted, and the data on how much is illuminating. Counterpoint Global’s recent work measures the fade rate, the speed at which a company’s excess return over its cost of capital decays, and finds sector persistence factors averaging around 0.79, which implies that roughly 79 percent of a company’s excess return persists from one year into the next, with fade rates ranging across sectors from about 0.10 to 0.30 and averaging around 0.21. In their older quintile analysis, something like 41 percent of the companies that started in the highest ROIC quintile were still in the top quintile nine years later, and the great majority never fell to the bottom tiers, though only a tiny fraction stayed top-ranked every single year, because there is a great deal of churn in between.

Two findings matter most for what I do.

1. Mauboussin shows that one-year persistence figures overstate the fade, and that five-year correlations, which filter out the noise, reveal that genuine structural advantages persist considerably longer than most analyst models assume, meaning the market is systematically too pessimistic about how long a real moat lasts.

2. This is the uncomfortable one for a small-cap specialist like me, large companies have shown consistently higher ROIC persistence than small ones since the mid-1980s. Small companies, on average, fade faster.

I want to be honest about that last point rather than hide it, because it sharpens my whole thesis rather than undermining it. If the average small-cap fades faster, then identifying the small-cap exceptions, the ones whose high returns will persist, is where the entire edge lives, and it cannot be done with a screen that simply ranks today’s ROIC. It requires understanding why the returns are high and whether the source of that advantage will endure. A high ROIC with no identifiable moat is a melting ice cube, soon to revert. A high ROIC protected by something structural is a compounder. The job is to tell them apart, and that is precisely what my embeddedness framework exists to do. Embeddedness is, in the language of this deep dive, simply a low fade rate with a mechanism: a business wired so deeply into its customer’s operations that competition cannot pry the returns loose, so the excess return that the average small-cap surrenders in three or four years persists in this one for ten or fifteen. The fade rate is the number; embeddedness is the reason.

The Sophisticated Case: When Reported ROIC Lies (And What To Do About It)

Before I connect the threads, one more real example, because I promised to show you the goodwill problem in the flesh and because it ties this piece directly to my last one on owner earnings. Equasens (Euronext Paris: EQS), the dominant software provider to French pharmacies and one of the most deeply embedded businesses I cover, presents a puzzle on a first glance at the screens. Rebuild the ratio from its EODHD-reported FY2024 accounts and the headline return on invested capital, with the goodwill left in, comes out at only about 14 to 15 percent, alongside a return on equity around 16 percent. Fourteen-odd percent is respectable but it is not the stratospheric figure you would expect from a sticky, mission-critical software business with a near-impregnable competitive position, the kind of business that should gush returns. So what is going on? Is Equasens secretly mediocre?

No, and the reason is the goodwill trap from the calculation deep dive, now made concrete. Equasens has spent years acquiring adjacent software niches, and every one of those deals loaded its balance sheet with goodwill and acquired intangibles, inflating the invested capital denominator, while the amortization of those acquired intangibles (which rose to about EUR 15.5 million in 2024) depresses the reported operating profit in the numerator. Both effects push the reported ROIC down. Look at the goodwill alone: it grew from about EUR 49.8 million in 2019 to EUR 104 million in 2024, more than doubling. That swelling denominator is most of the story behind the unremarkable headline return.

Worked Example Two: How To Compute ROIC Three Ways On Equasens

So let me do the work the screens never do, building the number up from the FY2024 accounts so you can see exactly where each version comes from. Start with the numerator. Equasens earned operating profit of about EUR 48.2 million on a tax rate near 20 percent, and after a couple of judgment calls on the acquired-intangible amortization you arrive at NOPAT of roughly EUR 38.5 million. That is the after-tax operating cash the business throws off. Now the only thing that changes across the three versions is the denominator, the invested capital, and watch what each choice is actually asking.

Three numbers, all true, all derived from the same NOPAT, every one answering a different question. The roughly 14.6 percent including goodwill is the verdict on capital allocation: across all its deals, Equasens deployed capital at a decent but not extraordinary rate, which is to say it paid sensible prices. Fine. But that figure tells you almost nothing about the operating quality of the underlying software business. Strip the acquisition goodwill out of invested capital and the return climbs to about 24.1 percent. Strip out the acquired intangibles as well, leaving only the capital the core operations genuinely need, and it reaches roughly 33.7 percent — the genuinely high, embedded-franchise return you expected all along. The core software operations require very little tangible capital, because the real investment is the code and the people, already expensed through the income statement.

The headline figure in the mid-teens and the true operating return near thirty-four percent are two different facts answering two different questions, and an investor who reads only the headline number concludes Equasens is ordinary when the embedded engine underneath is anything but. This is the Confession Lag from my earlier work wearing a different costume, the gap between the messy reported number and the real economic truth that the market is slow to price. The headline measure shows about 15 percent; the business earns something closer to 34 percent on the capital that actually matters; and the gap between those two numbers, on a name followed by a handful of analysts, is exactly the kind of mispricing the attention desert serves up to anyone willing to rebuild the ratio from scratch.

Deep Dive: The Other Places ROIC Will Mislead You

A few further warnings, briefly, so you do not become a ROIC zealot. Cyclicals lie at the peak and the trough: a steel maker, a semiconductor equipment firm, or a hazardous-waste recycler like Befesa will post a gorgeous ROIC at the top of its cycle and a wretched one at the bottom, and neither is the true through-cycle figure, which is why a cyclical must be normalized across the cycle before its returns mean anything. This is the same normalization discipline I apply to owner earnings, and it is no accident that the two ideas travel together: a number measured at a single point in a cycle is a snapshot of weather, not climate. Old, fully-depreciated assets inflate ROIC by shrinking the denominator, flattering tired incumbents that have not had to replace their plant yet. Banks and insurers do not fit the framework cleanly at all, because for a financial institution capital is the raw material rather than a means to an end, so ROIC as defined here is close to meaningless for them and you need return on equity or return on tangible equity instead. And the most sobering caveat of all, raised by thoughtful skeptics of the quality-investing creed, is that sustaining an eighteen percent return on capital for two or three decades, the Munger ideal, is genuinely rare, far rarer than the screens full of currently-high-ROIC names would suggest. Most high returns fade. Paying an expensive looking price is only justified when the persistence is real, and persistence is a judgment about the moat, not a line you can extrapolate from a spreadsheet. Treat a high ROIC as the beginning of an investigation into durability, never as the conclusion.

Why Does ROIC Analysis Pay Off More In The Attention Desert?

Now let me bring this home to where I actually hunt, because ROIC analysis pays more in some places than others. In a heavily-covered market, when a company’s returns on capital are high and durable, an army of analysts has already noticed, written it up, and bid the multiple to reflect it, so the quality is in the price. The mispricing is small. In the European small-cap attention desert, where the average non-US small-cap is followed by roughly 3.3 analysts and many by none at all, two distinct things go unpriced. The market misprices the level of returns, failing to compute a proper ROIC at all on a messy, acquisitive, goodwill-laden small-cap like Equasens and concluding it is ordinary. And the market misprices the persistence of returns, lazily extrapolating the average small-cap fade onto a specific embedded business whose advantage will actually endure, or failing to recognize the moat entirely. Both errors are gifts to the patient investor who does the work, and both persist far longer than they would in a crowded market, because there is no army of analysts to arbitrage them away. The very fact that small-caps fade faster on average is what makes the under-covered exceptions so mispriced, because the market tars them all with the same brush.

There is a quiet asymmetry here that I find endlessly comforting. The work required to rebuild a clean ROIC on a goodwill-laden French software company is exactly the kind of tedious, unglamorous, weekend-killing exercise that the marginal price-setter in an under-covered stock has no incentive to perform. A sell-side analyst covering forty names cannot afford to spend a day reconstructing one company’s invested capital three different ways. I can, because I cover almost nothing, and because the boredom is the moat. The attention desert is not a hardship to be endured on the way to an edge; the desert is the edge.

Where Does ROIC Meet Embeddedness And Owner Earnings?

This is where my obsessions click into a single method, and the trilogy completes itself. Supply chain embeddedness is the framework that explains why a high ROIC will persist, because it identifies businesses wired so deeply into their customers’ operations that competition cannot easily bleed away their returns. The mechanism is exactly the fade rate from the persistence research: a deeply embedded business, one whose product is mission-critical and painful to switch away from, has a long competitive advantage period, which is to say a low fade rate, which is to say its excess returns over the cost of capital persist for years rather than evaporating. Embeddedness is, in this precise sense, the structural reason a small-cap can defy the small-cap gravity that pulls returns back to the mean.

Owner earnings, the subject of my last piece, is the honest numerator: the reason reported ROIC misleads on a name like Equasens is that reported profit is distorted by acquisition accounting, and the owner earnings adjustments are how you recover the true return. The same instinct that adds back acquired-intangible amortization to find owner earnings is the instinct that strips goodwill out of invested capital to find the real ROIC; they are two halves of the same act of seeing through the accounting to the cash. And ROIC is what tells you whether a business deserves the premium multiple that the bear-base-bull scenario work will then apply, because there is no point modeling a generous bull case for a business whose returns are about to fade to the cost of capital. The three ideas are one process. Embeddedness tells you the high returns will last, owner earnings tells you what the returns truly are, and ROIC versus the cost of capital tells you whether the business is compounding your wealth or quietly consuming it. A genuinely embedded business with a high, persistent, properly-measured ROIC, trading in a market too sleepy to have noticed, is the whole thesis in a single sentence, and it is the rarest and most rewarding thing I ever find.

Frequently Asked Questions

What is return on invested capital (ROIC)? ROIC is net operating profit after tax (NOPAT) divided by invested capital. NOPAT is EBIT times one minus the tax rate; invested capital is debt plus equity minus surplus cash, or net working capital plus net fixed assets plus needed intangibles. It measures how many cents of after-tax profit a business earns per unit of operating capital, independent of how it is financed.

How do you calculate ROIC step by step? First compute NOPAT: take operating profit (EBIT) and multiply by one minus the tax rate. Then compute invested capital: add debt and equity and subtract surplus cash, or add net working capital, net property and equipment, and the intangibles the business genuinely needs. Divide NOPAT by invested capital and express it as a percentage. The judgement is in three adjustments: surplus cash, goodwill, and old fully-depreciated assets.

What is the difference between ROIC and WACC? ROIC is the return a business earns on its operating capital; WACC, the weighted average cost of capital, is what that capital costs, typically 7-12%. The spread between them is what matters. When ROIC exceeds WACC, every euro deployed creates value, so growth helps. When ROIC is below WACC, growth destroys value. The spread, not the level of ROIC, is the whole game.

What is the difference between a compounder and a value trap? A compounder earns a high ROIC and can reinvest fresh capital at that same high rate, so its intrinsic value snowballs even from an expensive-looking price. A value trap earns a low ROIC, often below its cost of capital, and looks statistically cheap precisely because the market correctly senses its growth is value-destroying. The low multiple is a warning label, not a discount tag.

Why can a stock at two times earnings be a worse buy than one at thirty times? Because the multiple says nothing about whether the business creates or destroys value as it grows. A two-times-earnings business earning below its cost of capital burns shareholder wealth every year it expands, so the low multiple is deserved. A thirty-times business reinvesting at 30% on capital compounds wealth so fast the entry multiple barely matters over a decade, Munger’s point exactly.

Does a high ROIC last, or does it fade? It usually fades. Competition drives returns toward the cost of capital over time. Mauboussin and Counterpoint Global find roughly 79% of a company’s excess return persists year to year on average, with fade rates of 0.10-0.30. About 41% of top-ROIC-quintile firms remain top-quintile after nine years, but very few stay top every year. A durable moat is what buys the slow fade.

Why does reported ROIC understate the quality of serial acquirers like Equasens? Acquisitions load the balance sheet with goodwill and acquired intangibles, inflating the invested-capital denominator, while amortization of those intangibles depresses reported operating profit in the numerator. Both push ROIC down. Strip goodwill out and you measure operating quality; keep it in and you measure whether management paid sensible prices. For Equasens the two answers are ~14.6% and ~33.7%; both true, answering different questions.

When does ROIC mislead, and where does the framework break down? ROIC flatters cyclicals at the peak and depresses them at the trough, so normalize across the cycle. Old fully-depreciated assets shrink the denominator and inflate the ratio. Banks and insurers do not fit — use return on equity or return on tangible equity instead. And sustaining 18% for two or three decades is genuinely rare, so treat a high ROIC as the start of an investigation into durability, never the conclusion.

Why does ROIC analysis pay off more in European small-caps? In heavily-covered markets, durable high returns are already noticed and priced. In the European small-cap attention desert (where the average non-US small-cap is followed by about 3.3 analysts) the market misprices both the level of returns (it never computes a clean ROIC on a goodwill-laden name) and their persistence (it lazily extrapolates the average small-cap fade onto a genuinely durable exception). Both errors are gifts to the patient.

Is a high dividend yield a good signal of value? Not on its own. A fat yield on a business earning below its cost of capital is often the market pricing a deserved disappointment, and the dividend frequently gets cut. Vodafone offered a yield north of 11% before halving its dividend in 2024 from 9 cents to 4.5. Ask whether high returns come with a reinvestment runway or just a fat payout that the low ROIC cannot sustain.

My Value Ramblings

So where does this leave us, fellow students? With a number, a relationship, and a warning. The number is return on invested capital, after-tax operating profit over the capital tied up in the business, and my screen starts it at a sustained fifteen percent because that sits well clear of the seven to twelve percent most businesses pay for capital, and that clearance is where compounding is born. The relationship, the one that matters more than the level, is the spread between that return and the cost of capital, because it determines whether the most celebrated thing in business, growth, is building your wealth or burning it. And the warning is that the cheap stock is often cheap for a reason your screen cannot see, that a two-times multiple on a business earning below its cost of capital is not a bargain but a correctly-priced disappointment, while a forty-times multiple on a business compounding capital in the high twenties can be the buy of the decade, exactly as Munger promised.

The discipline, one last time so it lodges: compute ROIC honestly, with the goodwill and cash and old-asset adjustments that the screens skip, compare it to the cost of capital rather than admiring it in isolation, ask whether high returns come with a reinvestment runway or just a fat dividend, and then, most importantly, ask the only question that really matters, which is whether the returns will last. That last question is not answered by ROIC at all. It is answered by the moat, by the embeddedness, by understanding why the business earns what it earns and whether anything can take it away. ROIC tells you the returns are high today. Only judgment tells you they will be high tomorrow. A screen is a starting point, never an ending point. Buffett would tell you that investors as a whole can extract from their businesses only what those businesses actually earn, and ROIC is simply the most honest measure we have of what a business earns on the capital you have entrusted to it. Find the ones that earn a lot, durably, in a market too bored to notice, and let the compounding do the rest. That, the way I see it, ticks every box that matters.

The Trilogy

This is the second of three companion pieces on the method. There are another two coming.

Every figure in this piece is real and sourced to the public record (the Kardex, Vodafone, Equasens and other ROIC and market figures computed directly from EODHD fundamentals and end-of-day data pulled June 2026, the Vodafone qualitative facts to the company’s own FY2023 and FY2024 results and Morningstar, the Munger passage to his 1994 talk on worldly wisdom, and the persistence data to Mauboussin’s 2007 study and Counterpoint Global’s recent work), but they are my starting point and not my ending point, so run them through your own spreadsheet and tighten them before you trust them with a euro. That, after all, is the whole spirit of the thing.

Sincerely,

The Boredom Baron

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

Subscribe now

Disclaimer:

The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments.

While I strive for accuracy, the information presented may contain errors or omissions, or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented.

This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal.

I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice.

This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment decisions.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.

The half above the paywall is the entire thesis, taught openly and for free, enough to decide for yourself whether Poland is worth your time: the four macro pillars, the sectors, the screening framework, and a bear case I have done my honest best not to soften.

The half below is where I stop teaching and start acting, the model basket, the position sizes, the fair-value ranges, and the precise conditions that would make me sell.

Read the free half first. If you are still here at the break, and still curious, the rest is waiting. Now let me start with a small story about two tickers and one letter.

In late 2024 the Polish state nuclear company Polskie Elektrownie Jądrowe named six Polish firms to support construction of the country’s first large reactor program. Among them was Ferrum SA, a Warsaw-listed maker of welded steel structures and large-diameter pipe whose subsidiary ZKS Ferrum had been pre-qualified by Westinghouse for reactor and turbine work. A defensible, slightly obscure small-cap for anyone tracking Poland’s coal-to-nuclear pivot. The kind of name you feel quietly clever for having found. Within hours, retail investors had piled instead into a completely different company, an agricultural-silos maker called Feerum SA, ticker FEE, on the strength of a name that rhymes. The Parkiet headline that immortalized the moment translated loosely as “Stowaway rally in Feerum: how investors mistook the companies”. One letter. Two unrelated tickers. A small-cap rally pointed with great conviction in precisely the wrong direction.

Then the kicker, because there is always a kicker.

In January 2025 the actual Ferrum SA was delisted from the GPW. So the correct ticker in the great mix-up no longer exists as listed equity at all. The mistake survives. The informed bet it was confused with is gone. The attention desert, in other words, ate the one name that was paying attention.

I open with this because it tells you almost everything you need to know about the Polish small-cap market in 2026, and it does it faster than I could in a chart. Europe’s largest single-country industrial program is being built by a supply chain so structurally under-researched that domestic Polish retail cannot reliably tell two tickers apart, and the foreign money is not even in the room to be confused. When MSCI reviewed Poland’s classification in 2025, the index provider cited “lack of information in English” as a stated reason for keeping the country in Emerging Markets rather than promoting it to Developed. Sit with that phrase for a second, because it is doing enormous work. That is the world’s largest equity-index provider telling you, in writing, that the information friction in Polish listed equities is high enough to deter it from treating the market as fully grown up. Which is a polite, technical, committee-approved way of saying: this market is mispriced because it is hard to read.

And the procurement, unlike the research coverage, is entirely real. PEJ has booked roughly 400 contracts worth over PLN 1 billion with Polish suppliers as of March 2026, against a published schedule of 43 tender lots running through end-2026 across civil works, balance of plant, electrical, instrumentation, and the unglamorous soft-services tail. Westinghouse has down-selected seven Polish firms for serial fabrication, the European Commission cleared the state-aid package SA.109707 in December 2025, and the US Export-Import Bank signed its first loan agreement with PEJ in January 2026. This is not a deck of slides waiting on a minister’s signature and a ribbon. This is an industrial program in early execution, contracting locally now, with the supply chain spread across a listed small-cap universe that almost nobody outside Poland is reading with any care.

Let me be a good student here, because I am one. I am not Polish. I do not speak Polish beyond the kitchen vocabulary you accumulate over a few visits and one heroic, doomed attempt to order pierogi without pointing. Almost everything that follows came out of the same research process I am about to teach you: GPW filings, Polish financial press shoved through DeepL, English-language trade press from MILMAG and Defence Industry Europe and World Nuclear News, and a market-data feed for the basics. The language barrier is real. It is also the soft, surmountable kind that dissolves the moment you open a translation tab in a second window. And the fact that this barrier exists, and that so few people bother to climb over it, is most of the reason the opportunity exists at all.

So this piece is about Polish small-caps, but more than that it is about a structural mispricing assembled from one part procurement scale, one part geopolitical relocation, one part industrial tailwind, and one part sheer inattention. The article ahead is long, and it is free, which is a deliberate combination. Free means you get the macro thesis, the sector map, and the names worth your own research. It does not mean you get the model-portfolio sizing, the probability-weighted fair values, or the buy levels, because those live behind the paywall and that is the whole arrangement. The free tier teaches you to fish. It just happens to be teaching you to fish in a lake most people do not know is stocked.

What this article is about, in one paragraph

Poland sits in an unusually favorable macro position for European industrial small-caps, and it sits there for four reasons at once. The country is running the largest coal-to-nuclear transition in Europe by absolute capex. It is the primary beneficiary of Western European manufacturing supply chains shortening eastward inside the EU. It carries the highest GDP-share defense budget in NATO at 4.8 percent, with the highest equipment share at 54.4 percent, plus the largest single slice of the new EU SAFE defense-loan envelope at EUR 43.7 billion. And it sits inside a structural attention desert created by the language barrier, the MiFID II research-unbundling shock, and the quiet fact that most European small-cap funds are, by mandate and by habit, DACH-and-Nordic operations that have never once thought about Warsaw. The thesis is that these four conditions, taken together, produce a genuine investable edge for a reader willing to carry the translation overhead. Each pillar on its own is a defensible idea you could write a note about. The four of them leaning on one another, in one country, at one time, is the case.

The 101 course: four macro pillars

Before a single ticker makes sense, you have to internalize the four structural conditions, because the names fall out of the macro and not the other way around. Each pillar is a story with measurable data behind it, and I am going to take them one at a time, slowly, like a good student should. At the end of each one I will tell you plainly what would have to happen for me to be wrong, because a thesis that cannot be falsified is not a thesis, it is a horoscope.

Pillar 1: the coal-to-nuclear transition is real, large, and procuring now

Poland’s coal share of electricity generation fell from over 80 percent in 2018 to 52.2 percent in 2025, per Notes From Poland’s 2026 review, and June 2025 was the first month in Polish history when renewables out-generated coal and lignite. That is a genuinely historic line for a country that used to run on coal the way a steam locomotive runs on coal. But renewables are the intermittent story. The structural baseload replacement, the thing that actually keeps the lights on at three in the morning in February, is nuclear, and Poland’s Nuclear Energy Programme targets 6 to 9 GW of installed capacity by the early 2040s, per the World Nuclear Association country profile. The flagship is three Westinghouse AP1000 reactors at Lubiatowo-Kopalino on the Baltic coast, with a total capex envelope of roughly PLN 192 billion, around USD 49 billion at current exchange rates. That is not a number you wave away.

What turns this from aspiration into something investable is the financing and the procurement, both of which have moved decisively from press-release land into signed paper. The Polish state has committed PLN 60.2 billion of public funding for 2025 to 2030, signed letters of intent with eleven export credit agencies worth more than PLN 100 billion in total, and, as noted above, secured the EC state-aid clearance and the first EXIM loan. The first concrete pour is targeted for Q4 2028, first commercial operation for 2036, slipped from 2033 in the December 2024 schedule revision. None of that timeline is comfortable, and I am not going to pretend it is. All of it is, nonetheless, happening, which is more than you can say for most energy mega-projects that get this much airtime.

Here is the part that matters for your portfolio, and the part the headlines skip. The investable layer is not the reactor. The tier-1 nuclear island (the reactor vessel, the primary loop, the steam generators, the fuel) is closed to Polish suppliers by Westinghouse’s pre-qualified vendor program, and the money there flies straight to Western specialty fabricators. The opportunity is tier 2 (balance of plant, modular fabrication, civil works, electrical, instrumentation) and tier 3 (site infrastructure, hydrology, transport, the soft-services tail), where the Polish-content target of 40 to 50 percent is explicit government policy rather than a hope. That is exactly where the seven down-selected Polish suppliers sit (Polimex Mostostal Siedlce, Baltic Operator, Mostostal Kielce, Mostostal Kraków, ZKS Ferrum, FAMAK, Energomontaż-Północ Gdynia), and three of those subsidiaries roll up into GPW-listed parents you can buy this afternoon: Polimex Mostostal (PXM), Mostostal Warszawa (MSW, via Mostostal Kielce), and Budimex (BDX, via Mostostal Kraków).

The boring possibility, the one almost nobody is pricing, is simply that the program executes within five years of its current schedule and the Polish-content target is largely delivered. I am not telling you it will run on time. Nuclear projects run on time roughly as often as airlines do. I am telling you that the equity market, to the extent it follows these names at all, is pricing a far more catastrophic delay than the political and financial momentum suggests is likely, and the gap between the priced-in despair and the probable outcome is where the trade lives. As it usually does, in the dull spread between what people fear and what actually happens.

What would prove me wrong here: the Westinghouse-PEJ-Bechtel EPC contract failing to sign during 2026 and sliding materially into 2027 or beyond; the first-unit completion slipping past 2040; or, the subtle one, the EPC routing balance-of-plant procurement through Bechtel’s own preferred subcontractor list rather than the Polish network Westinghouse spent years cultivating, which would quietly gut the content target no matter what the policy says.

Pillar 2: industrial nearshoring is moving real factories into Poland

I have said before that the loudest stories in markets are usually the wrong ones, and nearshoring is a useful test case. The loud version, the one that has been blaring since 2020, is “supply chains are coming home to America,” and it is mostly a comforting fiction. The quiet, accurate version is that Western European manufacturers, German ones above all, are shortening their supply chains eastward inside the EU. They are not moving back to Stuttgart or Munich. They are moving to Poznań and Wrocław. The wage arbitrage, the geographic proximity, the single-market integration, the dense existing industrial base, and the post-2022 logistics rethink all shove in the same direction, and unlike the American version, this one shows up in the data.

The data, then. Polish exports to Germany run at roughly 28 percent of total Polish exports, dominated by manufactured components, per the German Federal Statistical Office trade data. The Polish-to-German manufacturing wage gap is around 73 percent, which is to say a Polish manufacturing worker costs roughly 27 percent of a German equivalent on a fully loaded basis, and that gap has been stubbornly slow to close. And the cyclical signal is about as unambiguous as these things ever get: Polish industrial production grew between 6.9 and 9.4 percent through 2024 and 2025 while German industrial production was down 2.9 percent at the worst of the same stretch. The single cleanest anecdote I have found is the Mercedes Jawor EUR 1.3 billion eSprinter plant, where the head of operations described the Polish and German plants as “one production organism.” That is not the language of arms-length sourcing. That is the language of a marriage. The Polish plant is not a cheap supplier Mercedes might drop next quarter, it is load-bearing structure inside the German manufacturing system.

Stack onto Mercedes the LG Energy Solution battery plant in Wrocław (roughly 35 percent of European cell capacity at full ramp), Stellantis at Tychy, DHL’s expanding Poznań hub, and a long, quiet tail of German Mittelstand suppliers building Polish footprints, and the listed read-through sorts into two layers. Layer one is the picks-and-shovels: industrial real estate, where the only listed Polish pure-play of scale is MLP Group (MLG), with 1.7 million square meters of warehouse and light-industrial across Poland, Germany, Romania, and Austria and a 99 percent tenant-retention rate that is frankly unusual for a European logistics landlord. Layer two is the manufacturers themselves: aluminum systems (Grupa Kęty, KTY, the cleanest compounder on the exchange and a seventeen-year dividend payer), automotive rubber (Sanok), white goods (Amica, mid-recovery), trailers and dual-use logistics (Wielton), and on down the chain.

Which of these names actually captures the tailwind depends on a sub-sector cycle you have to read on its own terms, and that is a feature, not a bug. Automotive components are in the trough; the Stellantis Tychy redundancies were the tell. Industrial real estate is leading-indicator strong. Aluminum systems are growing structurally on the EU green-building retrofit cycle. White goods are cyclically weak with a credible recovery path. The point is not for me to pick the cycle winner for you, because I am writing a free piece and that is not what free pieces do. The point is that the underlying nearshoring tailwind is real and secular, and the cyclical noise sitting on top of it is precisely what opens the entry windows. The boring, structural relocation is the signal. The loud, cyclical panic is the discount.

What would prove me wrong here: a major Western European manufacturer publicly yanking Polish operations back west or out of Europe; the wage-arbitrage gap closing fast through Polish wage convergence; Polish industrial production turning sustainedly negative; or MLP’s leasing pipeline rolling over, which is the single cleanest real-time tell on the whole pillar.

Pillar 3: geopolitics and the G20 ambition have made defense procurement structurally large

Poland’s 2026 defense budget is PLN 200 billion, around EUR 46.86 billion, equal to 4.8 percent of GDP, the highest in NATO. Per the Notes From Poland coverage of the 2025 NATO figures, Poland now out-spends Germany by more than two to one on a GDP-share basis, which is the kind of sentence that would have read as a typo a decade ago. But the number I want lodged in your head is not the headline, it is the equipment share: 54.4 percent, also the highest in NATO. Roughly half of every Polish defense złoty lands on the industrial supply chain rather than on salaries and fuel. That is the line that turns a defense budget from a fiscal fact into an investable one.

The procurement pipeline is concrete to the point of being a spotter’s guide. K2 Black Panther tanks from Hyundai Rotem with coproduction at PGZ’s Bumar-Łabędy. K9 Thunder howitzers from Hanwha. AH-64E Apaches from Boeing with MRO localization at state-owned WZL No 1 in Łódź. F-35A Husarz jets from Lockheed, the first delivered to the 32nd Tactical Air Base in Łask on 20 May 2026. Patriot batteries from RTX. Miecznik frigates on Babcock’s Arrowhead 140 design. The Saab A26 submarine, picked in November 2025 over a crowded field of ThyssenKrupp, Naval Group, Navantia, Hanwha, Hyundai, and Fincantieri. And underneath all the platforms, the largest ammunition build-out in modern European history, because the lesson everyone took from Ukraine is that the shooting stops when the shells run out.

On top of the national budget sits EU SAFE, EUR 150 billion of EU-backed loans earmarked specifically for defense procurement, and Poland’s slice is EUR 43.7 billion, the largest of any member state. The agreement signed in May 2026, with EUR 6.5 billion unlocked as an advance and the remaining roughly EUR 37 billion disbursing across 2026 to 2030. The category split is worth memorizing because it tells you where the demand pools actually are: artillery 28 percent, anti-aircraft and anti-drone 26 percent, ground combat 19 percent, ammunition and missiles 14 percent (around PLN 23.8 billion just for ammo and missiles), strategic air 8 percent, and cybersecurity and AI 3 percent (around PLN 5.1 billion for cyber alone). Every one of those buckets has identifiable Polish listed-equity exposure, if you know where to look, which most people do not.

The names worth your own research in this pillar start with Niewiadów Polska Grupa Militarna (GNS), which became the first private 155mm artillery-ammunition producer on the GPW Main Market when it stepped up from NewConnect on 21 April 2026 following a reverse takeover. It carries a Northrop Grumman framework agreement for joint production of 180,000-plus rounds a year using Austempered Ductile Iron technology, plus an exclusive ST Engineering license for 40mm grenade ammunition covering the Polish Armed Forces and twenty EU export markets. There is Lubawa, the established defense-PPE incumbent with Polish MOD body-armor contracts and a growing NATO export book. There is Arlen, a post-IPO protective-clothing specialist with 81.4 percent public-sector revenue, which is about as pure a “demand pull from Polish state spending” as the exchange offers. There is Wielton Defence, the trailer maker’s military subsidiary with its LB6 low-bed semi-trailer and a Jelcz framework. And there is the WB Group, the dominant private Polish drone-and-electronics house (Warmate loitering munitions, a 10,000-unit framework with the Armaments Agency), reportedly mulling a Warsaw IPO in late 2026 or early 2027, which would be the listing this sector is actually waiting for.

Now the two caveats, because this is the pillar where I have done the most work and grown the most cautious. First, the listed pure-plays capture only a sliver of the total spend. Foreign primes (Lockheed, Hyundai, Hanwha, Babcock, Saab, Boeing) take 50 to 60 percent of the headline. Unlisted state-owned PGZ subsidiaries (Mesko, Dezamet, Nitro-Chem, HSW, Bumar-Łabędy) take another 20 to 30 percent. The listed-equity layer is the residual 7 to 11 percent, which is still PLN 80 to 130 billion cumulative across 2026 to 2030 in absolute terms, but it concentrates in dual-use civil-military infrastructure (Budimex) and defense IT (Asseco) rather than the pure ammunition plays everyone gets excited about. Second, and far more important, the entire spending case rests on continued Russian threat perception. A negotiated ceasefire would compress the urgency premium fast and hard, and I am going to return to that in the bear case at length, because it is the single most important risk in this whole piece and the one most readers will be most tempted to wave away.

The G20 piece is symbolic, but symbols move capital. Poland crossed USD 1 trillion of GDP in 2025, the twentieth-largest economy in the world by IMF rankings, and picked up an observer invitation to the December 2025 G20 Miami summit. Formal membership is a multi-year diplomatic slog that may never arrive. But the trajectory is the tell, because it signals that Poland is now in the room where European industrial-policy decisions get made, which is why Polish primes are increasingly the natural partners for Western and American prime contractors rather than the peripheral subcontracting jurisdiction they were a decade ago. Status is not a cash flow. But status is how cash flows get routed.

What would prove me wrong here: Polish defense spending dropping below 3.5 percent of GDP in the 2027 or 2028 budget; EU SAFE drawdown delays pushing disbursement past 2032; a Russia-Ukraine ceasefire-and-normalization that vaporizes the urgency premium; or the G20 observer seat quietly failing to convert toward anything more.

Pillar 4: the attention desert is the structural alpha source

Here is the part nobody likes to say out loud because it sounds glib, so I will say it plainly and then prove it. Polish small-caps are mispriced relative to Western European peers because the world’s small-cap research industry is simply not built to cover them. This is the attention-desert thesis, and it is not a vibe, it is a five-layer structure, and you can measure every layer.

First, the index classification gap. MSCI Europe Small Cap, the benchmark every European small-cap fund actually tracks, excludes Poland by mandate, because Poland sits in MSCI Emerging Markets, and MSCI EM Small Cap is roughly 75 percent Asia-weighted. So Polish small-caps appear in neither of the two natural benchmarks a small-cap manager would ever own, which means no major global small-cap fund has a Poland mandate by default. They would have to go out of their way to allocate, and going out of your way is the one thing a benchmarked fund manager is institutionally built never to do.

Second, the passive-money gap. The largest US-accessible Polish-equity ETF, iShares MSCI Poland (EPOL), holds about USD 609 million, almost all of it in the ten biggest GPW names (the banks, Orlen, KGHM, PGE, a couple of telecoms). There is essentially no passive money flowing into Polish small-caps at all. The Lyxor WIG20 ETF in Europe holds about EUR 43 million, which is a rounding error. Compare that to a single mid-cap on the Stoxx Europe 600 that routinely has hundreds of millions of passive flow tracking it for no reason other than its index membership, and you start to see the shape of the thing. The Polish small-cap universe is structurally un-indexed, which means the marginal buyer is a human who chose to be there, and there are not many of them.

Third, the sell-side coverage collapse. After the 2017 MiFID II research-unbundling reform, European broker research budgets shrank, and small-cap coverage was the first thing over the side, especially in markets where the commission pool was already thin. Polish-language coverage of mWIG40 and sWIG80 names got so structurally weak that the WSE itself now runs a pay-for-coverage program called PWPA, in which the exchange literally pays Polish brokers to keep research notes alive on forty mid- and small-cap names. Read that again. When the exchange has to subsidize the existence of research, the attention desert is no longer a metaphor I am using, it is a line item the exchange is funding.

Fourth, the language barrier, the one MSCI itself cited. Polish companies file under KNF rules in Polish, with English mirrors of wildly varying quality and timeliness. The big names (Asseco, Budimex, Kęty, MLP) run perfectly credible English IR. Plenty of smaller names file Polish-only and rely on the kindness of trade-press translators. That translation friction is the binding constraint that justifies the entire structure, and it is also, conveniently, the one structural feature you personally can defeat with a browser plugin and a little patience.

Fifth, the 2014 pension-reform vacuum, the slow domestic bleed nobody outside Poland talks about. In 2014 the Polish government effectively raided the OFE open-pension system, pulling the bond holdings to the state and leaving the OFEs as concentrated Polish-equity vehicles with steadily shrinking inflows as their members age out. The result is that domestic institutional capital in Polish small-caps has been quietly decumulating for a decade, with no ISA or workplace-pension equivalent stepping in to replace it. The Polish retail bid is real but small. The professional Polish bid has been a wasting asset for ten years.

Add the five layers together and you get a market mispriced not because it is bad but because the marginal informed buyer is, structurally, absent. The fix is underway, in fits and starts, which is the most Polish way for anything to happen. The WSE stated in October 2025 an ambition for MSCI Developed reclassification within three to five years, which would slam most of the gap shut by opening Polish names to the entire MSCI Europe small-cap fund universe and the passive flows that follow it like ducklings. Whether that reclassification actually arrives, and on what timetable, is a real question I treat honestly in the bear case. But for as long as the desert persists, which is to say for the foreseeable future, the structural alpha is just sitting there, getting no attention, which is of course the entire point.

What would prove me wrong here: MSCI reclassifying Poland to Developed faster than anyone expects, in 2026 or 2027, which would close the discount in a hurry and reward today’s holders but end the standing edge; foreign analyst coverage of GPW small-caps suddenly accelerating; trading volumes and spreads converging on Western European mid-cap norms; or, the perverse one, a wave of private-equity take-privates, which would pay you handsomely on whatever name gets bid while quietly shrinking the very universe the bull case needs.

The sector walk-through

The four pillars are the weather. The sectors are the ground you actually stand on, because that is where the structural story turns into supply chains, embedded positions, and named candidates. Let me walk through them one at a time, each with its own logic and its own worked example, and let me be precise about the framing before I start, because it matters. Nothing that follows is a recommendation. Every name is a starting point for your own research, to be weighed against your own portfolio, your own risk tolerance, your own time horizon, and your own appetite for the kind of governance you would never tolerate in Stockholm. I name names because a sector thesis with no names in it is a sermon, not an analysis. But the names are illustrations of the thesis. They are not the thesis.

Sector 1: the nuclear supply chain

Start with the math, because the math is what earns the right to the rest of the section. The PLN 192 billion AP1000 capex stack at Lubiatowo-Kopalino, spread over roughly twelve years from 2026 to 2038, breaks into three tiers with wildly different access for Polish listed equity, and the whole game is figuring out which tier a name actually plays in.

Tier 1 is the nuclear island: the reactor pressure vessel, the primary coolant loop, the steam generators, the fuel, and the safety-critical instrumentation wrapped around them. That tier is bolted shut to Polish suppliers by Westinghouse’s pre-qualified vendor program, and the revenue accrues to Western specialty fabricators (Mitsubishi Heavy, Doosan, KEPCO E&C, BWX Technologies, and the Westinghouse network itself). Call it 35 to 45 percent of program capex, roughly PLN 67 to 86 billion, of which Polish equity captures essentially nothing directly. So when a Polish small-cap gets breathlessly described as a “nuclear play,” your first question is always: which tier, and the honest answer for tier 1 is none of them.

Tier 2 is where it gets interesting: balance-of-plant fabrication, modular construction, electrical and instrumentation, control rooms, turbine-hall structures, cooling infrastructure, spent-fuel buildings. This is where the 40-to-50-percent Polish-content target concentrates and where the seven down-selected suppliers sit. Estimate tier 2 at 30 to 40 percent of capex, roughly PLN 58 to 77 billion, of which the Polish-content slice is PLN 23 to 39 billion. How that slice splits across the seven depends on capacity, certification, and parent-shareholder pressure, with the three Mostostal-branded plants plausibly taking 40 to 60 percent between them and the rest going to ZKS Ferrum (now delisted, naturally) and three private firms. The arithmetic leaves listed-equity tier-2 capture at PLN 9 to 23 billion cumulative across the twelve-year build, or PLN 0.8 to 1.9 billion a year at peak.

Tier 3 is the unglamorous earthwork: roads, peat clearance, hydrology, the marine off-loading facility, security fencing, worker housing, water and sewage, geological survey, and the soft-services tail of translation, training, and permitting. Estimate it at 25 to 35 percent of capex, roughly PLN 48 to 67 billion, led on the listed side by Budimex’s directly-signed MOLF technical-road contract with PEJ, with Mostostal Warszawa and Polimex competing alongside private specialists. Reasonable listed capture here is 25 to 35 percent of the tier, or PLN 12 to 24 billion cumulative.

Add tiers 2 and 3 and the listed-equity-addressable cumulative revenue from the AP1000 program lands somewhere between PLN 21 and 47 billion, modal estimate PLN 27 to 41 billion, spread across a back-loaded twelve-year build with a peak somewhere in 2029 to 2033 of PLN 3 to 6 billion a year. Divide that across three primary listed primes plus satellites and you get PLN 0.7 to 1.5 billion per name per year at the peak, in nuclear revenue alone. And here is the punchline: not one of the three is currently pricing in nuclear revenue at anything like that scale. That, in one sentence, is the trade.

Polimex Mostostal (PXM) is the most concentrated listed bet on the thesis. Through Mostostal Siedlce it is one of the seven Westinghouse down-selected suppliers, it has completed the first of three NQA-1 certification phases, and it carries a 2026-2028 cumulative revenue target of PLN 10 billion that explicitly leans on nuclear scope. The certification arithmetic deserves more respect than it usually gets, so here it is. NQA-1, the US Nuclear Quality Assurance Standard administered by ASME, is a three-phase audit and process-implementation regime that runs 18 to 30 months end to end and costs the fabricator several million złoty in re-engineering, documentation, training, and audit fees. Phase 1 sets up the quality-management framework. Phase 2 audits implementation across specific processes. Phase 3 validates serial-fabrication readiness on actual prototypes. Mostostal Siedlce clearing phase 1 is the leading-indicator catalyst that tells you whether nuclear scope is going to convert from MoU optionality into booked backlog, with the risk parked squarely in the phase-2 and phase-3 timing. The read-through to the equity is direct, and it is the thing to watch.

Subscribe now

The ownership structure at PXM is the inseparable complication, and I want you to hold it clearly because most coverage gets it backwards. Four Polish state-owned utilities (PGE, Enea, Energa, and Orlen via Orlen Technologie) hold a combined 63.48 percent in a concert agreement dating to the 2017 restructuring, when they swapped construction-contract receivables for equity to keep the company breathing. PGE is also the wholly-owning parent of PEJ, the AP1000 customer. So the customer of the largest growth opportunity is the parent of one of the four blockholders, and those blockholders vote as a bloc that the 36.5 percent free float has no seat in. That cuts both ways, and honesty requires both edges. Politically directed procurement, when it happens, flows toward names where the utilities own equity, which is good for you. Capital allocation, intra-group pricing, and dividend policy are set by people whose interest is the utilities’ balance sheets and not yours, which is not. Both are true at once, which is exactly what makes PXM either an interesting position or a polite no, depending entirely on how you weigh the two.

Budimex (BDX) is the largest, most diversified, and most balance-sheet-resilient name in the listed nuclear set, and the one I would point a nervous reader toward first. Its Mostostal Kraków subsidiary runs three steel-fabrication plants (Kraków, Kleszczów, Radomsko, under the Konstalex acquisition) with combined Group capacity over 18,000 tons a year, the largest steel footprint among the down-selected seven, well matched to the back-loaded fabrication peak in 2029 to 2032. Budimex also holds the only directly-signed PEJ commercial contract among listed names, the MOLF technical road, a purpose-built road from the site to the marine off-loading facility designed to move over 200 oversized components. The contract value is undisclosed, but the structural fact matters more than the number: Budimex is the one listed name with a customer relationship directly with PEJ rather than with the Westinghouse-Bechtel consortium standing in front of it.

The broader Budimex story is cross-pillar in a way that genuinely compresses single-thesis-failure risk, which is why it shows up in three of my four sectors. The Q1 2026 backlog of PLN 18.8 billion spans the CPK hub airport at Baranów, the NATO base buildout under the Poland Provided Infrastructure program, the PERN oil-pipeline expansion at Gdynia, Via Carpatia under Three Seas funding, and the first major international expansion via the Rail Baltica Latvia and Estonia segments worth roughly PLN 4.9 billion of pending awards. Nuclear is one slice of a portfolio with four other macro tailwinds running at once. The 2025 net profit was PLN 748 million on PLN 9.44 billion of revenue. The 2025 dividend of PLN 32.42 per share, paid in June 2026, was up 27 percent year over year, although at that level the payout runs north of 100 percent of earnings and around 170 percent of cash flow per Simply Wall St, which is a genuine sustainability question I will come back to rather than bury. The dividend is part of the equity story, not an afterthought, and a dividend you cannot repeat is a one-time gift dressed up as an income stream.

Mostostal Warszawa (MSW) is the smallest of the three Mostostal-branded listed names, controlled by Spain’s Acciona Construcción with 62.13 percent since the 2019 tender. Its Mostostal Kielce subsidiary is on the Westinghouse down-select for nuclear-island module mock-ups, the lowest tier of the seven but also, paradoxically, the scope most likely to convert early into serial fabrication. The 2025 result was a net loss of PLN 44 million, driven by a one-off PLN 49.4 million penalty reserve from PGE Energia Odnawialna walking away from an unrelated renewables agreement, with underlying performance ex the one-off modestly positive. At a market capitalization of roughly PLN 0.07 billion this is essentially retail or very-small-fund territory, the liquidity is too thin for institutional position-building, and the equity is structurally binary on whether Mostostal Kielce captures meaningful AP1000 module scope. If it does, the asymmetry from these depressed levels is large. If it does not, you own a small Polish contractor with cyclical exposure and a Spanish parent. I would not size it as anything other than a lottery ticket, and I would say so to your face.

A naming-convention warning that genuinely tripped me up at first, and will trip you up too if I do not flag it. The three Mostostal-branded listed names (Siedlce, Kraków, Kielce) are not one corporate group despite the shared name. Mostostal Siedlce rolls into Polimex. Mostostal Kraków rolls into Budimex. Mostostal Kielce rolls into Mostostal Warszawa. Three different listed parents, one shared brand, courtesy of a People’s-Republic-era heavy-construction holding that got broken up after 1990 with the regional plants keeping the name like siblings who kept the surname after a bitter divorce. Reporters and analysts conflate them with depressing regularity, and the Polish-content allocation across the seven down-selected suppliers depends materially on getting this map right, because each plant has different capacity, different certification timing, and a different parent leaning on it.

The structural risk under all of this supplier math is the EPC contract itself, the unsigned document on which everything turns. Westinghouse and Bechtel signed an Engineering Development Agreement in September 2023, amended in December 2025 to extend design and survey scope, with the full EPC targeted for mid-2026 signing, a target that has slipped before and may slip again. The question that actually matters for Polish suppliers is whether the EPC routes balance-of-plant procurement through Westinghouse directly, which is good for Polish content because Westinghouse has been courting the Polish supplier network since 2022, or through Bechtel as construction-management lead, which is bad, because Bechtel brings its own preferred-subcontractor list and it is not notably Polish. The contract has not been disclosed at the level needed to assess this, which means the single most important variable in the whole sector is one the market cannot yet see, and that is either a risk or an opportunity depending on whether you like buying ahead of disclosure.

The Feerum-Ferrum confusion that opened this piece was, fittingly, about the parent of the seventh down-selected name. ZKS Ferrum still operates at the entity level. The listed equity that gave you the read-through is simply gone. There are still meaningful listed nuclear plays. There is no listed pure-play Polish nuclear fabricator with full Polish-content scope, and the closest thing, Polimex, comes welded to a four-utility shareholder structure you cannot separate from the business. The cleanest worked example of what it looks like when one of these names captures real nuclear scope is the PXM PLN 10 billion 2026-2028 revenue target, which implies an acceleration to roughly PLN 3.3 billion a year from the PLN 4.13 billion 2025 base, with nuclear scope supplying the back-half kick. If the EPC signs in 2026, NQA-1 phase 2 clears in 2027, and serial scope flows through 2027 to 2028, the target is reachable. If the EPC slips to 2027 or 2028, the target slides with it, and the market’s patience, never abundant in a name like this, gets tested in public.

Sector 2: industrial nearshoring

If the nuclear story is one mega-program, the nearshoring story is a thousand small reshoring decisions adding up, each one individually defensible, each one a Western European manufacturer choosing to put the next factory in Poland rather than Bavaria, and the aggregate is a supply-chain reorganization happening in slow motion in plain sight.

The wage arbitrage is the foundation, and it has stayed wider for longer than the convergence theorists predicted back in 2015. The Polish-to-German fully-loaded manufacturing-wage ratio sits around 27 percent, which is to say a Polish worker delivers comparable output for roughly a quarter of the loaded German cost. The gap has narrowed, but at a glacial two to three percentage points per decade (it was around 22 percent in 2014), which is far slower than pure single-market economics would predict. It persists because Polish productivity is catching up faster than Polish wages, because the high-skill manufacturing clusters (Wrocław, Poznań, Tychy, Łódź) command premium domestic wages that still discount hard against Germany, and because the social-contribution and statutory-benefit gap moves like treacle. Whatever the precise mechanism, the arbitrage is durable enough to plan a fifteen-year factory investment around, which is exactly what the Germans are doing.

The macro signal is about as clean as macro signals come. German industrial production fell 4.5 percent in 2024 and a further 1.1 percent in 2025, two consecutive full years of contraction. Poland's industrial output, meanwhile, averaged growth of 1.2 percent across 2024 before accelerating sharply through 2025, with September printing at 7.4 percent year on year and March 2026 at 9.4 percent. That is a divergence measured in double digits, sustained across two years, between two economies that share a border. Whatever you think of the secular thesis, the cyclical share-shift from German to Polish manufacturing is happening right now, and it is in the numbers, not the narrative. The marginal Mercedes or Bosch or Siemens unit is being built in Poland. Not all of them, not one-for-one, but on the margin, consistently, quarter after quarter, which is how structural shifts always look while they are happening: boring, incremental, and easy to miss until they are obvious.

The cleanest listed expression of the picks-and-shovels layer is MLP Group (MLG), the only Polish-listed pure-play industrial-real-estate developer of real scale. The portfolio crossed 1.7 million square meters of gross leasable area in Q1 2026 across Poland, Germany, Romania, and Austria, with a land bank supporting roughly 2.3 million square meters of total potential. The 2025 actuals tell the story without me having to embellish: revenue PLN 420.5 million (up 13 percent), EBITDA before revaluation PLN 210.9 million (up 14 percent), gross asset value PLN 6.6 billion (up 28 percent), 99 percent tenant retention, 39 new tenants, and 21 percent of 2026 revenue growth already secured under signed leases before the year even started. Q1 2026 contract values were up 186 percent year over year. And the geographic mix is the part that matters most for the thesis: of the square meters under construction at year-end, Germany accounted for a third, which means MLP is increasingly capturing Western European demand at its source rather than only at the Polish hub.

The MLP tenant base is, by itself, the proof of the nearshoring story, which is why I keep coming back to it. The customer list is pan-European 3PL providers (DHL, DSV, Geodis, Kuehne+Nagel, ID Logistics), e-commerce fulfillment, automotive-component distributors feeding the OEM just-in-time network, and light assembly and packaging for Western European brand owners. And that 99 percent retention rate is not loyalty, it is physics. Relocating a tenant out of a 20,000-to-50,000-square-meter facility costs USD 5 to 15 million once you count IT and warehouse-management migration, service-level commitments, labor retraining, and certified-process re-qualification. That switching cost is what produces the retention, and the retention is what makes MLP’s net-asset-value trajectory more predictable than a typical European logistics landlord’s. You are not buying a building. You are buying the operational nervous system of three dozen Western European supply chains, and nervous systems do not move offices on a whim.

Grupa Kęty (KTY) is the aluminum compounder, and where MLP houses the manufacturers, Kęty is the manufacturer, which makes it a different and complementary expression of the same tailwind. Three segments: Aluminium Systems (architectural facades, windows, and doors through Aluprof, sold into the EU green-building retrofit cycle), Extruded Products (industrial extrusions for automotive lightweighting, EV battery housings, heat sinks, rail interiors), and Flexible Packaging (food and consumer packaging under Alupol). The 2025 actuals were revenue PLN 5.51 billion, EBITDA PLN 1.023 billion (crossing the PLN 1 billion line for the first time) at a 19 percent margin that is genuinely best-in-class for European aluminum mid-caps, and net profit PLN 560 million, with the company’s own 2026 forecast pointing to PLN 5.89 billion of revenue and PLN 1.11 billion of EBITDA.

What makes Kęty unusual, and what makes it the closest thing the GPW has to a dividend aristocrat, is the discipline. The 2025 dividend was PLN 49.05 per share at an 85 percent payout, the seventeenth consecutive year of payments, under a fixed policy that hands you 85 percent of net profit like clockwork. There is no other Polish mid-cap with anything close to that record. The structural tailwind underneath is the EU Energy Performance of Buildings Directive, which forces a multi-decade window-replacement and facade-upgrade cycle on a fixed regulatory calendar through 2050, and Aluprof gets specified by architects directly into building designs, locking in supply for the eighteen-to-thirty-six-month project life and creating real switching costs once a spec is set. That is a regulatory tailwind expressed as an order book, which is my favorite kind, because regulations are slower to change their minds than customers are. The bear case is the aluminum-price cycle and a yield that is fair rather than cheap, not anything structural about the moat.

Wielton (WLT) is the trailer maker at the bottom of its cycle, which makes it a completely different animal from Kęty’s steady compounder. 2024 sales fell 31 percent on an industry-wide European trailer slump driven by post-COVID destocking and weak freight, and the Q1 2025 net loss was PLN 53.2 million. What keeps it on the candidate list rather than the value-trap list is the cross-pillar optionality: the civilian trailer business is a clean nearshoring-and-freight-recovery proxy, and the Wielton Defence subsidiary launched in September 2024 rides the geopolitics pillar through the LB6 low-bed military semi-trailer and a 2025 Jelcz framework with the Polish state truck-maker. Wielton runs production in Poland, France (Fruehauf), Germany (Langendorf), the UK, and Spain, plus a legacy Russian assembly plant whose status under sanctions remains unresolved and is a real reputational overhang nobody has cleaned up. At a market cap around PLN 0.44 billion this is thin-liquidity, binary-cycle, cross-pillar deep value. A real candidate, but firmly in the deep-cyclical-recovery basket rather than the sleep-well basket, and sized accordingly or not at all.

Amica (AMC) is the white-goods recovery, and it earns a look for a reason most cyclicals cannot offer: the recovery is already visible in the actual quarters, not just promised in a strategy deck. The 2024-2030 “Back to Profitability” strategy carries quantitative targets sharper than the usual European-industrial mush (a 5 percent EBITDA margin by 2027 rising to 7 percent by 2030, RONA above 14 percent by 2027), and the 2025 quarters show the trajectory bending: revenue declines moderated from minus 9.8 percent in Q1 to minus 5.7 percent in Q2 to minus 2.0 percent in Q3, while the net result swung from a Q1 loss to a PLN 10.4 million Q3 profit. Founder Jacek Rutkowski handed the CEO seat to professional manager Robert Stobiński in May 2025 to run exactly this kind of reset. Over half of revenue is Western European (Germany, the UK, France, Italy, Scandinavia), so this is leveraged to a European consumer-durables recovery, against the formidable likes of Bosch, Whirlpool, Electrolux, LG, and Samsung. At roughly PLN 0.40 billion market cap against PLN 2 billion of revenue, the implied enterprise-value-to-sales below 0.2 is the valuation of a business the market has quietly written off, which is, of course, where recovery stories are supposed to start.

Beyond the four primaries, the nearshoring sub-sectors fan out: automotive rubber (Sanok Rubber, the closest GPW analog to a German Mittelstand sealing supplier, with its Draftex subsidiary giving direct OEM exposure to BMW, Mercedes, VW, Volvo, Ford, GM, and Fiat), furniture (Grupa Forte, 80 percent exports across 45 countries on an April-to-March fiscal year that complicates every comparison), construction chemicals (Selena FM, the Tytan and Quilosa brands with manufacturing across seven countries), and aftermarket auto distribution (Auto Partner, a different and more defensive cycle than OEM-tier-1 components because the aftermarket benefits from an aging European vehicle parc). Steel is represented by Cognor, although a 2025 net loss of PLN 125 million on Chinese dumping pressure weakens the near-term case considerably, and I would treat it as a thesis on hold rather than a thesis in motion. None of these secondaries is the single cleanest expression of the nearshoring trade on its own. Each adds a sub-sector lens you can weight however your read of the European industrial cycle suggests, which is the whole point of giving you the map instead of the destination.

Sector 3: defense-adjacent industrials

I have spent more research time on this sector than any other, and I am going to repay that by being honest that it is also the one where the listed-equity capture is narrowest relative to the spend. The PLN 1.2 trillion 2026-to-2030 procurement envelope (the national budget at 4.8 percent of GDP, roughly PLN 1.0 trillion over five years, plus the EU SAFE EUR 43.7 billion overlay) is the largest single Polish industrial program in modern history, six times the nuclear capex stack. And the listed slice of it is 7 to 11 percent. Keep that ratio front of mind, because the temptation in defense is to buy the headline and discover you bought a sliver.

The capture rates tell the whole story. Foreign primes take 50 to 60 percent: the K2s to Hyundai Rotem, the K9s to Hanwha, the Apaches to Boeing, the F-35s to Lockheed, the Patriots to RTX, the frigates to a PGZ-Babcock consortium, the submarines to Saab if Orka signs. Roughly USD 50 billion over five years flows to foreign-headquartered primes, and Polish listed equity captures essentially none of it directly, because the primes are foreign-listed or unlisted and the Polish content inside their contracts flows to PGZ subsidiaries and private subcontractors, not to anything you can buy. State-owned PGZ takes a further 20 to 30 percent, including the entire ammunition build-out and the indigenous platforms (HSW’s Krab and Borsuk), and PGZ is not listed and not investable. For listed Polish equity, PGZ is not the supply chain, it is the competition, which is a distinction worth sitting with before you get excited about any Polish ammunition name.

That competing-capacity point is the single biggest variable in the ammunition thesis, so let me make it concrete and slightly uncomfortable. Niewiadów’s planned 180,000 rounds a year of 155mm competes for the same Polish orders as PGZ Mesko (150,000 by 2028), PGZ Dezamet (100,000 expandable to 150,000), and the new PGZ-BAE joint facility announced in September 2025. Aggregate Polish 155mm nameplate by 2028 reaches 430,000 to 480,000 rounds a year. Polish demand at full SAFE-deployment scenarios runs 200,000 to 350,000. The 80,000-to-280,000-round surplus is deliberate, built for European export under SAFE-funded replenishment, but the export channel depends on European procurement decisions that are not yet signed. In other words, the capacity is being built on the assumption that Europe keeps buying shells at a wartime clip, and the day that assumption is questioned is the day the math gets ugly. Which is a preview of the bear case, and not an accident that it keeps surfacing.

Listed equity captures the residual 7 to 11 percent, PLN 80 to 130 billion cumulative, and it concentrates roughly 80 to 85 percent into two categories that are not the ammunition plays at all: dual-use infrastructure, where Budimex builds the NATO bases and hardened storage, and defense IT and cybersecurity, where Asseco supplies a long roster of NATO and EU institutions. The pure-play defense names (Niewiadów, Arlen, Lubawa, Wielton Defence, Zremb) split the remaining 15 to 20 percent, PLN 12 to 25 billion cumulative. So the listed defense trade is mostly a construction-and-software trade wearing camouflage, and the actual ammunition pure-plays are the small, exciting, dangerous tail.

The newest and most attention-worthy of those pure-plays is Niewiadów Polska Grupa Militarna (GNS), and the trade press has mostly mis-told its story, so here is the accurate version. The 21 April 2026 event was a transfer from NewConnect to the Main Market following a late-2025 reverse takeover, not a cash-raising IPO, a distinction worth getting right. The company is building two flagship lines: a 155mm artillery facility around three production lines of up to 60,000 rounds each, for a 180,000-round nameplate, targeting Q4 2026 serial production, with Northrop Grumman as strategic partner under a February 2026 framework agreement. The technology choice that matters is Austempered Ductile Iron rather than forged steel for the shell bodies, a cast-iron heat-treatment process that delivers comparable terminal performance at materially higher throughput and lower cost, which is precisely why Northrop wants a Polish partner: Northrop holds the process IP and the customer relationships, Niewiadów provides the European footprint and the Polish MOD relationship. Financial terms are undisclosed and the framework is not yet binding offtake. The 2026 qualification rounds (NATO STANAG ballistic and metallurgical validation) are the gating step, and the entire equity is a bet on them passing on schedule. If they pass, GNS becomes a meaningful European-market supplier through 2027-2028. If they slip past Q1 2027, Northrop has the optionality to take its European scope elsewhere, and the framework converts to a press release.

The second flagship is a 40mm grenade-ammunition facility under an exclusive ST Engineering license covering the Polish forces and twenty EU export markets, with PLN 67.4 million of investment, a 480,000-round nameplate, and a mid-2027 serial target. This leg is lower-risk than the 155mm because the ST Engineering rounds are already in service in multiple armies, so the execution risk is commercial (which of twenty markets actually prefer this pattern over Rheinmetall or Nammo) rather than qualification. The combined factory capex of roughly PLN 320 million is funded through a mix of bank debt, the balance sheet, and a post-EGM primary issuance, and the 2025 financials (PLN 70 million revenue, breakeven EBITDA, a modest loss on capex front-loading) are negligible against the 2026-2028 ramp the whole thing is built on. At full 180,000-round 155mm capacity and indicative pricing the bull case approaches PLN 3.9 billion of annual revenue; the bear case, with PGZ taking the bulk of Polish orders and European export capped by competing Northrop supply nodes, lands in the PLN 0.5 to 1.5 billion range. That is an enormous spread, and the entire spread sits on the qualification phase, which is why this is an option, not a position.

Lubawa (LBW) is the established defense-PPE incumbent, with a broad book across bulletproof vests, body armor, helmets, military tents, flood barriers, and fire-brigade equipment. The 9M 2025 result was revenue PLN 414.6 million (up 15.6 percent) but net profit of PLN 72.5 million (down 2.6 percent), the divergence telling you margins compressed as raw-material costs outran the company’s ability to pass them through. Key 2025 wins include PLN 115 million from the Armaments Agency for vests and a EUR 18 million NATO-country contract for anti-drone protective ponchos, the latter being the first export reference of size in a category growing on the back of drone proliferation. Ownership is Silver Hexarion at 47.65 percent, with the ultimate beneficial owner not transparently disclosed on the IR page, which is exactly the kind of governance fog that should weigh on how much you are willing to own of a company that makes armor for the Polish army. The investable question is whether SAFE-funded equipping generates enough volume to overwhelm the margin pressure, and the answer is not yet in.

Arlen (ARL) is the post-IPO protective-clothing specialist that pairs with Lubawa for the PPE layer, and it has had a rough first year as a public company. The June 2025 IPO priced at PLN 35.00 and popped 10 percent on debut; the shares have since retraced to around PLN 24 by mid-June 2026, roughly 31 percent below the IPO price, which is the market’s verdict on a year of waiting for the first full set of public results. 2024 revenue was PLN 461 million (up 26 percent) with 81.4 percent of sales from public-sector contracts (Armed Forces, Police, Border Guard, City Guards), the cleanest expression of “demand pull from Polish military spending” on the exchange. The structural support is the 50 percent Polish-domestic-content requirement on defense modernization funds, a hard floor under domiciled suppliers like Arlen. The bear case is direct competition with Lubawa, foreign competition from the German specialists with Polish MOD certifications, and a post-IPO lock-up overhang whose expiry the company has been coy about disclosing, which is its own small red flag.

Beyond these three the listed defense exposure shades into the cross-pillar names. Wielton Defence sits in the nearshoring section. Budimex captures the NATO base buildout I covered under nuclear. Asseco is the dominant defense-IT supplier, covered next. Zremb-Chojnice is a genuine micro-cap with 80 percent of contracts to armed-forces customers and a NATO serial contract, but the absolute scale is too small for most readers to bother. The structural shape to hold in your head is that a very large pie is sliced into a narrow listed exposure concentrated in a handful of names, each with a specific risk profile, and the cleanest summary is that PLN 80 to 130 billion of listed-addressable defense revenue, divided across Budimex, Asseco, Niewiadów, Arlen, Lubawa, and the satellites, is genuinely large relative to today’s market caps. The Budimex defense contribution alone, at the midpoint, is roughly twice the company’s current market cap. The asymmetry is real. So is the execution-and-political-risk discount the market slaps on it, and the bear case will give that discount its due.

Sector 4: CEE IT services

If defense is the largest single program, CEE IT is the sector that quietly stacks three structural drivers on top of one another: digitalization (the corporate and public-sector software-replacement cycle plus AI integration), regulatory compliance (the NIS2 cybersecurity directive, KPO digital funding, the SAFE cyber allocation), and defense IT (NATO institutional procurement plus Polish MOD digital scope). Any one of those is a sector-defensible thesis on its own. The three running concurrently is the setup for compounding revenue above GDP rates through 2030, and the reason IT earns its own chapter rather than a footnote in nearshoring.

Size the demand pool and the stacking becomes obvious. The Polish IT services and software market was roughly USD 19.5 billion in 2025, projected toward USD 40.6 billion by 2034 at an 8.5 percent CAGR, on a specialist labor base north of 525,000 people. Onto that organic growth, stack NIS2, transposed into Polish law via UKSC effective 3 April 2026, mandating cybersecurity uplift across critical-infrastructure operators with associated spend estimated at PLN 20 billion through the National Cybersecurity Fund. Stack the SAFE cyber allocation of PLN 5.1 billion. Stack the KPO digitalization scope, another PLN 10 billion-plus across public administration, healthcare e-records, energy SCADA, and rail signaling. The combined regulatory-and-defense-funded pool is roughly PLN 35 to 40 billion through 2030, sitting on top of the structural commercial-IT compounding, and the names with credentialed access to all three pools at once are rare and therefore valuable.

Asseco Poland (ACP) is the sector anchor and the macro proxy for the listed Polish IT universe. 2025 revenue was PLN 16.78 billion (up 11.7 percent); reported net profit was PLN 1.14 billion (up 119 percent), and that 119 percent is the kind of number that grabs eyeballs and, candidly, misleads. The 2025 profit was inflated by a roughly PLN 499 million one-off gain on the December 2025 Sapiens divestment; strip it out and continuing-operations growth was something more like 30 to 50 percent, still strong but a very different animal, with 2026 carrying roughly PLN 2 billion less revenue and PLN 350 million less operating profit than a Sapiens-consolidated comparison. The Q1 2026 preliminary print (revenue PLN 4.40 billion, EBITDA PLN 695 million, net profit PLN 228 million) suggests the post-Sapiens continuing business is tracking around 17 percent underlying organic growth, above the historical 12 percent pace, which is the number that actually matters. Of the PLN 16.78 billion, roughly PLN 12.6 billion is proprietary software, the 75 percent proprietary share being the moat indicator.

There is a second governance change at Asseco that got less press than it deserved. In early 2025, Cyfrowy Polsat (the Solorz-Żak vehicle that had been the largest holder) sold out, replaced by the Dutch-domiciled TSS vehicle at 24.84 percent, which then signed a shareholder agreement with the Adam Góral Family Foundation aligning the vote, with founder Góral staying on as CEO. It is the most significant structural change at the company since the 2007 listing, and the consensus read is shareholder-friendly: the treasury-share monetization handed Asseco fresh balance-sheet capacity that helped fund thirteen acquisitions in 2025, and TSS brings CEE-technology depth without disrupting Góral’s operational continuity. A new dominant shareholder is always a new set of incentives, so I am keeping a hand on it, but the early evidence is benign. And the defense-IT footprint (command-and-control, cybersecurity, and digital libraries for NATO bodies like the Bydgoszcz training centre and the NATO Communications and Information Agency, plus EU clients Frontex, ESA, and EDA) puts Asseco in line for a real share of both the SAFE cyber allocation and the broader PLN 20-to-35 billion Polish defense-IT pool, even if the company maddeningly declines to break the number out.

Subscribe now

Text S.A. (TXT), the company formerly known as LiveChat Software (and still tagged with the stale LVC ticker in plenty of databases), is the highest-margin Polish-listed SaaS pure-play and the cleanest single piece of attention-desert mispricing I have found anywhere. Trailing-twelve-month metrics as of mid-June 2026: revenue PLN 338 million, EBITDA PLN 145 million for a 42.8 percent margin (compressed from a 57 percent peak but still exceptional), free cash flow PLN 84 million, and a net-cash balance sheet (cash PLN 53 million against debt PLN 4 million). Market cap around PLN 1.03 billion at a roughly PLN 40 share price, trailing P/E about 8.3, customer base 30,000-plus paying across 150-plus countries, product portfolio spanning the flagship LiveChat widget, HelpDesk, ChatBot, KnowledgeBase, and the AI Copilot launched alongside the 2023 rebrand. Read those numbers again and remember the company is Polish-listed, because the numbers themselves are a global SaaS business.

The valuation discount at TXT is the textbook case. Comparable global SaaS names (Salesforce Service Cloud, Zendesk, Intercom, HubSpot Service Hub) trade at 15 to 30 times forward EV/EBITDA; Text trades around 6. The bear case is coherent and I will not pretend otherwise: the margin compression from 57 to 42.8 percent could be structural rather than an investment cycle, as AI-native competitors and hyperscaler bundling (Microsoft Dynamics Copilot, the cloud platforms’ own messaging stacks) erode standalone customer-engagement software over a multi-year horizon, in which case the cheap multiple is cheap for a reason and the market is reading the strategy correctly. The bull case is that a 42.8 percent margin is still extraordinary, that AI Copilot becomes a workflow-embedding product rather than a commoditized feature, and that even a partial re-rating toward the bottom of the peer range, nowhere near the top, is a large move from here. The single number that adjudicates between the two is the margin trajectory in the next couple of prints. Watch it like a hawk.

Vercom (VRC) is the highest-growth Polish-listed SaaS name, a different equity profile from Text despite the shared label. 2025 gross profit was PLN 255 million (up 15 percent), adjusted EBITDA PLN 136 million (up 23 percent), net income PLN 99 million (up 29 percent). The SaaS-quality metrics are the draw: a 116 percent net expansion rate (existing customers growing spend 16 percent a year), record net customer adds, and a stated 2028 EBITDA target of PLN 300 million implying roughly 30 percent compounding. The product is CPaaS infrastructure (email, SMS, push, WhatsApp Business messaging) under the Emaillabs, RedLink, and FreshMail brands, competing against the global giants (Twilio, Bird, Sinch) with CEE cost positioning and GDPR-native data residency as the structural edge. At a market cap around PLN 2.55 billion, a trailing P/E near 28, and EV/EBITDA around 20, the equity is priced for the growth to deliver, which is the whole tension: if Vercom hits the 2028 target, today’s valuation is roughly 8.5 times that future EBITDA and looks cheap in hindsight; if growth decelerates, a 20-times multiple compresses fast and unpleasantly. A real compounder, priced like one, to be owned with discipline rather than enthusiasm.

And Comarch, the obvious mid-cap peer to Asseco that would have been a fifth name in this section, was delisted from the GPW on 26 March 2025 after CVC Capital Partners’ PLN 1.75 billion tender for 64.74 percent. The founder Janusz Filipiak died in December 2023; CVC executed an opportunistic take-private that closed in early 2025; CGI then bought Comarch Polska from CVC in October 2025. And the Comarch story is not a footnote, it is the attention-desert thesis caught in the act. The pattern was textbook: a quality Polish mid-cap at a structural discount to global peers, a family-controlled block, a trigger event (the founder’s death), and a PE buyer with CEE-technology appetite. CVC paid a 30-to-50-percent premium to a market cap that was itself already a 30-to-50-percent discount to global IT peers, which means it arbitraged the listed-public discount into a private-control premium and walked off with a quality asset at a price that was attractive on a global benchmark and a steal relative to where the thing would trade if Poland were a Developed market. Every take-private like that tightens the scarcity premium on the survivors (Asseco and its listed subsidiaries, Sygnity, Atende, Talex, Text, Vercom) and simultaneously chips away at the MSCI-reclassification ambition by shrinking the eligible universe. Both effects are real, and they operate at the same time, which is the kind of contradiction this market specializes in.

The reader’s frameworks

I have now handed you four pillars, four sectors, and roughly two dozen names, and I have, by design, refused to tell you which to buy.

What I owe you instead is the thing that actually changes your behavior: a framework for screening these names yourself, plus the practical mechanics of researching a company when the primary sources are in Polish.

This is the most directly useful part of the piece, because nothing in the previous sections will move your portfolio without it.

The screening framework is seven filters plus a bonus, applied roughly in order.

1. Filter one is pillar applicability: does the name credibly map to at least one of the four pillars? If not, it may be a perfectly good equity, but it is not what this thesis is about, and the discipline of saying so keeps you out of the long tail of Polish names that have no structural tailwind at all.

2. Filter two is disclosure quality and reporting cadence: does the company run English-language IR with timely quarterly translation? The strong-IR names (Asseco, Budimex, MLP, Kęty) are far easier to live with than the Polish-only filers, and this is a weight on your time, not a hard gate.

3. Filter three is ownership structure and free float, because Polish ownership concentrates into a handful of recurring patterns (state-utility concert, foreign strategic parent, founder-family control, diversified float, PE-headed-for-the-exit) and each carries a different deal for minorities.

4. Filter four is liquidity, and in this market it is not a footnote, it is a hard constraint. Three-month average daily volume in złoty is the test, and the candidate set runs from PLN 25-to-40 million at the liquid end (Asseco, Budimex) to under PLN 1 million at the thin end (Mostostal Warszawa, Amica, Wielton, MLP on a quiet day). Position-building should not exceed roughly 20 percent of 30-day volume without expecting to shove the price against yourself, and a total holding you cannot exit inside five to ten trading days is, functionally, sized as if it could go to zero.

5. Filter five is state-ownership and political-economy overhang, weighed against the tailwind it enables.

6. Filter six is execution-stage and ramp visibility: a pre-revenue capacity build like Niewiadów asks for a patience a steady compounder like Kęty does not.

7. Filter seven is bear-case proportionality: large positions only in names whose bear case is bounded.

8. And the bonus filter is cross-pillar exposure, because names with credible multi-pillar revenue (Budimex, Polimex, Wielton, Asseco) carry lower thesis-failure correlation than single-pillar pure-plays, and lower correlation is worth paying for.

Now the language-barrier workaround, the genuinely useful bit, because this is the question new readers most want answered and most are too polite to ask. The process sorts into four tiers of source.

1. Tier one is primary: GPW filings at gpw.pl, KNF regulatory disclosures, the corporate IR pages of the larger names (Asseco, Budimex, Kęty, MLP run credible English mirrors), and Biznes PAP for current-report headlines you can skim even in Polish.

2. Tier two is the Polish financial press, read through translation: StockWatch.pl, Bankier.pl, Parkiet.com, BiznesRadar.pl, and WNP.pl for industrial sectors, with Notes From Poland as an English-native source for policy and political context.

3. Tier three is English trade press: MILMAG and Defence Industry Europe for defense, World Nuclear News and NUCNET for nuclear, Property Forum for real estate, trans.info for logistics.

4. Tier four is the aggregators (Investing.com, MarketScreener, Simply Wall St, Stock Analysis) plus a basic market-data feed.

The tooling is mundane and that is the point: Google Translate as a browser plugin handles headline-and-key-fact reading fine, DeepL handles management-commentary nuance better, and an hour spent building your own glossary of fifty to a hundred recurring terms (przychody is revenue, zysk netto is net profit, akcjonariat is shareholders, wolny float is free float) pays for itself within a week. The realistic time cost is thirty to sixty minutes per company for an initial dossier and fifteen to thirty minutes per quarterly update, with translation adding maybe 20 to 30 percent of overhead versus comparable Western European research. That overhead is the moat. It is also the part you can defeat with patience and a translation tab, which is the entire answer to the obvious objection of “if this is so good, why has nobody arbitraged it.” Nobody has arbitraged it because arbitraging it is mildly annoying, and mild annoyance, at scale, is one of the most durable sources of edge in all of investing.

The bear case (the part you should not skip)

A thesis that refuses to engage its bear case is not a thesis, it is a pitch deck. So here are eleven specific risks, steel-manned, presented in the strongest version of the bear argument before any comforting context. If you read this section carefully and the discount still looks justified to you, then you have done the work and you should pass, with my blessing. If it does not, you have found the scenarios to price into your sizing. Either outcome is a win. The only failure mode is reading the bear case as a checklist of things to dismiss on your way to buying, which is what most people do, which is part of why the opportunity exists.

The currency floats, runs 5 to 10 percent annual volatility against the euro in calm years and a great deal more in stress (it fell roughly 25 percent against the euro between February and October 2022, then clawed back 18 percent by mid-2023, and those are recent memories, not ancient history).

For a euro-based investor, your Polish equity is a leveraged bet on the local-currency performance plus the direction of PLN/EUR, and a year of 15 percent local gains paired with a 15 percent currency loss is a round trip to nowhere.

The scenarios that produce that are not exotic: Polish fiscal stress, EU funding disputes, NBP cutting deeper than the ECB, election uncertainty, regional contagion. Institutions can hedge with PLN forwards for 50 to 150 basis points a year. Retail mostly cannot hedge at all. Anyone holding these names in euros is implicitly long the złoty whether they meant to be or not, and that implicit position is never free.

Then state-ownership overhang, which international investors underrate because they file “state-controlled” as a known discount rather than a live operational constraint. The PXM four-utility concert is the case study: PGE, Enea, Energa, and Orlen Technologie control 63.48 percent, they are simultaneously PXM’s customers, and PGE’s subsidiary PEJ is the single largest customer for the next decade. Procurement can be politically routed, dividend policy can favor the utility balance sheets, intra-group service pricing can be set for the utility side, and executive pay gets approved by a board the four effectively control, all while the 37 percent free float is strapped into the back seat. A reader genuinely uncomfortable with that should simply pass, because the minority-governance discount is not obviously wide enough to pay you for it.

Governance and minority rights run roughly one standard deviation weaker than Northern European or UK norms, and the consequences are concrete, not theoretical. KNF enforcement is credible but slow, often 24 to 36 months where the SEC or FCA would take 6 to 12. Minority class actions are limited and activism is rare. Polish law tolerates a wider range of related-party transactions and asymmetric structures than a DAX or FTSE name. The specific examples in this very piece are not edge cases: Silver Hexarion’s 47.65 percent of Lubawa with an undisclosed ultimate owner, Acciona’s intra-group loan at Mostostal Warszawa, the Lubińska 72 percent concentration at Niewiadów that makes the founder’s individual decisions on capital allocation and exit timing dictate your outcome more than at any Western peer of comparable size. If you expect Stockholm governance, pass. The structural alpha is not a free lunch, it is a paid lunch where the bill arrives in scenarios you should model in advance.

Liquidity in the thin names is genuinely dangerous in dislocations in ways a comfortable bull-market backtest will never show you. Polish small-caps took 30 to 50 percent of additional drawdown beyond fundamental moves in March 2020, February 2022, and October 2023, because forced sellers found no natural buyers and price discovery simply stopped working for days or weeks. The recovery is not guaranteed and not symmetric: the names that crashed 50 percent in a liquidity event mostly recovered, but names that crash in a recession-driven dislocation can stay buried for 18 to 36 months. The discipline is hard size caps (total holding under five times daily volume), which is structurally limiting for institutional sizing across most of the thin set, and which you should treat as a feature of the asset class rather than an inconvenience to be ignored.

Political risk is two-headed and both heads bite. Domestically there is the 2027 presidential election, the 2025-2027 fiscal tightening forcing trade-offs between defense, nuclear, infrastructure, and social spending, and a PiS-PO alternation history that should stop anyone from assuming the current alignment is permanent. Internationally it is dominated by Russia-Ukraine, and the May 2026 episode was the live demonstration: on 13 May the US ordered a 4,000-troop rotation to Poland cancelled, on 22 May President Trump reversed it and added 5,000, and the volatility itself is the risk, because asset prices had quietly assumed US-NATO alignment as a constant and the market learned in nine days that it is a variable. EU-Poland fiscal relations affect KPO disbursement, SAFE drawdown velocity, and CPK financing, and a re-freeze on rule-of-law grounds would compress several tailwinds at once.

PE delisting risk is the Comarch lesson, and it is more uncomfortable the longer you sit with it. CVC paid a 30-to-50-percent premium to a price that was already a 30-to-50-percent discount to global peers, which from CVC’s seat was still a bargain, and from the minority’s seat converted a discounted, long-duration compounding position into a single cash payment that ended any participation in the structural re-rating that MSCI Developed would eventually deliver. The pattern is reproducible wherever there is a founder-or-family block and a trigger: Niewiadów at 72 percent, Lubawa at an opaque 47.65 percent, the smaller IT names with founder concentrations. A realistic estimate is a 20-to-40-percent probability of a take-private for any single concentrated name over five years, and the genuinely unpleasant part is that it can be a loss dressed as a win, trading your long compounding wedge for a one-time premium and missing the 100-to-300-percent re-rate that the names which stay listed eventually capture.

Tier-2 capture risk is the structural ceiling on every name whose revenue hangs on a foreign prime’s strategic choice. Niewiadów depends on Northrop keeping its European emphasis. The Mostostal subsidiaries depend on the Westinghouse-Bechtel EPC routing balance-of-plant through Polish-accessible channels. Asseco’s NATO-institutional revenue depends on those buyers continuing to prefer its stack over Lockheed, Leonardo, Thales, or Indra. A realistic haircut to tier-2 revenue projections for this strategic-choice uncertainty is 25 to 40 percent versus what the companies communicate, which is a good deal wider than the market currently applies, and the discipline is to apply it yourself before you fall in love with a target.

Ukraine endgame compression is the single most important risk across the entire thesis, not just the defense pillar, and most readers will reflexively wave it away, so let me steel-man it properly. The base rate is brutal. Nearly every major post-1945 European conflict was followed within three to five years by a settlement that let defense budgets compress hard, and the 1990s peace dividend cut German spending from 2.8 percent of GDP in 1989 to 1.3 percent by 2005. A negotiated Russia-Ukraine settlement in 2027 or 2028 could compress Polish defense spending from 4.8 percent of GDP back toward 2.5 to 3.0 percent over a few budget cycles, a 35-to-50-percent cut in the envelope, normalizing ammunition demand from a 200,000-to-350,000-round wartime-recovery scenario toward a 75,000-to-125,000-round peacetime baseline, into which four producers with 430,000-to-480,000 rounds of capacity would compete. Niewiadów’s bull case would collapse to a fraction. Worse, the equity reaction precedes the budget reality by twelve to eighteen months: the day a credible ceasefire is announced, the defense names compress 30 to 50 percent in a handful of sessions as the urgency premium evaporates, long before a single budget line actually shrinks. I put the probability of meaningful de-escalation over five years somewhere in the 35-to-55-percent range, and even the low end implies a 15-to-30-percent expected-value discount on bull-case defense revenue. That discount is the difference between the defense pillar being the strongest of the four and being, on a risk-adjusted basis, the weakest.

EU SAFE disbursement timing is the operational drag even if Ukraine never de-escalates. The EU has never managed defense-loan drawdowns at this scale, and the EUR 6.5 billion advance was the easy part; the remaining roughly EUR 37 billion disburses on conditionality with no precedent (procurement-plan validation, contract awards, milestone delivery). A 20-to-30-percent timing slip would compress supplier revenue ramps by 10 to 20 percent on the equivalent timeline, and for working-capital-intensive suppliers running thin margins (Polimex, Budimex, Niewiadów, Asseco) timing risk amplifies into liquidity stress and possible dilution if a disbursement gap forces supplementary financing.

Polish fiscal headroom is the deepest macro risk, the one that could trip every pillar at once. National debt to GDP was roughly 53 to 55 percent at end-2025, within EU thresholds but climbing about two points a year, against a 2026 budget carrying record defense spend, the PLN 60.2 billion nuclear commitment, continued CPK investment, and contingent SAFE liabilities. A Polish fiscal crisis in 2027 or 2028 (lower-probability but not negligible) would trigger across-the-board procurement compression, with the currency and the sovereign-bond market as the immediate canaries: a 100-to-150-basis-point widening in 10-year Polish yields, or a 10-to-15-percent PLN move, would presage equity stress the whole small-cap universe would feel in compounded form. Polish small-caps are, in the end, leveraged bets on Polish sovereign credit and currency strength, not just on the businesses underneath.

MSCI reclassification delivery is the catalyst the bull case leans on and among the most uncertain items in the bear case. The October 2025 ambition for Developed reclassification within three to five years would close most of the mispricing by opening these names to the entire MSCI Europe small-cap universe. But the criteria include a free-float-adjusted cumulative market cap that the Comarch-style delistings are pushing the wrong way, and English-disclosure quality, MSCI’s own stated concern, remains uneven across the broader universe. If reclassification slips from three-to-five years toward five-to-ten, the discount persists longer, which is paradoxically fine for an accumulator and bad only for someone whose return model assumed the re-rate on schedule. If it never arrives, the bull case narrows to whether individual operating fundamentals justify positions absent the multiple expansion, a much narrower question that far fewer names pass.

That is the bear case, steel-manned and not gutted. None of it is fatal on its own. Several in combination would be. This entire piece rests on the bet that the eleven risks priced collectively into Polish small-caps are larger than their likelihood-weighted impact across the four pillars taken together, and the structural alpha lives precisely in that gap. The currency, governance, liquidity, and political risks are real and grinding. The Ukraine endgame, the PE delistings, and the MSCI timeline are real and binary. If you read all that and conclude the discount is earned, you are entitled to the view, and I would rather you reach it honestly than buy on my say-so. The gap between priced-in pessimism and actual outcome is where every alpha thesis lives or dies, and the bear case is just the honest inventory of the ways that gap could close against you.

My Value Ramblings

So where does this leave a reader who has made it all the way down here. Let me try to be useful rather than gnomic, which is the least I can do given how long I have kept you.

The Polish small-cap thesis is not for everyone, and I would be doing you a disservice to pretend otherwise. It asks for patience, for translation overhead, for comfort with concentrated ownership structures and minority rights you would never accept in Stockholm or Amsterdam. It asks you to take on currency risk and political risk that simply do not exist in the same concentration on a Siemens or a Daimler. It asks you to accept that the catalyst for re-rating, MSCI Developed reclassification and the foreign flows that follow it, is multi-year and genuinely uncertain. If any of those is a dealbreaker for you, this is a dealbreaker, and that is a perfectly respectable place to land.

Share

What it offers in return is the one thing that has become genuinely rare in 2026 European equity markets: a real structural mispricing sitting on top of a real industrial program. Most large European equities now trade in efficient information environments, thirty analysts to a name and price discovery measured in milliseconds, where forming a contrarian view earns you precisely nothing because everyone already holds it. Polish small-caps trade in an information environment that looks like Western European mid-caps circa 1995, before the coverage collapse, before passive flows ate the marginal buyer, back when researching a company and forming an independent opinion could actually move your returns relative to the crowd. The opportunity is not that any single Polish small-cap is mispriced. It is that the entire price-discovery mechanism is running at lower fidelity than it does for the peers across the border, and that lower fidelity is the room you get to operate in. Edge, in the end, is just other people not bothering, and here a great many people are not bothering at once.

The boring possibility, the one almost nobody is pricing, is that Poland in 2030 turns out to be roughly what Germany was in 1990: the structurally important industrial economy of a regional integration project, with a listed-equity market that has graduated into the developed-market index and a small-cap universe trading at compressed discounts to its own history.

I do not think that is the modal outcome, and I am not going to insult you by pretending I do. I think it is plausible enough, on a five-to-ten-year horizon, to justify building the research process now, with the translation tab open and the Polish financial-press feeds configured, even if you do not size a single position for another year. The reader who builds the process during the discount is the reader who is ready when the catalysts arrive, and the catalysts, by their nature, do not send a save-the-date.

There is one name worth saying out loud, not as a recommendation but as a structural reference point, because it marks an inflection. The Niewiadów Polska Grupa Militarna step-up to the GPW Main Market on 21 April 2026 is, I think, the moment the listed Polish defense universe changed shape. Before that date, Polish defense was a state-owned story with no listed pure-play on the European ammunition surge. After it, there is a listed vehicle with Northrop Grumman framework backing, an exclusive ST Engineering license on the 40mm side, and a clear capacity-ramp path through 2027-2028. Whether the equity is fairly priced around PLN 14 to 15, where it sits as I write this, is entirely a question for your own work, and the qualification rounds are the thing that will answer it. The development worth marking is not the price. It is that the European ammunition-replenishment cycle can now be expressed in listed-equity terms at all, where six months ago it could not.

The piece you have just read is free, and free is doing exactly what it is supposed to do. You now have the macro thesis, the sector map, the screening framework, and the names worth your own research, in enough depth to decide whether you want to do the work to research them properly. The paid tier is where the model-portfolio sizing lives, the probability-weighted fair values per name, the buy levels, the conviction ranking, and the quarterly position updates. If you found the framework useful and want the specificity, that is what the subscription buys. If you found it useful and would rather do your own work from here, that is also a completely fine outcome, and I am genuinely glad to have given you a running start.

I will close with what is probably the most honest sentence in the whole piece. I cannot tell you with confidence that Poland is the next decade’s structural compounding equity story. I can tell you that the conditions look more like a structural opportunity than I have seen in any other European national market in years, and that the discount is widest precisely where the work is hardest. Whether you act on that, and how, is your call and yours alone. My job is only to point at where the boring possibilities are hiding, and they are almost always hiding in the same place: the dusty corner of the market where the language is hard, the analysts are few, and the headline writers, bless them, are looking somewhere else entirely.

Poland is one of those corners. The free article is over. The research is your own.

That is the thesis, taught in full and for free, because the teaching is the part I believe everyone should have.

Everything above this line was the why. Everything below it is the what, and the what is the part I would not give away, because it is the part that took the work. Below the break is the version of this research with money actually on it: the eleven-name model basket, with the weight I would put on each name and the reason; a bull, base, and bear fair value for every one of them; the four specific conditions that would make me sell; and the catalyst calendar I am actually watching, most of it reported first in Polish, which is the whole reason we are early.

Here is the honest pitch, because you have earned an honest one. The reason this opportunity exists at all is that reading Polish small-caps is mildly annoying, and mild annoyance, at scale, is one of the most durable edges in all of investing. You can do that reading yourself, and the free half above is a real map for doing exactly that. Or you can have the work already done, updated to this week’s close, and sized, for less than the cost of the translation overhead on a single name. One idea from the basket that works pays for the subscription many times over. None of it is a promise. All of it is one investor showing his actual homework, and the bear case below runs as long as the bull case on purpose.

If you have read this far, you are not a tourist. You are the reader this was written for.

The rest is one click away.

Read more

Here is what “this one” is. Over the last stretch, I have compiled (and currently doing final edits before I publish) a long free deep-dive that taught the Poland thesis (the four pillars, the sectors, the screening framework, the bear case) and named companies only as starting points for your own work. Alongside it went the paid members’ note, which stopped teaching and actually ranked the names, sized a basket, and gave fair-value ranges.

This report is the thing underneath both of them. It is the institutional-grade build, the version with all the workings showing, the one I would hand to a professional who wanted to tear the thesis apart and could not find a polite way to ask for the spreadsheet.

It runs to thirty-nine pages, and the table of contents is the honest advertisement. The four macro pillars with their current data. The sector economics with the worked supply-chain math, including the part where I show you that the Polish nuclear and defense programs are enormous and the listed-equity slice of each is a sliver, which is the single most important framing in the whole document. A full dossier on every name in the basket, each with a current data snapshot, a bull, base, and bear valuation, and the actual probability I attach to each scenario, because a fair value with no probability behind it is just a number wearing a confident expression. The model basket constructed in full, with the pillar caps and the liquidity discipline that drive the weights. The complete eleven-risk bear case, steel-manned rather than tokenized, including the one risk I think most readers will be most tempted to wave away and absolutely should not. A scenario analysis of what happens to the book if a pillar fails. An eighteen-month catalyst calendar. And a data appendix behind every figure I quote, so you can check my arithmetic, which you should, because I do so and so should you.

All of the prices and multiples were struck at the 12 June close, so the document is current as you read it, not as I wrote it three months ago.

A word on how to actually use it, because a report this long can be read the wrong way.

Do not treat the fair-value ranges as targets handed down from a mountain.

They are scenario estimates I built from the research, and they carry every ounce of the uncertainty that implies, which is rather a lot. The most valuable section is not the one with the upside numbers, it is the bear case, and the most valuable habit you can bring to it is to read that section looking for the scenario that makes you put the report down rather than the one that makes you reach for the buy button. If you finish the bear case and still think the discount is unjustified, you have done the work. If you finish it and decide the discount is earned, you have also done the work, and you have saved yourself from a thesis that was not for you. Either way you win. The only way to lose is to skim the risks on your way to the conclusion you already wanted.

Two housekeeping notes.

First, this is education and analysis, not personalized advice, and the full disclosures live in Appendix E of the report itself, which I would genuinely rather you read than skip.

Second, the deal: paid members get this report in about a month. You have it today. That gap is not an accident, it is the entire point of being a founding member, and it is the least I can do for the people who funded the search before the search had found anything.

Read more

Back in March, when American destroyers were exchanging fire with Iranian fast boats in the Strait of Hormuz and the Fear Gauge was pinned at 82, I kept pointing at the one indicator that refused to behave. Gold, the safe haven of last resort, the asset that is supposed to scream when the world catches fire, sat there and whispered. I called it the Dog That Didn’t Bark, and I told you it was the single most important signal of the whole crisis, because it meant the market had not actually repriced for the world it now lived in. The gap between what the prices were saying and what the headlines were screaming was where careful money would find its edge.

This week the silence finally ended. The dog did not start barking. Someone took it out back. Gold sank to a six-month low and is now set for its worst quarter in almost a decade, and the whole street has decided, all at once and on the same afternoon, that the burglar has gone home. The crisis trade is being unwound in a single violent rush. And the institution best placed to backstop a relapse, the European Central Bank, chose this exact week to seal one of the exits behind it.

That is the story, and it is a more dangerous one than the benign gauge readings let on.

At a Glance

Sentiment Gauge: -1.4 🟡 (Slightly Bearish) | Fear Gauge: 40/100 🟢 (Calm) Previous week: Sentiment -3.0, Fear 42

Both needles eased toward calm this week, and at the surface that looks like good news. The Fear Gauge slipped back under the Cautious line into Calm for the first time since late May, and press sentiment lifted more than a point and a half off last week’s relapse. But the divergence I usually flag between the two gauges has not gone away this week. It has moved inside each one. Read the Sentiment Gauge’s components and you find a tug of war: a roaring +3 on Geopolitical Risk and a +2 on Capital Flows sitting directly on top of a brutal -4 on monetary policy and a -3 on consumer confidence. Read the Fear Gauge the same way and the pattern repeats: the composite is calm only because Safe-Haven Demand has collapsed to 3 out of 100 and equity momentum has surged, while two components, the VIX and EUR/USD, are still flashing amber at 75. In other words, the calm is borrowed. It is being manufactured by the very unwind that should worry us, not by anything actually being fixed. We will take both gauges apart properly below the line.

Share

The Fifteen-Week Arc

For new readers, and as the weekly memory check for the rest of us, here is where the two gauges have travelled since the Iran-Hormuz crisis began in early March.

Fear Gauge: 82 → 83 → 79 → 80 → 70 → 46 → 43 → 45 → 35 → 51 → 56 → 55 → 39 → 42 → 40

Sentiment Gauge: -5.0 → -4.3 → -5.2 → -5.8 → -4.7 → -3.2 → -3.6 → -4.5 → -3.1 → -1.2 → -4.0 → -2.5 → +0.7 → -3.0 → -1.4

Read those two lines slowly, because the shape of them is the whole thesis. The Fear Gauge is now 42 points off its March peak and has settled into a band in the high thirties to mid fifties for two months, oscillating rather than trending. The Sentiment Gauge has done something more interesting: it has whipsawed violently from one week to the next, lurching from +0.7 two weeks ago to -3.0 last week to -1.4 now. That is not the signature of a market forming a considered view. It is the signature of a market reacting to headlines it cannot weight, swinging on every Trump social media post and every central banker’s aside.

The three theses I have been building through this arc are all still live, and two of them resolved in dramatic fashion this week. The Fragmentation Thesis (Week 1), that the post-1990 globalization settlement is breaking into blocs, kept compounding quietly behind the Iran headline. The Broken Safe-Haven Mechanism (Week 3), the dog that would not bark, did not heal this week, it inverted. And the Three Trigger Conditions I laid out in Week 1 saw their first genuine movement in over a month. More on all three below, where they belong, behind the paywall.

The Week in Context

This was a week of two headlines colliding, and the collision is the entire reason the gauges look the way they do.

The first headline was geopolitical relief. President Trump pulled back threatened military strikes on Iran after vowing days earlier to hit the country “VERY HARD” and threatening to seize its oil infrastructure, and he now insists a deal is close, possibly within days. Markets did what markets do with that kind of news. Asian and European stocks rallied, oil extended its decline from the $150-plus territory it had threatened, and copper and mining stocks surged on the prospect of normalized trade flows. The catch, and it is a large one, is that Iran has not confirmed anything. A Chatham House analyst put it about as bluntly as these things get, noting that both Iran and the United States will claim any memorandum of understanding as a win regardless of what it actually contains. The market has priced a resolution. It has not been handed one.

The second headline ran in precisely the opposite direction. The ECB raised interest rates for the first time since September 2023, becoming the first major central bank in the world to react to the Middle East energy shock with monetary policy. This is the June hike I first flagged as a hawkish pivot back in April, and now it has arrived. What matters is the character of it. This was not a hike into strength. It was a defensive move against imported, energy-driven inflation, delivered into an economy that is already soft. Governing Council member Joachim Nagel made clear the bank is prepared to hike again in July if the war shock demands it, while Slovenia’s Primož Dolenc called the move “just enough for now” and said it was needed to keep prices in check. So here is the unusual configuration: the ECB has tightened to fight energy inflation in the very same week that the geopolitical cause of that energy inflation started, possibly, to resolve itself.

Underneath those two headlines, the structural picture stayed exactly as uncomfortable as it has been. Portugal triggered the EU budget safeguard clause over energy crisis costs, the fiscal equivalent of a country reaching for the emergency cord, and notably it did so using the same mechanism the bloc deployed for defense. The automotive sector kept retreating into the bunker, with Renault joining VW and Stellantis in pushing a “Made in Europe” protection plan against Chinese competition. And in the most telling reversal of the week, European defense stocks, one of the biggest equity trades of the last few years, went sharply into reverse on funding concerns. The party trade of the war is over before the war is.

Then there was the circus in the middle of it all. SpaceX raised $75 billion in the largest flotation in history, and the AI public-market floodgates duly opened. I mention it here not because a giant American rocket company is in our wheelhouse (it emphatically is not), but because the IPO is one of the reasons gold cratered. Capital was vacuumed out of defensive assets and into the year’s marquee growth story. When you see gold’s worst quarter in a decade explained partly by a rocket IPO and partly by expectations of US rate rises rather than by any actual peace, you should be very careful about reading the gold move as a verdict on the war. It is a flow story dressed up as a fundamental one.

So the way I see it, this is not an all-clear. It is a market that has talked itself into a resolution that has not been signed, while its central bank has spent ammunition fighting a fire that may be going out on its own. That combination, optimism on the tape and tightening in the policy, is the cross-current that defines the week, and it is the lens through which everything below the line should be read.

The free read above tells you what happened and why the gauges moved. Everything that follows tells you what to do about it: the full five-dimension sentiment breakdown, the Fear Gauge component autopsy, the central-bank divergence and what it does to small-cap industrials, the Sector Spotlight on the defense reversal, four contrarian signals, two forward-looking sectors I am adding to the watch list, and the trigger scorecard for Founding Members.

I do not run a buy-this-now operation, and I never will. What I run is a discipline: I tell you when the crowd is wrong about the price of risk, and I show my work. This week the crowd has thrown away its insurance on the same afternoon the central bank tied its own hands. If you want to understand why that is an opportunity rather than a comfort, the rest of this letter is for you. A year of it costs less than a single bad trade made in a week like this one.

Read more